World Health Summit Berlin, Germany October 11–13, 2015

Science · Innovation · Policies

World Health Summit B ERLIN, GERMANY OCTO BER 11–13, 2015

Federal Foreign Office | BERLIN SUMMIT VENUE

Europasaal WORLD HEALTH SUMMIT tartup Pitches BERLIN, GERMANY Center Oce Speaker S tartup Media Europa-Foyer OCTO BER 11–13, 2015 S Presentation Willy-Brandt-Saal

Jungfernbrücke Unterwasserstraße Registration Adenauer-Saal

Stresemann-Saal

Rathenau-Saal Lounge

VENUE: Presidential Federal Foreign Oce Weltsaal

Werderscher Markt 1 M 8 10117 Berlin Lounge ENTRANCE: Unterwasserstraße 10 Area I nterview

Bag Counter 4 PROGRAM OVERVIEW PROGRAM OVERVIEW 5

SUNDAY | OCTOBER 11, 2015 MONDAY | OCTOBER 12, 2015

PLENARY HALL ROOM 1 ROOM 2 ROOM 3 ROOM 4 PLENARY HALL ROOM 1 ROOM 2 ROOM 3 ROOM 4 WELTSAAL WILLY-BRANDT ADENAUER STRESEMANN RATHENAU WELTSAAL WILLY-BRANDT ADENAUER STRESEMANN RATHENAU

WHS Council Meeting Developing Young Sustainable Humanitarian Health Antimicrobial Resistance Cultures and Health Newborn Mortality Young Physician Sexual Violence Leaders in Health Research Capacity Assistance versus (internal session) Alliance: Alliance: Alliance: Leaders Alliance: Strengthening Health System Support European Students’ National Uni versity of Charité–Universitäts- Monash University Alliance: Charité–Universitäts- Conference (ESC) World Health Harvard Medical Singapore (NUS) medizin Berlin InterAca demy Medical medizin Berlin ( ) German Medical Organization WHO School Robert Koch Institute (RKI) Stiftung Preussischer Panel (IAMP) Pennsylvania State Students’ Association Alliance: LinkGlobalHealth.org Kultur besitz (SPK) University (bvmd) World Federation of Initiative Global Health Next Academic Institutions 11:00–12:30 KEY 02 | Page 74 Generation Network for Global Health (GHNGN) (WFAIGH) The Post-2015 Development Agenda Alliance: Monash University Alliance Universities Allied for United Nations (UN) Essential Medicines World Health Organization (UAEM) Regional Oce for Europe Young Leaders for Health (YLH) e.V. Lunchbreak & Startup Presentations & New Voices in Global Health (NVGH) Poster Presentations 14:00–15:30 SYM 02 | Page 76 WS 17 | Page 78 WS 18 | Page 80 WS 19 | Page 82 WS 20 | Page 84 Lunchbreak & New Voices in Global Health (NVGH) Poster Presentations Value-Based Healthcare Universal Equity and Stem Cell Research– A European 13:00–14:30 WS 05 | Page 44 WS 06 | Page 46 WS 07 | Page 48 WS 08 | Page 50 The Boston Consulting Health Coverage Health Literacy Paving the path to Ecacy/E£ective- Quality Improvement Migration and Big Data Civil Society Partici- Group (BCG) German Federal Hertie School application ness Assessment & Patient Safety Refugee Health AbbVie Deutschland pation in Health Policy Berlin Institute of Ministry for Economic of Governance Innovative Medicines European Federation Geneva Health Forum Bielefeld University GmbH & Co.KG Processes Health (BIH) Cooperation and World Health Initiative (IMI) of Pharmaceutical Development (BMZ) ( ) Industries and Asso- Alliance: Pulitzer Center on Elsevier GmbH Brot für die Welt– Organization WHO German Stem Cell Evangelischer German Healthcare Network (GSCN) ciation (EFPIA) National University Crisis Reporting Alliance: Ent wicklungsdienst Partnership (GHP) Sanoﬁ of Singapore (NUS) | Johns Hopkins EBiSC University of Geneva Bloomberg School Oxfam Deutschland e.V. Rabin Martin StemBancc (UGE) of Public Health The Graduate Institute Berlin Institute of VAMED AG Geneva Health (BIH)

Social Entrepreneurs Medical Education WHS Science Global Health: Digital Health and Traditional Social Alliance: & Industry Circle Research and European Commission Organizations Development Monash University | Fraunhofer-Institut für Helmholtz Association Boehringer Ingelheim National University Bildgestützte Medizin Drugs for Neglected of German Research GmbH & Co.KG of Singapore (NUS) | MEVIS Diseases initiative Centres e.V. Karl Kübel Stiftung National University German Healthcare (DNDi) für Kind und Familie Health System (NUHS) Partnership (GHP) Global Health 19:00–23:00 WHS Night | Page 88 Inno vative Technology Fund (GHIT) Allianz Forum, Pariser Platz 6, 10117 Berlin Allianz Deutschland AG 17:00–21:00 KEY 01 | Page 60 Alliance Opening Ceremony & Reception German Federal Foreign Oce (AA) | German Federal Ministry of Health (BMG) | Alliance | World Health Organization (WHO) Keynotes Panel Discussions Workshops 6 PROGRAM OVERVIEW TABLE OF CONTENTS 7

TUESDAY | OCTOBER 13, 2015

PLENARY HALL ROOM 1 ROOM 2 ROOM 3 ROOM 4 WELTSAAL WILLY-BRANDT ADENAUER STRESEMANN RATHENAU TABLE OF CONTENTS 09:00–10:30 SYM 03 | Page 92 WS 21 | Page 94 WS 22 | Page 96 WS 23 | Page 98 WS 24 | Page 100 Ebola: Assessment, Antimicrobial Access to Essential Vision Research Trade, Diplomacy Program Overview¤4 Treatment and Prevention Resistance Medicines and Health Fukushima Medical and Global Health Institut Pasteur Koch-Metschnikow- Commodities in Africa University German Federal Welcome Messages¤8 Alliance Forum e.V. German Healthcare Alliance: Foreign Oce (AA) WHS Participants & Key Facts¤16 Partnership (GHP) The Graduate Institute Alliance: Charité–Universitäts- Alliance: WHS Track Information¤17 of International and Monash University UNAIDS medizin Berlin World Federation of Development Studies Academic Institutions WHS Vision, Mission, Goals¤18 for Global Health (WFAIGH) WHS Presidents¤20 WHS Scientiﬁc Committee & Ambassadors¤21 11:00–12:30 KEY 04 | Page 102 WHS Council¤22 Global Health Policy in the G7/G20 M8 Alliance¤24 Alliance WHS Startup Track¤30 The Rockefeller Foundation New Voices in Global Health¤32 The Global Fund WHS Night¤34 Lunchbreak & New Voices in Global Health (NVGH) Poster Presentations WHS Community & Social Media¤35 14:00–15:30 SYM 04 | Page 104 WS 25 | Page 106 WS 26 | Page 108 WS 27 | Page 110 WS 28 | Page 112 Summit Program, Sunday, October 11, 2015¤37 NCDs: A Call for Climate Change Education and Training Stress and the City: One World– Summit Program, Monday, October 12, 2015¤63 Common Action and and Health of Clinical and Trans- Flight, Migration and One Health Summit Program, Tuesday, October 13, 2015¤91 Sustainable Change Leopoldina– lational Scientists Mental Health Alliance: Sanoﬁ German National German Centers for Fliedner Klinik Berlin InterAca demy Medical Summit Venue¤120 Academy of Science Health Research (DZG) Alliance: Panel (IAMP) Accommodation¤122 Alliance: Berlin Institute Charité–Universitäts- Robert Koch Institute London School of of Health (BIH) medizin Berlin (RKI) City of Berlin¤124 Hygiene & Tropical World Wide Fund Federal Foreign Oce¤126 Medicine for Nature (WWF Germany) General Information¤130 Media Information¤134 16:00 –17:00 KEY 05 | Page 114 Contacts¤135 Climate Change and Health Federal Ministry for the Keynote Speakers and Chairs¤136 Environment, Nature Speaker Index with Pictures¤144 Conservation, Building and Nuclear Safety (BMUB) Speaker List¤157 Leopoldina–German National Supporting Institutions¤159 Academy of Sciences e.V. Summit Partners¤161 Alliance

17:00 –18:00 KEY 06 | Page 116

Global Health Security & Closing Ceremony Alliance | Munich Security Conference Foundation gGmbH (MSC) WELCOME MESSAGES

8 WELCOME MESSAGE ANGELA MERKEL WELCOME MESSAGE ANGELA MERKEL 9

Germany holds the G7 Presidency in The World Health Summit is an excellent 2015 nimmt Deutschland die G7-Präsi- Der World Health Summit ist eine hervor- 2015. Health matters are a key item on venue for expert discussion on the health dentschaft wahr. Auf unserer Agenda ragende Plattform für den fachkundigen our agenda. We are primarily focusing topics that move us worldwide. We can haben auch Gesundheitsfragen einen Austausch über Gesundheitsthemen, die on infectious diseases, which are one of expect it to deliver valuable input, also zentralen Platz. Unser Augenmerk gilt uns weltweit bewegen. So lässt er auch the most common causes of death world- as regards the G7 objectives and the post vor allem Infektionskrankheiten. Sie ge- mit Blick auf die Zielsetzungen der G7 wide. The Ebola epidemic in West Africa 2015 agenda for sustainable development. hören weltweit zu den häufigsten Todes- oder auf die Post-2015-Agenda für nach- was a painful reminder of what a devas- ursachen. Welche verheerenden Folgen haltige Entwicklung wertvolle Impulse tating impact the uncontrolled outbreaks As patron of the World Health Summit, I unkontrollierte Ausbrüche solcher Krank- erwarten. of such diseases can have. would like to welcome all the participants heiten haben können, hat uns die Ebola- to Berlin. The conference will open doors Epidemie in Westafrika schmerzlich vor Als Schirmherrin des World Health Summit Close international cooperation is vital for you to new insights, contacts and Augen geführt. heiße ich alle Teilnehmerinnen und Teil - Angela Merkel in order to be better prepared for such collaboration. This personal benefit can nehmer in Berlin herzlich willkommen. epidemics in the future or, in the best pay dividends to many people. The hopes Um für die Zukunft besser auf solche Ihnen ö¬net die Tagung Türen zu manch case scenario, to be able to prevent them of countless numbers of people are rest- Epidemien vorbereitet zu sein oder sie neuen Erkenntnissen, Begegnungen und in the first place. Whether it is a matter ing on this. I am extremely grateful for bestenfalls sogar verhindern zu können, Kooperationen. Dieser persönliche Gewinn of being able to provide rapid emergency your great dedication in so many fields. kommt es vor allem auf einen engen kann sich für viele bezahlt machen. Damit aid at any time or of promoting research internationalen Schulterschluss an. Ob verbinden sich Ho¬nungen unzähliger in the fight against antimicrobial resist- es nun darum geht, jederzeit rasche Menschen. Lassen Sie mich Ihnen daher ance and neglected tropical diseases, Nothilfe gewährleisten zu können oder für Ihr vielfältiges Engagement aufrichtig we can only overcome such global chal- etwa im Kampf gegen antimikrobielle danken. lenges if we work together across national Angela Merkel Resistenzen und vernachlässigte Tropen- and cultural borders and across the scope Chancellor of the krankheiten entsprechende Forschun- Angela Merkel of professional and political competence. Federal Republic of Germany gen voranzutreiben – nur wenn wir über Bundeskanzlerin der Grenzen von Ländern und Kulturen, über Bundesrepublik Deutschland fachliche und politische Zuständigkeiten hinweg zusammenarbeiten, können wir solche globalen Herausforderungen meistern. 10 WELCOME MESSAGE FRANÇOIS HOLLANDE WELCOME MESSAGE JEAN-CLAUDE JUNCKER 11

The world climate conference (COP21) La conférence mondiale sur le climat se As President of the European Commission, I am con- Yet, alongside these trends, will be held in Paris this December. Health tiendra à Paris au mois de décembre vinced that, by working together in a focused way we have many opportunities and climate are both inextricably linked prochain. Santé et Climat, ces termes on certain health-related issues, we can ensure longer, to improve eciency, ac - and interdependent. This was the theme sont liés l’un à l’autre, tant l’une dépend richer lives for the citizens of Europe and the world. cessibility and resilience of of the World Health Summit 2014, whose de l’autre. Ce fut le thème du sommet I aim to focus on the issues that matter and make a healthcare. From electronic participants stressed the importance of mondial de la santé 2014 dont les parti- di¬erence; and to concentrate on those areas where prescriptions to telemonitor - international solidarity. cipants avaient mis l’accent sur l’impor- European action can really add value to people’s lives. ing, digital technology can tance de la solidarité internationale. Although national health policy remains a national o¬er Europeans bet ter qual - We have witnessed this solidarity in competence, there remains a lot we can do together. ity care. I would like to see a re cent months, when the Ebola virus once Cette solidarité, nous l’avons observée Europe that is able to exploit against struck West Africa. To be e¬ec- ces derniers mois lorsque le virus Ebola There are many pressing trends in healthcare. those new opportunities: inno - François Hollande Jean-Claude Juncker tive, this solidarity must be based on s’est à nouveau abattu sur l’Afrique de vative, investing, and digital. exchanges and shared knowledge and l’Ouest. Pour être ecace, cette solidarité First, we all see the epidemics that can devastate experiences. Therefore, by maintaining doit s’appuyer sur l’échange et le partage developing countries. Fresh outbreaks like Ebola grab The EU can help Member States address the challenge education as one of the six main themes des connaissances et des expériences. the headlines, while others such as HIV and malaria of increased calls on health services, and more complex of the 2015 World Health Summit, there Aussi, en retenant l’éducation parmi les continue their grim toll. Our common humanity compels technology. Under my Presidency, the European Com- is no doubt that its organizers wanted to 6 principaux termes du sommet mondial us to respond: and I am glad the EU is mobilising in mission will support the EU’s capacity to deal with crisis highlight the importance of the training 2015, ses organisateurs ont sans aucun this fight, with political, diplomatic, humanitarian and situations in food safety or pandemics; especially Ebola. period for future health actors to raise doute voulu souligner l’importance que financial tools – not to mention some promising new We will develop EU policies on medicines and pharma- their awareness of the main issues for the revêt la période de formation des futurs research into Ebola treatments. ceutical products – while taking fully into account that future: education, prevention, detection. acteurs de la Santé pour les sensibiliser medicines are not goods like any other. We will develop aux grands enjeux de demain: éducation, Second, we have a population that is getting older. expertise on how health systems perform, feeding into Your involvement and your declarations prévention, détection. In Europe today, we see 65 as the age for retirement; our broader economic policy coordination. And we will at this World Health Summit will play an but, not so far into the future, one in three adults ensure that the healthcare sector – like so many others – important role in informing the interna- Par votre participation et vos interven- could be over that age. That poses a challenge for our is able to capture the benefits of a borderless digital tional community. Thank you very much. tions au sommet mondial de la santé, healthcare systems: set up to focus on acute conditions; single market. vous avez tous un rôle important: éclairer but which now must deal increasingly with chronic, de - la communauté internationale. Je vous generative illness. This will call for a systemic change, In these areas and more, we can work more e¬ectively en remercie chaleureusement. blurr ing the boundaries between health and social care, when we work together. I wish you all the best doing so and between home and hospital; and also calls for at the World Health Summit. François Hollande François Hollande investment to fight such chronic conditions. President of the French Republic Président de la République And third, there is a growing resistance to antibiotics – a resistance which already today causes 25,000 deaths a year. This is a major public health challenge – calling Jean-Claude Juncker for a coordinated, committed response. President of the European Commission

12 WELCOME MESSAGE WHS PRESIDENTS WELCOME MESSAGE WHS PRESIDENTS 13

2015 will surely be remembered for ment, and the private sector. Over the an economically advanced country can The world is right to expect much from mag ni ficent accomplishments in science past six years the M8 Alliance has de- be deeply challenged by an unforeseen the M8 Alliance. Entering our new action- and medicine. But there have also been veloped a respected and authoritative crisis. And we saw how the enthusiasm oriented phase, let us continue working un precedented developments in an area voice in decision-making on global health of the next generation of healthcare together as we fulfill our founding mission that a¬ects all our lives intimately and issues. Moreover, among the world’s leaders obliges us to give them the best to improve global health. This year’s directly: global health. Here it is often the leading academic health centers we have guidance and opportunities that we can. World Health Summit program reflects catastrophes that linger in public memo- built new bonds of friendship, trust, and Coming out of this year’s Regional Meet- that spirit. ry: the aftermath of the Ebola epidemic, collaboration. ing, the M8 Alliance’s statement focuses and reports placing the number of refu- us on resilience and on action. Action, Thank you all for your support, and Shunichi Fukuhara gees and displaced people at an all-time On that solid foundation, 2015 has been that is, to overcome the challenges of welcome to the World Health Summit high. We fight against microbes that have a unique and pivotal year. This year’s rapid aging, responding to and prepar- 2015! evolved resistance to drugs, permitting WHS Regional Meeting was held six ing for crises, and fostering new leaders. them to reclaim entire regions and spread months ago in Japan. From that meeting While each M8 Alliance member will to new ones. We witness the rising toll the M8 Alliance issued a statement in confront these challenges to resilience of climate change, which now a¬ects the which we strongly emphasized the need in its own way, we will learn from each health of billions of people. As organizers for resilient health systems. What does other, and we will share our experiences Shunichi Fukuhara Detlev Ganten of the World Health Summit, we hear all that mean? Some of the attendees were with the world. WHS President WHS President these calls to action. able to see what it means, firsthand. Fukushima Medical University co-spon- After six years of building a strong base, The M8 Alliance of Academic Health sored the meeting and kindly invited us 2015 may be remembered as the year Detlev Ganten Centers, Universities, and National to visit. There we saw how the people of when we mobilized our base into action. Acade mies is now six years old. In 2009 Fukushima were still responding to the The M8 Alliance will now encourage and we gathered at the first World Health triple disaster of 2011. We saw how global support specific actions by its members Summit, which has become a unique health issues were manifest at the local as they build resilient health systems forum for promoting global health level, and how they were being dealt locally and as they set examples from through networking and dialogue among with locally. We saw a population that is which the global healthcare community medical practitioners, academia, govern- aging very rapidly. We saw how even can benefit. 14 WELCOME MESSAGE CHARITÉ, BIH, MDC WELCOME MESSAGE CHARITÉ, BIH, MDC 15

The first World Health Summit (WHS) much has been achieved in the last years Universitätsmedizin Berlin, an outstanding On behalf of Charité–Universitätsmedizin was held in 2009 on the occasion of the and awareness of the importance of this university hospital, and the Max Delbrück Berlin, Max Delbrück Center for Molecular 300th anniversary of the Charité. The forum and its topics has steadily grown, Center for Molecular Medicine in the Medicine in the Helmholtz Association Summit aimed to provide a unique and great challenges remain. Scientific re - Helmholtz Association (MDC), one of and Berlin Institute of Health, it is there- contemporary platform to address the search has continued to produce new the leading European institutions for fore with great pleasure that we welcome many pressing challenges facing global insights into health and has helped forge biomedical research, join forces. Bringing you to this year’s World Health Summit. health. Bringing together high-ranking the development of new medications and together the complementary strengths Our continued and combined e¬orts to representatives from diverse health- treatments, yet global su¬ering prevails. of the MDC and Charité under one roof translate research findings from bench related sectors worldwide, the Summit Indeed, challenges relating to global is what makes the BIH truly unique. In to bedside and bedside to bench remain Karl Max Einhäupl Erwin Böttinger was met with widespread enthusiasm, health are steadily increasing and cannot April 2015, the BIH has been transformed of paramount importance if we wish to reflecting the need for an open and be resolved by any country or any single into a corporation under public law by sustainably improve the health and lives democratic forum of this kind. The World healthcare sector alone. As a result, the the Berlin House of Representatives. of people all over the world. The World Health Summit has since been held in need for a strong World Health Summit The degree of high level political support Health Summit plays an essential role Berlin on an annual basis each October that unites leaders and experts from all that the BIH receives reflects the start of in strengthening this translation and we and is regarded as the preeminent strate- healthcare related fields whilst simultane- a paradigm shift in translational medicine are confident that the 2015 meeting will gic forum for global health, uniting the ously facilitating mutual development and an even stronger political involve- stimulate the development of creative fields of academia, politics, the private of sustained and relevant solutions for ment in global challenges. solutions and thus facilitate lasting and sector, and civil society. foreseeable problems is greater than ever. meaningful progress. The 2015 World Health Summit is once Upon invitation from the M8 Alliance of On the international front, WHS Regional again hosted by the Ministry of Foreign Axel Radlach Pries Thomas Sommer Academic Health Centers, Universities Meetings in Singapore (2013), São Paulo A¬airs and will focus on topics such as and National Academies and under (2014) and Kyoto (2015) have become Antimicrobial Resistance; Health in the the high patronage of Angela Merkel forceful initiatives for solutions to regional Post-2015 Development Agenda; Climate (Chancellor of the Federal Republic of problems within the global healthcare Change and Health; Digital Health; Medi- Germany), François Hollande (President context. In Berlin, this call has been ad - cal Education; and Refugee Health. Each Karl Max Einhäupl Erwin Böttinger of the French Republic) and Jean-Claude dressed by the successful establishment of these topics exercises an immediate Chairman of the Executive Board Chief Executive Ocer ( ) Juncker (President of the European of the Berlin Institute of Health (BIH). The and pervasive influence on our daily lives. Charité–Universitätsmedizin Berlin from November 2015 Berlin Institute of Health (BIH) Commission), the World Health Summit BIH is funded by the Federal Ministry of We welcome the fact that the World enjoys solid political support and serves Education and Research and the Berlin Health Summit treats these topics with as a key strategic platform in times of Senate. The BIH represents an impressive according attention. global conflicts, natural disasters and and highly significant new institutional demographic changes. However, whilst collaboration in which the Charité– Axel Radlach Pries Thomas Sommer Dean Scientific Director (interim) Charité–Universitätsmedizin Berlin Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) 16 WHS PARTICIPANTS & KEY FACTS WHS TRACK INFORMATION 17

PARTICIPANTS AND KEY FACTS

Participants Profile Education and Leadership Evidence to Policy The World Health Summit brings together Especially in times of limited resources we need The links between health, poverty alleviation and about 1,500 decision makers and representatives Academia well-trained leaders to build high-performing and development, as well as the role of health in the of all health-related fields from more than sustainable health systems. They will be change formulation and implementation of foreign policy 80 countries to address the most pressing issues agents who will better serve the needs identified have been recognized in the UN Resolution on that medicine and healthcare systems will face by their communities. Thereby they will be con- Global Health and Foreign Policy. Global Health over the next decade and beyond. tributing to the improvement of health outcomes a¬ects all the core functions of foreign policy: and health equity. In addition we need to develop achieving security, creating economic wealth, Who will attend the WHS 2015? WORLD interdisciplinary strategies for a more e¬ective supporting development in low income countries • Top-level researchers and members Private Civil health communication system. How can we clearly and protecting human dignity. Sector HEALTH Society of the scientific community articulate and support the synergies between • High-profile political decision-makers SUMMIT health and other sectors? How can we develop Global Health for Development • Executives and representatives shared solutions to drive people-centered, inclu- The outcome document of the Rio+20 United from the healthcare system sive development? Nations Conference on Sustainable Development • Leaders of the health-related industry gives health a central place as a precondition and technology sector Research and Innovation for, and an outcome and an indicator of all three • Representatives of civil society and Policy Cross-sector collaborations between global health dimensions of sustainable development: econo- Makers foundations and foreign policy programs and new capacity mic growth, social improvement and environmen- • Students and young professionals building initiatives are vital to improve the current tal protection. Health must be a part of the post- from all health-related fields coordination and to stimulate the financing of 2015 development agenda. This agenda presents health research. This is also crucial to strengthen an opportunity to rethink what makes develop- the links between evidence and policy. To improve ment inclusive, innovative and relevant for every- the health status of its people and to contribute one. The importance of Universal Health Cover- KEY FACTS to its social and economic development a systems age in enhancing health, social cohesion and DATE: October 11–13, 2015 approach at the country level is needed. Strengthen - sustainable human and economic development VENUE: German Federal Foreign Oce ing a country’s research capacity is mandatory is emphasized. It is therefore an essential compo- Werderscher Markt 1, 10117 Berlin in order to provide a supportive environment for nent of sustainable development and poverty Entrance: Unterwasserstraße 10 sustainable growth. reduction. 18 WHS VISION, MISSION, GOALS KOLUMNENTITEL 19

The World Health Summit (WHS) is the annual conference of the M8 Alliance of Academic Health Centers, Universities and National Academies. Through the Interacademy Medical Panel (IAMP), it is organized in collaboration with national academies of science in more than 67 countries.

VISION GOALS

The vision behind the World Health Summit is • To bring together all stakeholders to improve health all over the planet, catalyzing at the level of equals that process through collaboration and open • To establish a unique and sustainable dialogue, and steering tomorrow’s agenda to high-level forum and network im prove research, education, healthcare, and • To help deﬁne the future of medicine, policy outcomes. research and healthcare • To ﬁnd answers to major health challenges – MISSION both today and tomorrow • To make global recommendations and The WHS mission is to bring together researchers, set health agendas worldwide physicians, key government ocials, and representatives from industry – as well as from NGOs and healthcare systems all over the world – to address the most pressing issues facing every facet of healthcare and medicine in the upcoming decade and beyond. 20 WHS PRESIDENTS WHS SCIENTIFIC COMMITTEE & AMBASSADORS 21

PRESIDENTS FORMER PRESIDENTS WHS SCIENTIFIC COMMITTEE WHS AMBASSADORS

The WHS Scientiﬁc Committee consists of the M8 Alliance Executive Committee and these members of the WHS Council:

SHUNICHI FUKUHARA 2014 2013 RIFAT ATUN DAVID DE KRETSER MANFRED DIETEL REINHARD SCHÄFERS Dean JOSÉ OTÁVIO AULER JR. JOHN EU LI WONG Director, Global Health Professor Director, Institute (former) Ambassador School of Public Health, Dean CEO Systems Cluster (Reproductive of Pathology Federal Republic Kyoto University, University of São Paulo National University Health Harvard T.H. Chan Endocrinology) Charité–Universitäts- of Germany Japan Medical School, Brazil System, Singapore School of Public Health Monash University medizin Berlin

DETLEV GANTEN 2012 2011 BÄRBEL-MARIA KURTH EDUARDO PISANI ERICH R. REINHARDT RAINER SAUERBORN CHARLES YANKAH Chairman of the Board MICHAEL J. KLAG STEVE WESSELINGH Director Executive Director Chairman Director Chairman Charité Foundation, Dean Dean Robert Koch Institute International Federation Medical Valley Institute of Public Health, Afrika Kulturinstitut Germany Johns Hopkins Bloom- Monash University, (RKI) of Pharmaceutical EMN e.V. Heidelberg University e.V., Berlin berg School of Public Melbourne, Australia Manufacturers & Health, USA Associations

2010 2009 HEINZ RIEDERER GÜNTER STOCK TIMO ULRICHS STEVEN K. SMITH AXEL KAHN Managing Director President Head Pro Rector (Health) Dean iNG innovation. ALLEA (All European Tuberculosis-Division, Imperial College London, Sorbonne Paris Cité, Nachhaltigkeit. Academies) Koch-Metschnikow- United Kingdom France Gesundheit Forum e.V. 22 WHS COUNCIL WHS COUNCIL 23

COUNCIL

ALA ALWAN GUDRUN DOLL-TEPPER JÖRG HACKER TIKKI PANG MATTHIAS SCHELLER* Regional Director, Vice President Education President Visiting Professor for CEO Eastern Mediterranean German Olympic Sports German Academy of Sciences Public Policy Albertinen-Diakoniewerk World Health Organization Confederation Leopoldina National University of Singapore HANS JOACHIM SCHELLNHUBER RIFAT ATUN GEORG DUDA* SIR ANDREW HAINES Director Director, Global Health Director, Julius Wol¬ Institut Professor (Public Health) ANDREAS PENK Potsdam Institute for Climate Systems Cluster Charité–Universitätsmedizin Berlin London School of Regional President, Europe Change Research Harvard T.H. Chan School Hygiene & Tropical Medicine Pfizer of Public Health KLAUS DUGI THOMAS SOMMER* Corporate Sen.Vice President ZSUZSANNA JAKAB EDUARDO PISANI Scientific Director (interim) GERD BINNIG Medicine Regional Director, Europe Executive Director Max-Delbrück-Centrum für Director Boehringer Ingelheim World Health Organization International Federation of Molekulare Medizin (MDC) Definiens AG Pharmaceutical Manufacturers THOMAS ESCHENHAGEN STEFAN KAUFMANN & Associations GÜNTER STOCK ZULFIQAR BHUTTA Director Director President Chair, Global Child Health German Centers for Max Planck Institute for WOLFGANG PLISCHKE ALLEA (All European Academies) University of Toronto Health Research (DZG) Infection Biology Former Member of the Board of Management TIMO ULRICHS JAMES CHAU ARMIN FIDLER ILONA KICKBUSCH Bayer AG Head, Tuberculosis Division Anchorman, CCTV News Adviser Health Policy Director, Global Health Program Koch-Metschnikow-Forum e.V. UNAIDS Goodwill Ambassador and Strategy Graduate Institute Geneva MARTINA POETSCHKE-LANGER The World Bank Director, Cancer Prevention SUSANNE WEBER-MOSDORF PIERRE CORVOL BÄRBEL-MARIA KURTH* German Cancer Research Center Former Assistant Director General Professor DAVID DE KRETSER Director World Health Organization (WHO) (Experimental Medicine) Professor Robert Koch Institute (RKI) OLIVIER RAYNAUD Collège de France (Reproductive Endocrinology) Independent Advisor SONJA WEINREICH Monash University PHILIPPE MEYER Senior Health Advisor Emeritus Professor THOMAS CUENI ERICH R. REINHARDT Bread for the World Manager TIMOTHY G. EVANS French Academy of Sciences Chairman Director, Health Nutrition Interpharma, Switzerland Medical Valley EMN e.V. VERA ZYLKA-MENHORN & Population JOEL MENARD Senior Medical Editor The World Bank Professor, Faculty of Medicine MANFRED DIETEL* HEINZ RIEDERER Deutsches Ärzteblatt Paris Descartes Director, Comprehensive Managing Director TEDROS GHEBREYESUS Cancer Center iNG innovation. Nachhaltigkeit. * = Berlin Chapter Minister of Foreign A¬airs JÜRGEN MLYNEK Charité–Universitätsmedizin Berlin Gesundheit Federal Democratic Republic Former President of Ethiopia Helmholtz Association of ERNST TH. RIETSCHEL* German Research Centres Chairman Berlin Institute of Health (BIH) 24 M8 ALLIANCE M8 ALLIANCE: MEMBER INSTITUTIONS 25

MISSION GOALS

The M8 Alliance’s vision is to harness academic The M8 Alliance is improving global health excellence to improve global health. through pursuit of ﬁve strategic goals:

The M8 Alliance of Academic Health Centres, • Developing a worldwide network of academic Universities and National Academies is a colla- health science centers, and bringing together boration between academic institutions com- universities and healthcare providers; mitted to improving global health. Working together with political and economic decision- • Facilitating dialogue through the World Health makers, its primary goal is to develop science- Summit across a global network of stakeholders based solutions to health challenges all over who are engaged with academic health science the world. centers. These stakeholders include (among others) individuals and institutions active in This international network is the outstanding government, industry and commerce, inter- academic foundation upon which the World governmental agencies, healthcare providers, Health Summit – the pre-eminent annual forum academies of medicine and science, profes- for healthcare dialogue – is built. It functions sional associations and the media; as a permanent platform for framing the future considerations of global medical developments • Setting an agenda for global health improve- and health challenges in an equitable fashion. ment by addressing issues of interest to academic health science centers, and con veying The M8 Alliance promotes both “bench-to-bed- findings and recommendations based on scien- side” translation of research and the transfor- tific evidence through the generation mation of current medical care approaches to of key statements; treating the ill. It is seeking to accomplish this through the creation of a healthcare system • Positioning the M8 Alliance as an authoritative, focused on the e¬ective prevention of diseases, credible and respected influence when it comes as well as the adaptation of health-related to decision-making in global health; and solutions to rapidly changing living conditions through research in priority areas like shifting • Creating a knowledge base amongst M8 Alliance demographics, urbanization and climate. members, which directly involves the promotion of mutual learning, research collaboration, the enrichment of educational capabilities and enhanced clinical outcomes. 26 M8 ALLIANCE: LEADERSHIP M8 ALLIANCE: LEADERSHIP 27

M8 ALLIANCE EXECUTIVE COMMITTEE M8 ALLIANCE HEADS OF DELEGATION

Australia France Singapore USA

CHRISTINA MITCHELL FRÉDÉRIC DARDEL JOHN EU LI WONG MICHAEL J. KLAG Dean, Monash University, President, Paris Descartes CEO, National University Health Dean, Johns Hopkins Melbourne (Paris 5), Sorbonne Paris Cité System, Singapore Bloomberg School of Public Health, Baltimore BEN CANNY GÉRARD FRIEDLANDER Deputy Dean, Monash Dean, Faculty of Medicine, Switzerland University, Melbourne University of Paris Descartes International SHUNICHI FUKUHARA JOHN EU LI WONG JOSÉ OTÁVIO AULER JR. DETLEV GANTEN HENRI BOUNAMEAUX Acting International Past International President Past International President Founding President JEAN-YVES MÉRINDOL Dean, Faculty of Medicine, LAI-MENG LOOI President CEO Dean Chairman of the Board Brazil Président, Sorbonne Paris Cité University of Geneva Co-Chair, InterAcademy Dean National University Health University of São Paulo Charité Foundation, Medical Panel (IAMP) School of Public Health, System, Singapore Faculty of Medicine Germany JOSÉ OTÁVIO AULER JR. ANTOINE FLAHAULT Kyoto University Dean, University of São Paulo Germany Professor for Public Health, STEVEN A. WARTMAN Development Medical Education Faculty of Medicine University of Geneva and President & CEO, Association Academic Publications and Membership KARL MAX EINHÄUPL Descartes, Université Sorbonne of Academic Health Centers EDUARDO KRIEGER CEO, Charité– Paris Cité (AAHC), USA President, Brazilian Academy Universitätsmedizin Berlin of Sciences AXEL RADLACH PRIES Uganda Dean, Charité– Canada Universitätsmedizin Berlin NELSON K. SEWANKAMBO Principal, Makerere University HÉLÈNE BOISJOLY Dean, University of Montreal Japan United Kingdom AXEL RADLACH PRIES MICHAEL J. KLAG BEN CANNY ANTOINE FLAHAULT TARIK MÖRÖY SHUNICHI FUKUHARA Dean of Host Institution Dean Associate Dean Incoming International President, Clinical Research Dean, School of Public Health, PETER PIOT Charité–Universitäts - Johns Hopkins Bloomberg Monash University Faculty President Institute Montreal (IRCM) Kyoto University Director, London School of medizin Berlin School of Public Health of Medicine Director Hygiene & Tropical Medicine Institute of Global Health Strategic Co-operation Governance and University of Geneva China Russian Federation ELIO RIBOLI and Stakeholder Liaison Fundraising Director, School of Public Joint Projects XUETAO CAO IVAN DEDOV Health, Imperial College London President, Chinese Academy President, Russian Academy of Medical Sciences & Peking of Medical Sciences Union Medical College EVGENY SIDORENKO DEPEI LIU Vice-President, Russian Chinese Academy of Academy of Medical Sciences Engineering WElCOME TO THE World health summit Berlin 2015 30 WHS STARTUP TRACK WHS STARTUP TRACK 31

WHS STARTUP TRACK 2015 THE 10 FINALISTS

Innovation is the driving force behind every The “WHS Startup Track” highlights and displays Vision Technologies Rewalk Robotics great improvement to human wellbeing. outstanding ideas and innovative business UK Israel The World Health Summit 2015 gives a voice concepts that have the potential to change the Focus: Eye Care Technology Focus: Leg Substitution to startup companies taking responsibility way people are diagnosed, cured and informed. www.givevision.net www.rewalk.com for the improvement of global health. HeartGenetics, Genetics & Biotechnology SA Sonormed GmbH Selection Jury Portugal Germany Startups from all over the world applied with a • Friedrich von Bohlen und Halbach Focus: Genetic Testing Focus: Tinnitus Treatment short digital pitch deck. The selection process (dievini Hopp BioTech holding GmbH & Co.KG) www.heartgenetics.com www.tinnitracks.com took into account the originality of the concept, • Shari Langemak the financial viability of the business, evidence (Medscape Germany) Mediteo Tissue Analytics, Inc. TISSUEANALYTICS of fundraising or partnership ventures, and most • Jürgen Zöllner Germany United States of America SIMPLIFYINGWOUNDCARE importantly, the potential impact on global public (Charité Foundation) Focus: Medication Manager Focus: Wound Analysis health. Due to the 2015 celebration of 50 Years • Hemdat Sagi www.mediteo.de www.tissue-analytics.com of German-Israeli Diplomatic Relations, additional (Israeli Embassy in Germany) credit was given to organizations with a connec- • Mirco Dragowski /Alexander Kölpin mPharma Viomedo UG tion to Germany and/or Israel. (Bundesverband Deutsche Startups e.V.) Ghana Germany • Kai Uwe Bindseil Focus: Medical Network Focus: Clinical Trials More than 70 applications from 17 countries were (Berlin Partner für Wirtschaft und Technologie) www.mpharma.co www.viomedo.de assessed by the jury to select the 30 shortlisted • Min-Sung Sean Kim organizations, which were subsequently invited to (XLHealth) NG Needle VivoSensMedical the World Health Summit 2015. Of these, 10 finalists • Ana Dujic Israel NG Need e Germany smart.needles will pitch their ideas in front of the audience and (German Federal Foreign Oce) Focus: Needle Navigation Aid Focus: Fertility jury on Monday, October 12. The Winner of the www.ngneedle.com www.vivosensmedical.com WHS Startup Track 2015 will be honored at the WHS Night (see page 34 for details). Benefits Pitch & Award

The “WHS Startup Track” o¬ers participants the chance Finalists will pitch their ideas on Monday, October 12, to display their business ideas and to network with the at 13:00 in the “Europasaal”. The winner will be awarded world’s leading minds in the healthcare sector. They will at the “WHS Night” on the evening of Monday October 12. 1965 - 2015 establish strategic partnerships to improve their visibility 50 שנה ליחסי הדיפלומטיי Further information on the WHS Startup Track, the ישראל- גרמניה 50 Jahre and credibility with potential investors, industry, political Diplomatische Beziehungen shortlisted companies and the ﬁnalists is available at: Deutschland-Israel decision makers, doctors, and patients. www.worldhealthsummit.org/the-summit/startup-track.html 32 NEW VOICES IN GLOBAL HEALTH NEW VOICES IN GLOBAL HEALTH 33

NEW VOICES IN GLOBAL HEALTH – POSTER PRESENTATIONS

The selected “New Voices” are: OCTOBER 11–12, 2015 09:00–17:30 Assef Hamdan Jacob Novignon Xiong-Fei Pan An-Najah National University | Palestine PATH Ghana | Ghana London School of Hygiene OCTOBER 13, 2015 Prevalence of Uncontrolled Hypertension among Fiscal space for health in Sub-Saharan African and Tropical Medicine | UK 09:00–13:30 Patients Taking Anti-hypertensive Medications countries: an eciency approach Economic evaluation of including Haemophilus EUROPASAAL in Nablus Governorate – Palestine influenzae type b vaccine in the national Teeranee Techasrivichien Expanded Program on Immunization in China Netsanet Berhe Kyoto University | Japan The New Voices in Global Health (NVGH) initiative promotes French School of Public Health | France Behind The Mask: a mixed method, nationwide Jared Bakuza the active participation of young scientists in the World Prevalence and Risk Factors of Hypertension cross-sectional study on mental and psycholo- Dar es Salaam University | Tansania Health Summit. It is supported by the M8 Alliance of Aca- in Urban and Rural India: A Nationally Represen- gical correlates of mask use among Japanese On the Factors maintaining neglected tropical demic Health Centers, Universities and National Academies. tative Survey high school students diseases infections in Endemic Countries: The NVGH is aimed at empowering research, policy and Field Observations from a Rural Setting in advocacy initiatives among future leaders in global health, Heiko Phillipin Dorcus Henriksson Tanzania who are invited to send in abstracts of their scientific work Kilimanjaro Christian Medical Centre | Tansania Karolinska Institutet, Stockholm | Sweden and ideas. Fighting the Burden of Blindness: Community empowerment and dialogue with Establishing a Diabetic Retinopathy Network health service providers in Uganda: An approach The M8 Alliance Executive Committee identified the best in 11 Low-Income Countries for health systems strengthening. Experiences applications based on international academic standards. from the CODES project The selected candidates will present their work in a special Caroline Ramirez poster exhibition, thus playing an active role in the World Ateneo School of Medicine and Public Health | Jyoti Shrestha Health Summit. Philippines Asian University for Women | Bangladesh Factors a¬ecting access to prenatal, delivery, Increasing Health Literacy to Minimize Stigmatiza- and postpartum services in the Eastern Visayas tion against People with Epilepsy in Developing Region, Philippines Countries 34 WHS NIGHT WHS COMMUNITY & SOCIAL MEDIA 35

WHS NIGHT 2015 WHS COMMUNITY SOCIAL MEDIA

After two days of intense work with fellow The World Health Summit provides an ideal frame- The vision of the World Health Summit is im- DATE: October 12 World Health Summit participants from all over work for networking with like-minded experts proved health worldwide – catalyzed through OPENING: 6:30pm the world, take an evening to relax at our social from all over the world. The WHS Community has collaboration and open dialogue. This dialogue BEGINNING: 7pm event, the WHS Night. been designed to ease the way for participants already starts before the meeting and does LOCATION: Allianz Forum, to get in touch prior to, during, and after the not end when participants leave Berlin after Pariser Platz 6, 10117 Berlin The WHS Night o¬ers an excellent opportunity Summit. three days of intense and fruitful discussions. to meet and exchange with our distinguished guests including speakers, delegates and repre- This networking tool o¬ers contact details, CV Stay in touch with fellow participants and the sentatives from our supporting institutions. and pictures of speakers and attendants to fully World Health Summit team via our social media registered participants. Reserve your admission outlets and be informed 365 days a year. We Snacks and drinks will of course be served, to this exclusive part of the WHS and optimize are looking forward to exchanging opinions whilst a DJ will satisfy the needs of those who your WHS experience: and insights before, during, and after the World wish to dance! A shuttle service will be available Health Summit via: for transportation between the Summit venue • Enhance your networking opportunities prior and the Allianz Forum, where the WHS Night to the Summit www.facebook.com/worldhealthsummit will be hosted. • Gain access to proﬁles of other registered www.twitter.com/WorldHealthSmt participants www.linkedin.com/company/whs-foundation-gmbh Tickets are available for 39 Euros at the venue. • Promote your presence by publishing your personalized participant proﬁle, visible to all This year’s Twitter handle is: registered participants #WHS2015

Simply click on the “Login” button at the top-right To access the complimentary Wi-Fi within corner of our homepage’s navigation bar and the venue, please use: type in the login data all registered participants Name: WorldHealthSummit received via email to access the WHS Community. Password: #WHS2015 www.worldhealthsummit.org/login Summit Program, Sunday, October 11, 2015 m, SUN 11

Summit Program ra g ro SUNDAY, OCTOBER 11 P 38 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 39

WORKSHOP EDUCATION AND LEADERSHIP

WS02 DEVELOPING YOUNG LEADERS Developing young leaders in to provide universal access to 11 ROOM 2 | ADENAUER medicine and global health is health care, increasing the e- IN HEALTH crucial to improving national ciency and quality of public health 10:30–12:00 M, SUN health and well-being. Health services, improving health out- RA

is a cornerstone of economic comes particularly for women G and children. The next generation progress, sustainable develop- Ben Tanya Mathias RO ment, democratic governance of health professionals will build Canny Herfurth Krisam P HOSTS SPEAKERS and global security. Many coun- the fundament for the future of European Students’ Conference (ESC) Alexandra Bartsch tries are embarking on e¬orts health worldwide. European Students’ Conference | German Medical Students’ Association Fundraising | Germany (bvmd) Karin Ge£ert Global Health Next Generation Network German Medical Students’ Association (GHNGN) (bvmd) e.V. | National Ocer, Alexandra Caity Julius M8 Alliance: Public Health | Germany Bartsch Jackson Murke Monash University Tanya Herfurth Universities Allied for Essential Young Leaders for Health (YLH) e.V. | Medicines (UAEM) Student | Germany

Young Leaders for Health (YLH) e.V. Caity Jackson Women in Global Health | Associate | CHAIRS Sweden Karin Joceline Chris Ben Canny Joceline Kranenburg Ge¬ert Kranenburg Redd Monash University | President, Academic Global Health Next Generation Network Board, Faculty of Medicine Nursing and (GHNGN) | Board Member & Project Health Sciences | Australia Coordinator | Netherlands

Julius Murke Mathias Krisam Young Leaders for Health (YLH) e.V. | Charité–Universitätsmedizin Berlin | Student | Germany Student | Germany

Chris Redd Universities Allied for Essential Medicines (UAEM) | Executive Board Member | United Kingdom 40 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 41

WORKSHOP RESEARCH AND INNOVATION

WS03 SUSTAINABLE RESEARCH Michael Makanga John Reeder 11 ROOM 3 | STRESEMANN European-African Capacity Building Suistainable Research Capacity CAPACITY STRENGTHENING Partnerships on Emerging Strenghtening 10:30–12:00 M, SUN AIMING BEYOND OUTBREAKS AND EMERGENCIES Infectious Diseases World Health Organization (WHO) | RA

European and Developing Countries Director, Special Program for Research G Clinical Trials Partnership (EDCTP) | and Training in Tropical Diseases | Garry Thomas RO Head of Africa Oce, South South Switzerland Aslanyan Kariuki P HOSTS SPEAKERS Cooperation | South Africa World Health Organization (WHO) Nancy Edwards Building Sustainable and Scalable M8 Alliance: Implementation Research Capacity: The Ebola outbreak in West Africa ex - in the a¬ected countries, as well as World Federation of Academic Is Community Engagement a Missing posed the fragility of the health systems willingness of a¬ected populations to Institutions for Global Health (WFAIGH) Institute of Population and Public Health and lack of health research capacity. engage in research activities. This panel (CIHR) | Scientiﬁc Director, Community In the 24 previous occurrences of Ebola, will discuss how to build and strengthen CHAIRS Health Research Unit | Canada the virus was controlled early by rapid regional, national, institutional and indi - Pierre Chris Buekens Lewis Garry Aslanyan response, active surveillance and quaran- vidual capacities to conduct high quality Jill Gilmour World Health Organization (WHO) | tine. This time, the outbreak occurred health research (e. g. clinical trials, oper- Building and Sustaining Research Manager, Partnerships and Governance | in countries recovering from conﬂict, ational and/or implementation research) Capacity: Perspectives from IAVIs Work Switzerland with out the health infrastructure or during infectious disease outbreaks in Eastern Africa quantity/quality of trained personnel re sulting in health emergencies. It will Pierre Buekens Imperial College London | Head, to e¬ectively deal with the problem. critically assess what types of e¬orts Tulane University | W.H. Watkins IAVI’s Human Immunology Laboratory | The outbreak catalysed a number of would ensure sustainable research capa - Professor & Dean, School of Public Health United Kingdom research and development activities that city building beyond outbreaks and emer- and Tropical Medicine (SPHTM) | Nancy Michael Thomas Kariuki were focused on delivering e¬ective gencies that would result in an increased Edwards Makanga United States of America Research Capacity Building in Africa: therapeutic, diagnos tic and preventive health system preparedness and com- The AESA Approach interventions. However, the successful munity engagement in research. Panel- Alliance for Accelerating Excellence in testing and implementation of these lists will share their current and future Science in Africa (AESA) | Director | Kenya interventions required the availability plans as well as global collaboration of functioning health research infrastruc- e¬orts under way towards achieving Chris Lewis tures and increased research capacity these goals. Experiences of Funding Research

during the Ebola Crisis Jill John Department for International Gilmour Reeder Development (DFID) | Health Advisor | United Kingdom 42 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 43

WORKSHOP

WS04 UNDERSTANDING OPPORTUNITIES AND CONTRA- Recent armed conﬂicts have stripped tarian notions of engaging in these states 11 ROOM 4 | STRESEMANN DICTIONS BETWEEN HUMANITARIAN HEALTH fragile states of health infrastructure, in neutral and impartial ways, independ- workforces, supply chains, records, and ent from political inﬂuence. A second 10:30–12:00 ASSISTANCE VERSUS HEALTH SYSTEM SUPPORT M, SUN instruments of health governance. As related reason springs from the concern IN CONFLICT-AFFECTED STATES RA

a result, the 1.2 billion people living in that the ways indigenous health sectors G

these fragile and conflict-a¬ected states may allocate resources or undertake Margaret Florian RO shoulder an outsized burden of disease. initiatives can fuel conflict; thus support Bourdeaux Westphal P HOSTS SPEAKERS These populations account for half of will only propagate conflict dynamics. Harvard Medical School Christian Janke the world’s HIV infected, a third of its Munich Centre for Global Health TB, half of its infant mortality and a third It is clear international actors need better LinkGlobalHealth.org Initiative Security | Co-Founder | Germany of its maternal mortality. Most diseases ways to protect and recover health sys- with pandemic potential emerge first tems in conflict-a¬ected states – methods CHAIRS Fatime Arenliu Qosaj in fragile states. Worse, studies show that honor the spirit of the humanitarian Post Conflict Health System Margaret Bourdeaux civilian mortality and morbidity increase movement and its call to ‘lessen human Development in Kosovo Brigham and Women’s Hospital Boston | after the cessation of conflict and remain su¬ering from armed conflict’ and yet Christian Ministry of Health | Kosovo Haggenmiller Instructor in Medicine, Global Health high for decades after the end of hostili- also support the emergence of indigenous Equity | United States of America Nezar Ismet Taib ties, never returning to pre-conflict health systems and institutions that can Providing Public Health During Conflict baselines in many cases. deliver coordinated, need-based and Christian Haggenmiller Directorate General of Health in Duhok well-resource health care to their popu- LinkGlobalHealth.org | Co-Founder | Governorate | General Director | Iraq Yet, despite multiple international agree- lations for years to come. Germany ments urging donors to invest in health Florian Westphal system recovery and rebuilding, donors This workshop will consider this thorny Humanitarian Assistance in collectively are more reluctant to do problem, hearing from indigenous health Complex Emergencies so than they were a decade ago. One sector leaders, humanitarian organiza- Médecins Sans Frontières (MSF) | reason for this reluctance is that sup- tion personnel, fragile state health sys- Managing Director | Germany porting indigenous institutions of any tem researchers, and development and kind is fundamentally a political act and security organization actors. thus cuts against traditional humani- 44 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 45

WORKSHOP EVIDENCE TO POLICY

WS05 QUALITY IMPROVEMENT Andreas Roos Anupam Sibal 11 ROOM 1 | BRANDT VAMED Management und Service Patient Safety and Quality– & PATIENT SAFETY Schweiz AG I CEO I Switzerland Beyond Accreditation 13:00–14:30 M, SUN NATIONAL STANDARDS OF CARE Apollo Hospitals Group | RA

Group Medical Director | India G

Indraprastha Apollo Hospitals | Benedetta Aymeric RO Senior Consultant Pediatric Gastro- Allegranzi Lim P HOSTS SPEAKERS enterologist and Hepatologist | India Geneva Health Forum Benedetta Allegranzi Successful Models to Reduce Patient M8 Alliance: Harm due to Infection Through Safety Patient safety issues are the avoidable they will happen to a very small number National University of Singapore (NUS) Climate Improvements errors in healthcare that can cause harm of patients – we just can’t predict which 6TH EDITION APRIL 19-21 2016 M8 Alliance: University of Geneva | Professor, Institute to patients. Harm in this context means ones. But these are not patient safety University of Geneva (UGE) of Global Health | Switzerland injury, su¬ering, disability or death. Not issues. Patient safety improvement is all harm is avoidable. Some treatments about tackling the causes of errors in José Otávio Andreas VAMED Robert Andrew Johnstone Auler, Jr. Roos or drugs are expected to cause harm, care that can come from bad working The Empowered Patient as a Part of such as chemotherapies or certain drug environments or the lack of training and CHAIRS the Team Managing Quality & Safety therapies. Rare allergic reactions, for support for sta¬. European Patients Forum (EPF) | José Otávio Auler Jr. example, are “expected” in the sense that Board Member | United Kingdom University of São Paulo Medical School I Dean I Brazil Daphne Khoo National Standards for Healthcare– John Eu Li Wong The Singapore Experience National University of Singapore | Robert Andrew Anupam Ministry of Health | Group Director, Johnstone Sibal Dean | Singapore Healthcare Performance Group | Singapore

Aymeric Lim Systems Approach to Improving Quality and Safety in the National University Hospital

National University Hospital | Chairman Daphne John Eu Li of the Medical Board | Singapore Khoo Wong 46 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 47

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS06 MIGRATION AND The current migration wave to Western nomic prospects for migrants and their 11 ROOM 2 | ADENAUER Europe is unmatched in the history families in countries of destination. REFUGEE HEALTH of the continent, sign and symptom of 13:00–14:30 M, SUN MAINTAINING HEALTHCARE the recent globalization process and Established migration concepts like RA

the increasing political unrest in di¬e - pull and push factors and the so-called G healthy migrant e¬ect are not sucient rent parts of the world. This migration Zulﬁkar G. Philipa RO is massive, unprecedented, extremely to explain and understand the impacts Abbany Mladovsky P HOSTS SPEAKERS diverse and mostly unregulated. In Ger - on health and society of this global Bielefeld University Philipa Mladovsky many, the number of asylum seekers phenomenon. New concepts are needed Migration and Health in Europe– increased from 30,100 persons in the to adapt health policy strategies that Pulitzer Center on Crisis Reporting Challenges for Health Systems year 2006 to 202,834 persons in 2014 take into account the social transforma- and Policy and is expected to grow up to 1 million in tion processes in sending and receiving CHAIRS London School of Economics 2015. In the future migration into Europe regions. These policies need to respect Zulﬁkar G. Abbany and Political Sciences | Professor, will become a routine for which Germany various domains, internal as well as Deutsche Welle | Science Editor | International Development | and other European countries ought external policies, in order to refer to the Christian Roumyana Haggenmiller Petrova-Benedict Germany United Kingdom to be prepared. concept of “health in all policies”.

Alexander Krämer Christian Haggenmiller There are multiple driving forces like civil In the workshop renowned experts in Bielefeld University | Professor Refugee Health Challenges wars and political instability as well as migrant and refugee health and inter- and Chair | Germany and Opportunities environmental degradation due to extreme national journalists will present their LinkGlobalHealth.org | Co-Founder | Charles Yankah weather events and climate change in views of this currently most burning Germany African Cultural Institute e.V. (ACI) | countries of origin. On the other hand problem in Europe.

President | Germany Samuel Loewenberg these forces include better life and eco - Alexander Charles The Refugee Health Crisis Krämer Yankah Pulitzer Center on Crisis Reporting | Journalist | United States of America

Roumyana Petrova-Benedict Overview of Migration Health in Europe International Organization for Migration (IOM) | Senior Regional Migration Health

Manager for Europe and Central Asia | Samuel Belgium Loewenberg 48 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 49

WORKSHOP RESEARCH AND INNOVATION

WS07 BIG DATA Healthcare produces data, Big Data. stances provide great opportunities for 11 ROOM 3 | STRESEMANN Every day laboratory results, patient the medical enterprise and bring enor- histories, trial outcomes, surgery reports mous potential especially in the ﬁeld of 13:00–14:30 M, SUN and many more are collected continu- Personalized Medicine in which, establish- RA

ously by healthcare systems worldwide. ing models based on big amounts of G data is a central element. However, the Today, modern ascertainment systems, Je¬rey Lydia RO storing devices and the Internet make potential of Big Data has not been reached Leek Pintscher P HOSTS Olaf Lodbrok it possible to gather, save and share all so far. Connecting Basic Research AbbVie Deutschland GmbH & Co.KG this data more eciently. These circum- and Healthcare Big Data Elsevier GmbH Elsevier GmbH | Managing Director, Health Analytics EMEA/LA | Germany M8 Alliance: Johns Hopkins Bloomberg School Jonathan Mangion of Public Health Thermo Fisher Inc. | Senior Manager, Bioinformatics Next Generation Olaf Ingo Lodbrok Ruczinski CHAIRS Sequencing, Live Technologies | United Kingdom Tarik Möröy Clinical Research Institute Montreal | Lydia Pintscher President and Scientiﬁc Director | Canada Wikidata: Giving More People More Access to More Knowledge Ingo Ruczinski Wikimedia Deutschland–Gesellschaft Johns Hopkins Bloomberg School of zur Förderung Freien Wissens e.V. | Public Health | Professor, Biostatistics | Product Manager | Germany Jonathan Jutta United States of America Mangion Ulbrich Jutta Ulbrich SPEAKERS Realizing the Potential of Big Data Requires a Dialogue Je£rey Leek of all Stakeholders Involved Personalized Medicine is a AbbVie Deutschland GmbH & Co.KG | Population Health Intervention Head, Patient Engagement | Germany Johns Hopkins Bloomberg School of

Public Health | Professor, Biostatistics | Tarik United States of America Möröy 50 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 51

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS08 CIVIL SOCIETY PARTICIPATION Based on a human rights approach, people ponse strategies and their implementation 11 ROOM 4 | RATHENAU – often represented by Civil Society Organ- and to build on lessons learned for a IN HEALTH POLICY PROCESSES isations (CSOs) – are recognized as future strategy against health crises and 13:00–14:30 M, SUN key actors in their own development and in achieving Universal Health Coverage. RA

protectionists for their right to health, G rather than passive recipients of com- In the last years the World Health Organ- Susan Purcell Shecku Kawusu RO modities and services. Nonetheless, CSOs isation (WHO) has given strategic promi- Gilpin Mansaray P HOSTS Shecku Kawusu Mansaray are often acting as a ‘gap filler’ in terms nence to the renewal of the concept of How Community Mobilization was a Key Brot für die Welt – of service provision, stepping into doing Primary Health Care, focussing also on to Fight the Ebola Crisis in Sierra Leone Evangelischer Entwicklungsdienst what governments cannot or fail to do an institutionalized participation of civil Sierra Leone Adult Education Association and not perceived as an equal partner in society in policy dialogue and account- Oxfam Deutschland e.V. (SLADEA) | Advisor | Sierra Leone developing strategies and instruments ability mechanisms. Martin Ekeke Monono for achieving Health for All. This is often CHAIRS Institutionalized Engagement with related to a not-involving attitude of The workshop aims on analyzing the Susan Purcell Gilpin Civil Society on Country Level governments and parts of the interna- following questions: Mareike Martin Ekeke Haase Monono World Council of Churches (WCC) | World Health Organization (WHO) tional community, but occasionally also How does the Global Health Architecture Program Executive, Health and Healing | Regional Oce for Africa | Coordinator, to the lack of capacity of CSOs to engage. look like in the year 2015? How are CSOs Switzerland Organization of Service Delivery | Congo Thus, even CSOs often play a crucial involved in shaping the agenda and what role in terms of advocacy and account- is their role? How can CSOs engage more Mareike Haase Kenneth Mwehonge ability, their participation and voice in meaningfully with political and decision Brot für die Welt–Evangelischer Are Civil Society Organizations policy and decision making processes making processes and how can we bene - Entwicklungsdienst | Policy Advisor, Equal Partners at the Negotiation Table is still very limited. fit more from their experiences and capa- Health | Germany in Shaping National Health Policy? cities? What do CSOs perceive as major Coalition for Health Promotion and Social Barbara Kenneth Barbara Kühlen The Ebola outbreak in 2014 dramatically challenges, what are examples of best Kühlen Mwehonge Development (HEPS) | Program Ocer, Oxfam Deutschland e.V. | Advisor, illustrated that many health systems are practice? How does WHO engage with Advocacy and Networking | Uganda Global Health Policy | Germany too weak to cope with a serious health CSOs and foster their capacities and parti- Cornelia Ulbert crisis. As communities and CSOs played cipation in global health processes? SPEAKERS The Global Health Architecture in a key role in the emergency response Can a stronger and more institutionalized the Year 2015: Room for Meaningful and controlling the spread of Ebola, it is relationship between WHO and CSOs Björn Kümmel Participation of Civil Society? crucial to involve them as an important support WHO’s role as a responsive global Civil Society Participation in Health Duisburg-Essen University | Scientific partner in the elaboration of future res - health agency? Policy Processes–A German Director, The Institute for Development Björn Cornelia Governmental Perspective Kümmel Ulbert and Peace (INEF) | Germany Federal Ministry of Health (BMG) | Deputy Head, Global Health | Germany 52 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 53

WORKSHOP RESEARCH AND INNOVATION

WS09 SOCIAL ENTREPRENEURS AND Making More Health (MMH) is a global people in need, the NGO and business 11 ROOM 1 | BRANDT initiative run by Boehringer Ingeheim world, and social entrepreneurial ideas. TRADITIONAL SOCIAL ORGANIZATIONS (BI) to identify, support and scale social 15:00–16:30 M, SUN MAKING MORE HEALTH entrepreneurial solutions to global health Michael Rabbow from Boehringer Ingel- RA

challenges. Together with Ashoka (the heim and Kerstin Maria Humberg from G ( ) largest global network of social entre- the KKS Karl Kübel foundation open Sylvester Osei Manuela RO preneurs) we explore innovative path- the session with thoughts on the poten- Ageykum Pastore P HOSTS Frank Kornely ways with non-traditional stakeholders tial of co-creation among the business Managers Onsite: An Exposure Week Boehringer Ingelheim GmbH & Co.KG to make more health happen for indi- and social world. Manuela Pastore will in India–Social and Entrepreneurial viduals, families and communities by highlight some relevant aspects and key Karl Kübel Stiftung für Kind und Familie Learnings including its employees throughout the challenges to make co-creation happen Boehringer Ingelheim GmbH & Co.KG | process. The knowledge of social entre- – inside the company and outside – and CHAIRS Team Leader, Cardiovascular Marketing | preneurship approaches and project- introduces into the MMH pilot project in Germany Kerstin Maria Humberg speciﬁc implementation are reinforced – India. The speakers, all actively involved Karl Kübel Stiftung für Kind und Familie | Manuela Pastore inside and outside the company. Volun- into the example MMH pilot project in Krystian Michael Fikert Rabbow Vice Chairperson of the Foundation Making More Health: Partnering teering and Youth Venture Programmes India will share the di¬erent standpoints, Council | Germany “Across the Borders” is Like a Startup as well as an Executive in Residence chances and challenges of such a colla- Boehringer Ingelheim GmbH & Co.KG | program for the employees are part of borative approach: Ralf Tepel, represent- Michael Rabbow Leading Manager, Team Making More the initiative. ing the Karl Kübel Institute for Develop- Boehringer Ingelheim GmbH & Co.KG | Health I Communications | Germany ment Education in India, represents Team Leader, Corporate A¬airs | “Co-Creation and collaboration with the “social” world and introduce into Germany Ralf Tepel unusual partners and across the di¬erent the main activities run together with The MMH Pilot Project: sectors, that’s what we are looking for Boehringer Ingelheim during the MMH SPEAKERS Doing the First Steps Together– Frank Ralf now. There is much more in it, if we just pilot project. As a participant of the Kornely Tepel Seen from the NGO Perspective Sylvester Osei Ageykum try…” says Manuela Pastore, MMH core MMH exposure week in India, Frank Karl Kübel Stiftung für Kind und Familie | Making More Health project manager at BI. Kornely, manager from Boehringer Member of the Board, Development Boehringer Ingelheim GmbH & Co.KG | Ingelheim, explains how the exposure Cooperations | Germany Corporate Communications & Public The workshop session will focus on this led to changemaking ideas and leader- A¬airs | Ghana innovative partnering and explain via ship learnings inside the company. The the MMH pilot project in India how a Irish MMH and Ashoka fellow, Krystian Krystian Fikert social entrepreneurial initiative driven Fikert, will explain how in this collabora- MyMind: Making More Health by a pharma business and Ashoka and tion even social entrepreneurial ideas Through Social Innovation. A Social traditional NGO activities can be com- can grow. A ﬁnal discussion with all Entrepreneur Meets Corporate bined to create a win-win to all: to the workshop participants is very welcome! MyMind Ltd. | CEO | Ireland 54 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 55

WORKSHOP EDUCATION AND LEADERSHIP

WS10 MEDICAL EDUCATION Susan Michie Joanne Yoong 11 ROOM 2 | ADENAUER WHY DON’T DOCTORS AND PATIENTS FOLLOW EVIDENCE Health Psychology–Changing Behav- Health Economics: The Economic iour in Health Professionals Cost of Non-adherence by Patients 15:00–16:30 AND WHAT CAN BE DONE ABOUT IT? M, SUN University College London | Director, and Physicians RA

UCL Centre for Behaviour Change | National University of Singapore (NUS) | G Professor, Health Economics | Singapore United Kingdom Sophia Dragan RO Ang Ilic P HOSTS SPEAKERS

M8 Alliance: Sophia Ang The last thirty years has seen an explo- implement a form of continuous quality Monash University Safety and Evidence (Hospital Setting): sion in the discipline of Evidence Based improvement; and be willing to change The Art and Science of Achieving Com pli - Medicine, to the extent that it is now behaviour with respect to the adherence M8 Alliance: ance in Doctors –Our Experience inClosed the pervasive and dominant paradigm to evidence. National University of Singapore Loop Communication of Critical Results guiding clinical practice. The principles (NUS) and Correct Site Surgery Checklists of EBM inform health professionals’ Despite its ascent, it is clear that for many M8 Alliance: National University Health Services decision making by integrating the best practitioners and patients care and self- Yee Keow Susan Chiong Michie National University Health System (NUHS) | Vice Chairman, Medical Board | available evidence with clinical expertise management is conducted ignoring much Singapore (NUHS) Singapore and patient values. Competency in EBM available evidence. This extends from the requires that clinicians are competent lack of adherence to guidelines and con- Yee Keow Chiong CHAIRS across a variety of disciplines including sensus statements, irregular prescription Behaviour Change and Evidence clinical epidemiology, biostatistics, infor - of therapeutic interventions to the failure Shing Chuan Hooi in the Community: mation science and knowledge transfer. of the adoption of lifestyle interventions National University of Singapore (NUS) | Neighbourhood Health Service for common, preventable non-communi- Vice Dean (Education), Yong Loo Lin National University Health System For evidence of best practice to be cable diseases. In this session we will School of Medicine | Singapore (NUHS) | Resident, Paediatric Medicine | Paul Dujeepa adopted by clinicians, it must survive the explore various challenges to the use of Glasziou Samarasekera Singapore Dujeepa Samarasekera ‘evidence pipeline’. Clinicians must be evidence in health, and how educational National University Health System Paul Glasziou able to implement the ﬁve steps of EBM; strategies might overcome these. (NUHS) | Director, Yong Loo Lin School An Overview of Evidence Based Practice of Medicine, Centre for Medical Education Bond University | Head, Faculty of Health (CenMED) | Singapore Sciences and Medicine | Australia

Dragan Ilic

Strategies for Teaching EBM to Health Shing Chuan Joanne Care Professional Students Hooi Yoong Monash University | Head, Medical Education Research and Quality Unit (MERQ) | Australia 56 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 57

WORKSHOP RESEARCH AND INNOVATION

WS11 WHS SCIENCE Andreas Vilcinskas State Senator Cornelia Yzer 11 ROOM 3 | STRESEMANN Fraunhofer Society | Head of the Federal Government Berlin | & INDUSTRY CIRCLE Project Group “Bio-Ressources” | Senator for Economics, Technol- 15:00–16:30 M, SUN Germany ogy and Research | Germany RA G

Detlev Markus Andreas RO Germany looks back on a unique and international networks and Ganten Neumann Vilcinskas P HOSTS SPEAKERS tradition in the field of Life to improve structures and pro - Fraunhofer-Institut für Alexander Kekulé Sciences and Health Industry. cesses through translational Bildgestützte Medizin MEVIS Universitätsklinikum Halle (Saale) UKH | The close cooperation between and applied sciences that lead Director, Institute for Medical Micro- science and economy is key to market-ready products which German Healthcare Partnership (GHP) biology | Germany to this success and accelerates are essential to improve the the result-orientated translation health of people in need and CHAIRS Jochen Maas process from basic research global health worldwide. Pro- Sanofi-Aventis Deutschland GmbH | Detlev Ganten to the application in patient care gress in health and health sys- Roland Stefan Cornelia Director, Research and Development | Göhde Oelrich Yzer World Health Summit President and product development. tems will only be sustainable Germany Charité Foundation | Chairman of the The “World Health Science & and successful if academia, the Board | Germany Markus Neumann Industry Circle” (WHS-SIC), private sector, politics and civil Bioscientia–Institut für Medizinische jointly launched in June 2015 by society take responsibility and Roland Göhde Diagnostik GmbH | Managing Director, the World Health Summit, the closely work together. WHS-SIC Sysmex Partec GmbH | Senior Managing International Business | Germany Fraunhofer-Gesell schaft (FHG) also actively participates in the Director | Germany and the German Healthcare World Health Summit and uses German Healthcare Partnership (GHP) | Stefan Oelrich Partnership (GHP), aims to in- this international forum to create Chairman of the Board | Germany Sanofi Aventis Deutschland GmbH | General Horst Karl Hagen tensify the dialogue between new opportunities for exchange Hahn Pfundner Manager, Commercial Operations| Germany Horst Karl Hahn science and industry, to activate, and collaboration. Fraunhofer Institute for Medical Image Hagen Pfundner establish and expand national Computing MEVIS | Head of Institute | Roche Pharma AG | Managing Director | Germany Germany Verband Forschender Arzneimittelher- steller e.V. (vfa) | Chairman of the Board | Germany Jochen Ernst Th. Ernst Th. Rietschel Maas Rietschel Berlin Institute of Health (BIH) | Chairman of the Board of Directors | Germany 58 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 59

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS12 GLOBAL HEALTH: The magnitude of the infectious disease The simple acknowledgement that 11 ROOM 4 | RATHENAU problem in the developing world and not one sector or institution can solve RESEARCH AND DEVELOPMENT the failure of the commercial market to the big global health challenges alone. 15:00–16:30 M, SUN catalyze needed health solutions serve Companies need to share the technical RA

as critical obstacles to global economic and ﬁnancial risk with governments G

development and prosperity. Over the and charities. Rapid air travel and urban- Ann Jean-Pierre RO past decade, innovative R&D partner- ization make global health R&D more Aerts Paccaud P HOSTS SPEAKERS ships have given rise to unprecedented critical than ever, and now is the time Drugs for Neglected Diseases initiative Ann Aerts hope: several drugs and vaccines are for countries to harness their research (DNDi) The Relationship Between R&D now being developed for malaria, tuber- and industry expertise and know-how and E£ective Healthcare Delivery culosis, Chagas disease and other neg- for game-changing partnerships. Global Health Innovative Technology in low-Income Settings lected tropical diseases. What shifted? Fund (GHIT) Novartis Foundation | Director | Switzerland CHAIRS Robert David Robert Arch Arch Reddy Kei Katsuno NTDs as a Sustainable Business Global Health Innovative Technology Investment: Cross-Sector Glbal Health Fund (GHIT) | Director, Investment R&D Collaboration in the 21st Century Strategy & Development | Japan Takeda Pharmaceutical Company Ltd. | Jean-Pierre Paccaud Director, Value Creation Alternatives | Drugs for Neglected Diseases initiative United States of America (DNDi) | Director, Business Development | David Reddy Switzerland Kei Lorenzo Relevance of Global Health R&D Katsuno Savioli in the Age of SDGs Medicines for Malaria Venture (MMV) | CEO | Switzerland

Lorenzo Savioli Importance of Cross-Sector Partnerships and High-Level Policy Buy-in Global Schistosomiasis Alliance (GSA) | Chair of the Executive Group| Switzerland 60 SUNDAY, OCTOBER 11, 2015 SUMMIT PROGRAM 61

KEYNOTE GLOBAL HEALTH FOR DEVELOPMENT

KEY01 OPENING CEREMONY STATEMENTS OF 11 PLENARY HALL | WELTSAAL & RECEPTION YOUNG LEADERS IN HEALTH 17:00–21:00 Roopa Dhatt M, SUN

Initiative Director | Women Leaders in RA Global Health Initiative (WLGHI) | G

Hermann Axel R. RO

United States of America P Gröhe Pries HOSTS SPEAKERS Aymen Meddeb German Federal Foreign Oce (AA) Hermann Gröhe Founder and President | Young Leaders Federal Ministry of Health for Health e.V. | Germany German Federal Ministry of Health (Bundes ministeriuim für Gesundheit) | (BMG) Lana Zaim Federal Minister of Health | Germany Public Relations and Applicants’ Support | M8 Alliance Myriam El Khormi 26th European Students’ Conference |

World Health Organzation (WHO) Ministry of Social A¬airs and Employment Germany Margaret Shunichi (Ministère du Travail, de l’Emploi et du Chan Fukuhara CHAIRS Dialogue social) | Minister of Social A¬airs and Employment | France Shunichi Fukuhara World Health Summit President, Margaret Chan Kyoto University | Dean, Vice President, World Health Organization (WHO) | School of Public Health, Vice President Director General | Switzerland Department of Healthcare Epidemiology | Victor J. Dzau Japan National Academy of Medicine | Victor J. Detlev Dzau Ganten Detlev Ganten President | United States of America World Health Summit President Birgit König Charité Foundation | Chairman of the Allianz Private Krankenversicherungs-AG | Board | Germany CEO | Germany

Axel R. Pries Charité–Universitätsmedizin Berlin |

Dean | Germany Birgit König Summit Program, Monday, October 12, 2015 n 12 m, Mo

Summit Program ra g ro MONDAY, OCTOBER 12 P 64 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 65

PANEL DISCUSSION RESEARCH AND INNOVATION

SYM01 ANTIMICROBIAL Antimicrobial resistance (AMR) is de- ening our ability to treat common PLENARY HALL | WELTSAAL RESISTANCE ﬁned as the resistance of a microorgan- infectious diseases, resulting in death 9:00–10:30 ism to an antimicrobial drug that was and disability of individuals whom until originally e¬ective for treatment of recently could continue a normal course infections caused by it. Standard treat- of life. Without e¬ective anti-infective

ments become ine¬ective and infections treatment, many standard medical treat- Manica BT persist, increasing the risk of spread ments will fail or turn into very high risk Balasegaram Slingsby HOSTS Marie-Paule Kieny to others. New resistance mechanisms procedures. Implementing the Global Action Plan M8 Alliance: emerge and spread globally, thus threat- on AMR National University of Singapore (NUS) World Health Organization (WHO) | Robert Koch Institute (RKI) Assistant Director-General, Health Systems and Innovation | Switzerland M, MO N 12 RA

CHAIRS G Lewis Schrager

Lothar Wieler TB Vaccine Development: A Critical, Sally Lothar RO Davies Wieler P Robert Koch Institute (RKI) | President | Long-Term Investment Strategy Germany in Combatting the Spread of Drug- Resistant Mycobacterium Tubercolosis John Eu Li Wong Aeras | Vice-President, Scientiﬁc A¬airs | National University of Singapore (NUS) | United States of America Dean | Singapore BT Slingsby SPEAKERS The Necessity of Global Health R&D in the Context of Antimicromial Resistance Marie-Paule John Eu Li Manica Balasegaram Kieny Wong Global Health Innovative Technology Innovation and Access in the Fund (GHIT) | Executive Director and Fight Against AMR CEO | Japan Médecins Sans Frontières (MSF) | Executive Director, Access Campaign | Ada E. Yonath Switzerland Species-Speciﬁcity in Infectious-Diseases Susceptibility and the Microbiome Sally Davies Weizmann Institute of Science | Director, AMR–The Global Problem Helen and Milton A. Kimmelman Center Lewis Ada E. Government UK Department of Health | Schrager Yonath for Biomolecular Structure and Assembly | Chief Medical Ocer | United Kingdom Israel 66 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 67

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS13 CULTURES AND HEALTH Paul Ulrich Unschuld Ella Watson-Stryker ROOM 1 | BRANDT Patient-Physician Relationship: Impact of Culture on 9:00–10:30 A Matter of Trust Treatment of Patients Charité–Universitätsmedizin During the Ebola Crisis Berlin | Director, Horst-Goertz- Médecins Sans Frontières (MSF) |

Institute for the Theory, History Manager, Health Promotion | Detlev Reinhard Paul Ulrich and Ethics of Chinese Life United States of America Ganten Schäfers Unschuld HOSTS SPEAKERS Sciences | Germany M8 Alliance: Andreas Heinz Charité–Universitätsmedizin Berlin Urbanicity, Poverty and Minority Status– Mental Health in Inner Cities Cultural diversity is deﬁned as West Africa have highlighted Stiftung Preussischer Kulturbesitz (SPK)

Charité–Universitätsmedizin Berlin | the di¬erences that exist in the the need for healthcare workers M, MO N 12

Director, Clinic for Psychiatry and world, a society or an institu - to be properly trained in respect RA

CHAIRS G Psychotherapy | Germany tion. This concept is important to the cultural diversity in these

Detlev Ganten to understand and take into countries in order to provide Andreas Jalid Ella RO Inge Missmahl Heinz Sehouli Watson-Stryker P World Health Summit President account when trying to bring adequate help. In the current Treating People in Seemingly Hopeless Charité Foundation | Chairman of the about transformative ideas to climate of expansion of non- Situations–Implementing Mental Health Board | Germany a society, especially concerning communicable diseases in the in Afghanistan the healthcare of the public. world, it is very important for H.E. Reinhard Schäfers Ipso gemeinnützige Gesellschaft mbH | Recent catastrophic events such all the stakeholders to be aware WHS Foundation GmbH–World Health Founder and Director | Germany as the 2011 Earthquake and and properly informed about Summit | Ambassador | Germany David Napier Tsunami in Japan, or the 2014 this topic when developing

Günter Stock The Cultural Determinants of and continuing Ebola crisis in solutions to the public health Inge Michael Berlin-Brandenburg Academy of Health and Wellbeing issues in their countries. Missmahl Stanley-Baker Sciences and Humanities (BBAW) | University College London | Director, President | Germany Department of Anthropology | United Kingdom

Jalid Sehouli Culture & Women’s Health Charité–Universitätsmedizin Berlin |

Director, Clinic for Gynecology | Germany David Günter Napier Stock Michael Stanley-Baker Max Planck Institute for the History of Science | Postdoctoral Research Fellow | Germany 68 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 69

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS14 NEWBORN MORTALITY Every year worldwide about 3 million increasing attendance rates in labor, babies die within the first month of life. birth asphyxia remains the major cause ROOM 2 | ADENAUER REDUCING NEONATAL DEATH 9:00–10:30 Of these, about one million die within of death within the first 24 hours. For 24 hours of birth and three of four die example, in India, where 60% of women within the first week of life. As a pro- are attended by a skilled care provider in

portion of child deaths, these neonatal labor, a third of all neonatal deaths occur Ben Vishwajeet deaths represent about 40% of all deaths within the ﬁrst day – and of these a third Canny Kumar HOST Jessica Holden of children under the age of 5 – a pro- are due to birth asphyxia. Overall, birth Providing Newborn Care M8 Alliance: portion that is increasing. If the Millen- asphyxia ranks eighth as a global burden in a Conﬂict Zone Monash University nium Goal 4 of reducing early child of disease, with estimated numbers of Médecins Sans Frontières (MSF) | Doctor, mortality by two thirds is to be achieved, disability-adjusted life years (DALYs) due Obstetrics and Gynaecology | Australia

CHAIRS then action to reduce neonatal deaths to birth asphyxia exceeding those due M, MO N 12

Jayasree Iyer – deaths within the ﬁrst week of life – to all childhood conditions preventable RA

Ben Canny G Progress Towards Therapy is urgently required. As Joy Lawn and by immunization. If we are to reduce Monash University | President, for Reducing Newborn Mortality colleagues appealed “Innovative ap- neo natal death rates, and improve child Hege Karsten RO Academic Board, Faculty of Medicine Ersdal Lunze P Access to Medicine Foundation | Head, proaches are required to…improve care health among survivors, then the con- Nursing and Health Sciences | Australia Global Health and Research | Netherlands in settings where far too many babies sequences of birth asphyxia must be Euan Wallace do not cry at birth”. tackled. Vishwajeet Kumar Monash University | Professor and Enculturating Science–From Scientiﬁc Obstetrician, Department of Obstetrics To date, approaches to improve neonatal Using experiences from resource-limited Evidence to Community Impact & Gynaecology | Australia outcome have been, justiﬁably, focused settings, this session will illustrate how Shivharh Community Empowerment Lab | on ensuring that women are attended cheap cost-e¬ective training of basic Founder and CEO | India SPEAKERS by a trained health professional in labour healthcare workers can be integrated Jessica Graeme Graeme Polglase and on simple measures to protect the with experimental research to improve Holden Polglase Hege Ersdal The Physiology of the Newborn baby from infection and cold. However, care and introduce novel therapies, re - Delayed Cord Clamping: Reducing Transition even in low resource countries that have ducing asphyxia mortality and morbidity. Newborn Mortality in sub-Saharan Africa Monash University | Research Group Stavanger Acute medicine Foundation Head, Perinatal Transition | Australia for Education and Research (SAFER) | Project Manager and Principal Investi- DISCUSSANT gator, Stavanger University Hospital,

Departments of Health Studies | Norway Karsten Lunze Jayasree Euan Boston University School of Medicine I Iyer Wallace Research Assistant Professor I United States of America 70 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 71

WORKSHOP EDUCATION AND LEADERSHIP

WS15 YOUNG PHYSICIAN Successful institutions need good of this personalized leadership training ( ROOM 3 | STRESEMANN LEADERS leaders. And whether they are in high- programme a dedicated IAMP YPL Direc - 9:00–10:30 income countries or poorer countries, tory is available here: www.iamp-online. institutions providing healthcare, edu- org/iamp-young-physician-leaders- cating future physicians or promoting directory). These training events take

the public’s health are no di¬erent. place immediately prior to WHS meet- Jo Ivey Peter Yet decision-makers in such institutions ings. This session will be designed by the Bou¬ord McGrath HOST SPEAKERS are often appointed from among people 20 participants of the 2015 YPL event M8 Alliance: Selected Young Physician Leaders (YPL) trained in medicine, not leadership. taking place on 9–11 October. Discussions InterAcademy Medical Panel (IAMP) will likely focus on leadership challenges The InterAcademy Medical Panel (IAMP) for young physicians and their solutions in

CHAIRS Young Physician Leaders (YPL) programme countries with di¬erent socio-economic M, MO N 12

aims to bridge this gap. Launched in conditions. The session is open to every- RA

Jo Ivey Bou£ord G 2011, to date some 108 young physicians one – students, young medical personnel The New York Academy of Medicine | from 32 countries have participated in at the start of their careers, as well as RO President | United States of America P 5 international and one regional edition delegates holding more senior positions. Peter McGrath The World Academy of Sciences | Program Ocer | Italy 72 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 73

WORKSHOP EVIDENCE TO POLICY

WS16 SEXUAL VIOLENCE Vikram Patel Swati Shirwadkar ROOM 4 | RATHENAU THE HEALTH SECTOR RESPONSE Mental Health of Adolescents in Fast Exploring Hidden Spaces: 9:00–10:30 Developing Countries Like India Sexual Abuse of Children in India London School of Hygiene & Tropical University of Pune | Medicine | Professor, International Mental Professor, Sociology | India

Health, Human Development and Family Klaus Berit Studies | United Kingdom Beier Kieselbach HOSTS SPEAKERS

M8 Alliance: Rolf Holmqvist Charité–Universitätsmedizin Berlin Treatment Programs for Juvenile Prevalence rates derived from epidemio- Comparing a fast developing country, O£enders with Antisocial Behaviour logical studies conﬁrm that sexual vio- such as India, to developed European Pennsylvania State University

Linköping University | Professor, lence suggest that without doubt repre- countries, large di¬erences concerning M, MO N 12

Behavioural Sciences and Learning | sents a global health problem. Research criminological data and cultural condi- RA

CHAIRS G Sweden in victims demonstrates marked long- tions inﬂuencing the probability of sexual

Klaus Beier term e¬ects of sexual traumatization in o¬ending against women and children Christine Jennie RO Berit Kieselbach Heim Noll P Charité–Universitätsmedizin Berlin | childhood on neurobiological systems become obvious. This does not neces- Epidemiology of Sexual Violence Director, Institute of Sexual Sciences and in adulthood, and these changes contrib- sarily mean that there is no transferabil- Against Women and Children: Sexual Medicine | Germany ute to health problems. Recently, neuro- ity of health science knowledge across International View; WHO-Perspectives imaging studies provided new evidence countries. Christine Heim on Prevention of Sexual Violence suggesting neural correlates of sexual Charité–Universitätsmedizin Berlin | Within the Health Care System deviancy (e.g. pedophilia), which is one This workshop will scrutinize the main Director, Institute of Medical Psychology | World Health Organization (WHO) | of the risk factors for sexual o¬ending epidemiological, neurobiological and Germany Technical Ocer, Prevention of Violence against children. Furthermore, research therapeutic knowledge concerning Management of Noncommunicable Rolf Vikram on anti-social behaviour (another impor- sexual violence against women and Holmqvist Patel Diseases, Disability, Violence and Injury tant risk factor for sexual o¬ending) children in order to translate this knowl- Prevention | Switzerland indicates the need for early intervention edge to devise strategies for the im- Jennie Noll in adolescents or young adults. provement of primary and secondary Sexual Traumatization and Health: prevention from an international level The Victims focusing on the healthcare system. Pennsylvania State University | Professor, Human Development and Family Studies | United States of America 74 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 75

KEYNOTE EVIDENCE TO POLICY

KEY02 THE POST-2015 When addressing current and future development is meeting our expecta- PLENARY HALL | WELTSAAL DEVELOPMENT AGENDA social, economic, and environmental tions and in which directions we need 11:00–12:30 challenges that are facing the planet, to focus our future e¬orts. Firstly, some there is now an established consensus of the targets set in 2000 are yet to be that these challenges are interlinked and met; the reasons behind this must be

must be addressed through an integrat- addressed and new strategies devised Rifat Debra A. ed approach. The social and economic to accelerate progress in these areas. Atun Jones HOSTS SPEAKERS and environment factors play an undeni- Secondly, we must consider how our M8 Alliance Mark Dybul able role in human health; only through planet, and with it the development The Changing Landscape of integration of the three dimensions will agenda, has evolved over the past 15 United Nations (UN) Global Health and Development it be possible to achieve the transform- years; the constantly changing environ-

World Health Organization The Global Fund to Fight AIDS, Tuber- ative change required to secure long-term ment means that our future goals are M, MO N 12

Regional Oce for Europe culosis and Malaria | Executive Director | environmental and human well-being. also ever-changing. Most importantly, RA

United States of America we must ensure that our future plans for G

CHAIRS As we reach the target deadline for the healthcare and development are not only Mark Macharia RO Dagﬁnn Høybråten Dybul Kamau P UN’s Millennium Development Goals, it achievable but truly sustainable in order Rifat Atun Gavi, The Vaccine Alliance | is time to reassess in which areas global to achieve long-term, stable progress. Harvard T. H. Chan School of Public Health | Chairman of the Board | Switzerland Professor, Global Health and Population | Zsuzsanna Jakab United States of America Health in the Post-2015 Development Macharia Kamau Agenda: A call for Integrated Action United Nations (UN) | Ambassador & World Health Organization | Regional

Permanent Representative, Kenya Mission Director for Europe | Denmark Dagﬁnn Freda C. to United Nations | United States of Høybråten Lewis-Hall Debra A. Jones America SDGs and Health – From Implementation to Delivery Save the Children | Director | United States of America

Freda C. Lewis-Hall Pﬁzer Inc. | Chief Medical Ocer | United States of America Zsuzsanna Jakab 76 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 77

PANEL DISCUSSION EVIDENCE TO POLICY

SYM02 VALUE-BASED In healthcare, the days of business as reducing errors, enforcing practice PLENARY HALL | WELTSAAL HEALTHCARE usual are over. Around the world, every guidelines, making patients better 14:00–15:30 healthcare system is struggling with “consumers,” implementing electronic TRANSLATIONAL RESEARCH rising costs and uneven quality despite medical records – but none have had the hard work of well-intentioned, well- much impact. At its core is maximizing

trained clinicians. Healthcare leaders value for patients: that is, achieving Christina Rånge- Stefan and policy makers have tried countless the best outcomes at the lowest cost. mark Åkerman Larsson HOSTS Hartwig Huland incremental ﬁxes – attacking fraud, Standardized PROM for Science The Boston Consulting Group (BCG) and Quality Control Berlin Institute of Health (BIH) Martini Klinik at UKE GmbH | Chief Physician, Urology | Germany CHAIR M, MO N 12

Joseph Jimenez RA Stefan Larsson Towards Sustainble Healthcare– G

The Boston Consulting Group | an Industry Perspective Mark Jonas RO Dybul Oldgren P Senior Partner & Managing Director | Novartis International AG | CEO | Sweden Switzerland European Federation of Pharmaceutical SPEAKERS Industries and Associations (EFPIA) | President | Belgium Christina Rångemark Åkerman On the Road to Value, Jonas Oldgren Outcomes are the First Step (Health Care) Registry-Based International Consortium for Health Randomized Trials–a Disruptive Hartwig Melvin Huland Samsom Outcomes Measurement (ICHOM) | Technology in Clinical Research President | United States of America Uppsala University | Executive Director, Uppsala Clinical Research Center | Sweden Mark Dybul The Impact of Focusing More on Health Melvin Samsom Outcomes in Developing Countries Developing the Value Focussed The Global Fund to Fight AIDS, University Hospital– Tuberculosis and Malaria | Executive Learnings from the Karolinska Director | United States of America Karolinska University Hospital | Joseph Jimenez Chief Executive O¬er, Research and Education | Sweden 78 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 79

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS17 UNIVERSAL Richard Sezibera Je£rey Sturchio ROOM 1 | BRANDT HEALTH COVERAGE Regional E£orts to Strengthen The Private Sector Role in 14:00–15:30 UHC: The EAC Experience Achieving Universal Health East African Community (EAC) | Coverage: Progress and Secretary General | Rwanda Prospects

Rabin Martin | President and Charles-Etienne Ilona Michael CEO | United States of America de Cidrac Kickbusch Rabbow HOSTS Lilian Dudley Implementing UHC: German Federal Ministry for Economic An Academic Perspective Cooperation and Development (BMZ) The private sector has long- There is no single blueprint for University of Stellenbosch | Director made signi ﬁcant contributions long-term sustainability of UHC. German Healthcare Partnership (GHP) and Professor | South Africa

to improving the health of The discussion will address the M, MO N 12

Rabin Martin Roland Göhde billions of people around the role that the private sector RA How is the German Healthcare Partner- world, creating novel solutions plays(and could play) in helping G The Graduate Institute Geneva ship Helping Countries to Achieve UHC? to some of the largest health countries to achieve this goal. Lilian Heike Richard RO Dudley Kuhn Sezibera P Sysmex Partec GmbH | Senior Managing and development challenges. Particularly with respect to CHAIRS Director | Germany Universal Health Coverage innovative ﬁnancing and devel- Ilona Kickbusch German Healthcare Partnership (GHP) | (UHC) has been recognized as oping products and services The Graduate Institute of International Chairman of the Board | Germany an enabler to improve access with a systemic approach to and Development Studies | Program to higher quality health services meet ongoing health challenges Heike Kuhn Director, Global Health Programme | and a critical component of such as maternal health, child UHC and the SDGs in the Year of the Switzerland achieving the Sustainable De- survival, infectious disease and German G7 Presidency and the Addis velopment Goals. Following chronic illness. The workshop Michael Rabbow Ababa Funding for Development Roland Dorcas Je¬rey the United Nations Summit to will also examine the challenges Göhde Makgato-Malesu Sturchio Boehringer Ingelheim GmbH & Co. KG | Conference: A German Perspective adopt the Post-2015 Develop- of scaling up and sustaining Corporate A¬airs, Team Leader | German Federal Ministry for Economic ment Agenda, this panel will public-private partnerships and Germany Cooperation and Development (BMZ) | explore the multiple and com- private-private partnerships that Head of Department | Germany plex processes required to help seek to improve access to a¬ord- SPEAKERS H.E. Dorcas Makgato-Malesu countries achieve the vision able and quality care for all. Charles-Etienne de Cidrac Botswana’s Experience with the UHC, with a focus on the role AXA Global Life | Director, Health Private Sector in Promoting UHC of the private sector. Strategy and Innovation | France Ministry of Health | Minister of Health | Botswana 80 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 81

WORKSHOP EDUCATION AND LEADERSHIP

WS18 EQUITY AND Health literacy is the personal character- with competing daily concerns. At the ROOM 2 | ADENAUER HEALTH LITERACY istics and social resources needed for organisational and policy level we need 14:00–15:30 individuals and communities to access, to ensure provision of services that both understand, appraise and use informa- mitigate diagnosis and treatment delay, tion and services to make decisions yet ensure judicious provision of limited

about health. Health literacy is increas- healthcare and disease prevention Cynthia Marie Birk ingly recognised as not just an individual resources. How can we: Baur Jørgensen HOSTS SPEAKERS trait but also a characteristic related to Hertie School of Governance Cynthia Baur organisations. Health literacy responsive- • provide advice and services through Health Literacy–the Policy ness describes the way in which services, public/private sectors, workplaces, World Health Organization (WHO) Landscape to Drive Change environments and products make health healthcare professionals that optimise

Centers for Disease Control and information and support available and access and uptake of health services? M, MO N 12 CHAIRS

Prevention | Strategic Communication accessible to people with di¬erent health • maximise health literacy of people, RA

Klaus Hurrelmann Professional, US Department of Health literacy strengths and limitations. Low and health literacy responsiveness of G

Hertie School of Governance | Professor, and Human Services | United States health literacy is associated with organisations/health systems, to maxi - Sujavee Kai RO Good Kolpatzik P Public Health and Education | Germany of America mise health outcomes and equality? • Reduced understanding and access Richard Osborne Sujavee Good to healthcare and health insurance This workshop will take a whole of Deakin University | Chair in Public Health, Health Literacy in low and • Increased use of medical services system approach to generating health School of Health and Social Development | Middle-Income Countries • Higher patient-related and doctor- outcomes while maximising health Australia World Health Organization (WHO) | related medical errors equity. Presenters are global leaders Program Coordinator, Sustainable Develop- • Poor health outcomes and innovators in their respective ﬁelds. ment and Healthy Environments | India Based on their experience, which is Klaus Richard Marie Birk Jørgensen At the individual level, people are re- at the cutting edge of their respective Hurrelmann Osborne Health Literacy in Daily Life quired to recognise health opportunities, ﬁelds, real world and contrasting solu- and the Workplace understand and follow advice, yet deal tions will be presented and discussed. National Research Center for the Working Environment | Senior Researcher | Denmark

Kai Kolpatzik Health Literacy Challenges and Solutions for Germany’s Largest Private Health Insurer AOK Bundesverband | Head, Prevention | Germany 82 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 83

WORKSHOP RESEARCH AND INNOVATION

WS19 STEM CELL RESEARCH– Stem cells are considered as This workshop will present a ROOM 3 | STRESEMANN PAVING THE PATH TO APPLICATION exciting new tools for decipher- number of current case studies 14:00–15:30 ing disease mechanisms, as an with focus towards applied re - TRANSFER OF KNOWLEDGE FROM BASIC RESEARCH TO APPLICATION IS important resource for the de - search such as the use of pluri- CHALLANGING – WHAT ARE THE IMPLICATIONS FOR THE USE OF STEM CELLS velopment of new medicines, as potent stem cells for drug de -

well as for regenerative medicine velopment and clinical transla- Tim Arnd Daniel strategies. Societal expectations tion of therapeutic concepts. Allsopp Hoeveler Pipeleers HOSTS CHAIRS Daniel Pipeleers for a rapid translation of research It will discuss the issues deter- (Stem) Cell-based Approaches Innovative Medicines Daniel Besser are high. Recognition of the con - mining their use as tools, and for Cell Therapy in Diabetes Initiative (IMI) German Stem Cell Network (GSCN) | siderable potential has triggered hurdles of pre-clinical develop- Brussels Free University (VUB) | Director, Managing Director | Germany translational research initiatives ment prior to entering clinical German Stem Cell Center for Beta Cell Therapy in Diabetes |

at EU level, such as the Horizon trials. Examples will be drawn M, MO N 12 Network (GSCN) Joachim Müller-Jung Belgium

Frankfurter Allgemeine Zeitung (FAZ) | 2020, several national programs from the translation of stem cell RA

Elly M. Tanaka G EBiSC Head of Department | Germany as well as public and private research from academic and

Stem Cells and Organ Regeneration funding initiatives. The rewards industrial sectors. Discussion Daniel Casja Fatiha RO StemBancc Fatiha Sadallah Besser Lindberg Sadallah P Center for Regenerative Therapies of a successful advancement framework will include: Innovative Medicines Initiative | TU Dresden (CRTD) | Project Section Berlin Institute of Health using human stem cells are po - Principal Scientific Ocer | Belgium Leader | Germany (BIH) tentially substantial, but uncer- • Matching expectation from SPEAKERS DISCUSSANTS tainties exist. stakeholders involved (clinicians, scientists, patients, SME, pharma)? Tim Allsopp Egbert Flory Based on the recent substantial • Can translation be accelerated Translating Human Pluripotent Stem Cell Paul-Ehrlich-Institut | Head, Tissue progress in basic and applied without compromising utility, Research into Reliable Tools Engineering | Germany Pfizer Inc. | Head, Cell Improve Outreach stem cell research, robust and especially patient safety? Zameel Ulrich Elly M. Programme | United Kingdom Arnd Hoeveler cost-e¬ective manufacture of • How to ensure that results are Cader Martin Tanaka European Commission | Head, Advanced stem cell products at an indus- reliable, particularly when so ci - Zameel Cader Therapies and Systems Medicine | Belgium trial scale, standardization of ety expectations are elevated? StemBancc–Stem Cells quality criteria and product e - • What are the barriers to pro - for Drug Discovery Casja Lindberg cacy as well as development of duct development and can University of Oxford | Director, UNG Diabetes | Sweden better application technologies manufacturing be made cost- The Oxford Headache Centre, StemBANCC | United Kingdom Mohan C. Vermuri are areas of intense and inno- e¬ective? Thermo Fisher Scientific Inc. | Director vative development. The first • When can society expect to see Ulrich Martin Research & Development, Cell Biology, clinical trials to include products the first results and how likely Egbert Joachim Mohan C. Flory Müller-Jung Vermuri Induced Pluripotent Stem Cells Life Sciences Solutions | United States derived from pluripotent human will it be that healthcare sys- for Heart Repair of America stem cells are just taking place. tems are ready to reimburse? German Stem Cell Network (GSCN) | Designated President 2016 | Germany 84 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 85

WORKSHOP

WS20 A EUROPEAN EFFICACY/ The session seeks to discuss the challeng- produce EU relative e¬ectiveness assess- ROOM 4 | RATHENAU EFFECTIVENESS ASSESSMENT es in developing and using EU relative ments that can inform national decision- 14:00–15:30 ecacy/e¬ectiveness assessments that making. Despite this, national HTA author- ARE WE THERE YET? can inform member states’ decision- ities still seem to use their own methods making processes about the clinical added and few joint assessments have led to

value of new medicines at the point of actual decisions. National processes still Karen Andrea regulatory approval (market launch). It will take precedence. Facey Rappagliosi HOSTS SPEAKERS gather representatives from the various European Federation of Pharmaceutical Michael Berntgen actors most concerned in this issue: mem- EUnetHTA is about to enter its third EU Industries and Association (EFPIA) European Medicines Agency (EMA) | ber states’ Health Technology Assessment Joint Action of Member States and is Head, Scientiﬁc and Regulatory (HTA) authorities, law-makers, decision- tasked with showing how its fairly theo- Sanoﬁ

Management | United Kingdom makers, industry, patients, medical pro- retical work and pilot ventures can be M, MO N 12

fessionals. They will debate what European translated into decisions that make a real RA

CHAIR Elisabeth George G member states can deliver jointly to sup - di¬erence for patients’ access to medi- National Institute for Health and Care Karen Facey port better and faster reimbursement cines. This panel will debate the challeng- Ricardo Augustus Bettina RO Excellence (NICE) | Associate Director, Guerreiro Baptista Ryll P University of Glasgow | Honorary Senior decisions that are based on the concept es of developing a rapid e¬ectiveness Appraisals | United Kingdom Leite Research Fellow, Health Economics and of clinical added value, with the aim of assessment at the point of product launch Health Technology Assessment, Scotland | Ricardo Augustus facilitating patient access to new medicines. so that it can inform the reimbursement United Kingdom Guerreiro Baptista Leite of a new medicine. Will we see the same Parliament of Portuguese Republic | The premise of the EU in its e¬orts to evolution as in the field of Europe’s regula- Scientific Coordinator for Public Health | move towards joint relative ecacy/ tory framework, or have times changed Portugal e¬ectiveness assessments, and more too much for history to repeat itself? What broadly all joint work in aspects a¬ecting role can European regulators play in en- Claire Le Jeunne HTA is simple. Health is a preserved author- suring clinical data is not reinterpreted University Hospital Paris Centre–Cochin | ity and so each member state needs to 28 times across Europe? What can politi- Chief, Internal Medicin | France determine where a new medicine will be cians do to foster a better understanding Andrea Rappagliosi placed in its health system’s clinical path- of the need for this cooperation? What Sanofi Pasteur MSD | Vice President, way and to determine whether it adds role can medical professionals play in Market Access, Health Policy and Medical value to currently existing treatments. ensuring that the output from joint work A¬airs | France But this can lead to duplication of e¬ort can make a meaningful contribution to across member states as the same clinical clinical practice in member states? Is in- Bettina Ryll evidence is assessed and delays in deci- dustry ready to adapt to the risk inherent Melanoma Patient Network Europe | sion-making. Hence it has been a driving in joint assessments in exchange for more Founder | Sweden ethos of the European network for HTA speed and predictability? How can the (EUnetHTA) for the past nine years to system ensure patient-driven priorities develop agreed methods for HTA and become truly part of the e¬ort? 86 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 87

KEYNOTE RESEARCH AND INNOVATION

KEY03 DIGITAL HEALTH As the digital and genetics revolutions more personalized and precise. The PLENARY HALL | WELTSAAL converge with healthcare into the excit- essential elements that are making 16:00–18:00 ing new ﬁeld of Digital Health, we are the digital health revolution a reality increasingly able to track, manage, and include wireless devices, hardware improve both our own health and that sensors and software sensing techno-

of our loved ones. Digital Health is also logies, microprocessors and integrated Günther H. Thomas helping to reduce ineciencies in health- circuits, the Internet, social networking, Oettinger Südhof HOSTS Klaus Lindpaintner care delivery, while at the same time mobile and body area networks, health Democratizing Precision Medicine – European Commission streamlining access, reducing costs, information technology, genomics, a Next Generation Sequencing Paradigm improving quality and making medicine and personal genetic information. Helmholtz Association of German Thermo Fisher Scientiﬁc Inc. | Research Centres e.V. Chief Scientiﬁc Ocer | United States of America M, MO N 12 RA

CHAIR G Luka Mucic

Otmar D. Wiestler Big Data and Networks Shaping Saïd Friedrich von RO Aïdi Bohlen und Halbach P Helmholtz Association of German the Future of Healthcare Research Centres e.V. | President | SAP SE | CFO & COO | Germany Germany Thomas Südhof The Post-Genomic Age in Neuroscience: SPEAKERS Challenges for Understanding Brain Günther H. Oettinger Diseases European Commission | Commissioner, Stanford University School of Medicine | Digital Economy & Society | Belgium Avram Goldstein Professor, Molecular Klaus Otmar D. Lindpaintner Wiestler & Cellular Physiology | United States Saïd Aïdi of America Modernizing Tunisia’s Healthcare System Ministry of Health | Minister of Health | Friedrich von Bohlen und Halbach Tunisia Precision Medicine: The Paradigm-Shifting Merger of Molecular Medicine With IT dievini Hopp BioTech holding GmbH & Co.KG | Managing Director | Germany Luka Mucic 88 M ONDAY, OCTOBER 12, 2015 SUMMIT PROGRAM 89

SOCIAL EVENT

ALLIANZ FORUM BERLIN WHS NIGHT AT THE The WHS Night provides participants PARISER PLATZ 6 with an excellent opportunity to meet 18:30–21:00 ALLIANZ FORUM BERLIN and mingle with our distinguished guests, among them WHS speakers, delegates and representatives from

supporting institutions. Tickets will Antoine Detlev be available on site for €39. We hope Flahault Ganten HOSTS Detlev Ganten you’ll be able to join us! World Health Summit President Allianz Deutschland AG Charité Foundation | Chairman of the M8 Alliance Board | Germany

State Senator Cornelia Yzer M, MO N 12 SPEAKERS

Federal Government Berlin | Senator for RA

Antoine Flahault Economics, Technology and Research | G

University of Geneva | Director, Institute Germany Shunichi Cornelia RO Fukuhara Yzer P of Global Health | Switzerland

Shunichi Fukuhara World Health Summit President Kyoto University | Dean, Vice President, School of Public Health, Vice President Department of Healthcare Epidemiology | Japan Summit Program, Tuesday, October 13, 2015 m, TUE 13

Summit Program ra g ro TUESDAY, OCTOBER 13 P 92 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 93

PANEL DISCUSSION RESEARCH AND INNOVATION

SYM03 EBOLA: ASSESSMENT, TREATMENT The Ebola virus causes an acute, serious break control relies on applying a PLENARY HALL | WELTSAAL AND PREVENTION illness which is often fatal if untreated. package of interventions, namely case 9:00–10:30 The current outbreak in west Africa management, surveillance and contact (ﬁrst cases notiﬁed in March 2014) is tracing, a good laboratory service, the largest and most complex Ebola safe burials, and social mobilization.

outbreak since the Ebola virus was ﬁrst Community engagement is key to Ilona Suerie discovered in 1976. There have been successfully controlling outbreaks and Kickbusch Moon HOSTS Amy Maxmen more cases and deaths in this outbreak to reduce human transmission. The Role of the Global Media Institut Pasteur than in all others combined. Good out- in Disease Outbreaks M8 Alliance Pulitzer Center on Crisis Reporting | Journalist | United States of America The Graduate Institute of International and Development Studies Suerie Moon, Ph.D Strengthening a Fragile Global System CHAIRS for Disease Outbreak Response: Wim Samba O. Leereveld Sow Reﬂections on Reforms Ilona Kickbusch Harvard T.H. Chan School of Public Health | The Graduate Institute of International Research Director and Co-Chair | 13 and Development Studies | Program United States of America Director, Global Health Programme |

Switzerland Samba O. Sow M, TUE

Learning from Mali’s Successful RA

Jean-Claude Manuguerra G Response to the Ebola Outbreak Institut Pasteur | Director, Laboratory Center for Vaccine Development, Mali Jean-Claude Florian RO for Urgent Response to Biological Manuguerra Westphal P (CVD-MALI) | Director General | Mali Threats (CIBU) | France Florian Westphal SPEAKERS Working Together for the Beneﬁt of Patients–The Cooperation Between Wim Leereveld Humanitarian and Public Health Actors How to Strengthen Research for Médecins Sans Frontières (MSF) | Neglected Tropical Diseases Managing Director | Germany Access to Medicine Foundation | Amy CEO and Founder | Netherlands Maxmen 94 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 95

WORKSHOP RESEARCH AND INNOVATION

WS21 ANTIMICROBIAL Antimicrobial resistance (AMR) is persist, increasing the risk of spread ROOM 1 | BRANDT RESISTANCE deﬁned as the resistance of a micro- to others. New resistance mechanisms 9:00–10:30 organism to an antimicrobial drug that emerge and spread globally, thus was originally e¬ective for treatment threatening our ability to treat common of infections caused by it. Resistant in fectious diseases, resulting in death

microorganisms (including bacteria, and disability of individuals whom until David C. Anton fungi, viruses and parasites) are able recently could continue a normal course Grolman Peleg HOSTS Dena Lyras to withstand attack by antimicrobial of life. Without e¬ective anti-infective The Vicious Cycle of Antibiotics: Koch-Metschnikow-Forum e.V. drugs, such as antibacterial drugs (e. g., treatment, many standard medical treat- The Emergence of Clostridium Dicile anti biotics), antifungals, antivirals, and ments will fail or turn into very high risk M8 Alliance: Monash University | Professor and Deputy antimalarials, so that standard treat- procedures. Monash University Head, Microbiology | Australia ments become ine¬ective and infections Canice Nolan CHAIR Tackling Antimicrobial Resistance– Anton Peleg The Role of Government, Policy and Dena Timo Lyras Ulrichs Global Epidemic of Antimicrobial International Health Agencies Resistance–Where do we European Commission | Senior Coordi-

Currently stand? nator for Global Health, Strategy and 13 Monash University | Director, Infectious International | Belgium Diseases | Australia Timo Ulrichs M, TUE

The Growing Threat of Antimicrobial RA

SPEAKERS G Resistance in Tuberculosis Akkon Univerity for Human Science | Canice RO David C. Grolman P Nolan An Industry Perspective on Head, Department for Emergency Relief Antimicrobial Resistance: and Disaster | Germany What Does the Future Hold? Koch-Metchnikov Forum e.V. (KMF) | Pﬁzer Inc. | Medical Director, Global Founder | Germany Established Pharma Business | Australia 96 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 97

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS22 ACCESS TO ESSENTIAL MEDICINES AND Many countries in Africa have This panel discussion will explore: ROOM 2 | ADENAUER HEALTH COMMODITIES IN AFRICA made sub stantial progress in 9:00–10:30 scaling up access to medicines • The potential crisis in the supply THE EXAMPLE OF ARVS AND DIAGNOSTICS for HIV, malaria and tuber culosis, of antiretrovirals in Africa and with support from international what can be done to secure

agencies. Nevertheless, problems a¬ordable, quality supplies Manica Sandra Michael still persist with low or inconsist- while also aggressively scal ing Balasegaram Lambert Rabbow HOSTS CHAIRS Margareth Ndomondo-Sigonda ent availability and a¬ordability up Treatment coverage. The New Partnership For Africa’s German Healthcare Roland Göhde of essential medicines, including • The implications of the Fast- Development (NEPAD) | Pharmaceutical Partnership (GHP) German Healthcare Partnership (GHP) | antiretroviral medicines, in low Track AIDS response, including Coordinator | South Africa Chairman of the Board | Germany income and lower middle income 90-90-90: providing tests to UNAIDS Skhumbuzo Ngozwana countries. These problems arise 90% of all people living with Luiz Loures Serenus Biotherapeutics Ltd. | President | in part due to persistent bottle- HIV, treatment to 90% of all United Nations (UN) | Assistant South Africa necks in the mul tiple phases of people diagnosed, and Secretary-General | Switzerland the drug supply chain, and because • viral suppression for 90% of Janet Luiz Robert UNAIDS | Deputy Executive Director | Michael Rabbow Byaruhanga Loures Sebbag of funding constraints. Rapidly all people on HIV treatment. Switzerland Boehringer Ingelheim GmbH & Co. KG | emerging threats, such as Ebola, • The evolving demand for Team Leader, Corporate A¬airs | Germany have highlighted the need for the pharma ceuticals in Africa. 13 SPEAKERS Robert Sebbag timely development and sustain- • Procurement eciencies and Manica Balasegaram Sanoﬁ | Vice President, Access to able supply of a¬ordable and the impact of donors. M, TUE Médecins Sans Frontières (MSF) | Medicines | France innovative medicines, and the • Industrial policy and its role RA

Executive Director, Access Campaign | critical need for Africa to develop in public health. G Switzerland Representative from the East African competencies to deal with its • Regulatory harmonization Xavier Margareth RO Community Secretariat (tbd) speciﬁc challenges including neg- and trade barriers. Crespin Ndomondo-Sigonda P Xavier Crespin lected tropical diseases. Devel- • Technology transfer and capa- West African Health Organization DISCUSSANTS oping domestic markets within city development, including (WAHO) | Director General | Burkina Faso Africa requires sound national South-South, North-South and Janet Byaruhanga Sandra Lambert strategies, a coherent policy frame- triangulation approaches. African Union Commission | Healthy Merck (Pty) Ltd. South Africa | Regional work, robust and wellcoordinat- • Investment oppor tunities Policy Ocer | Ethopia Director, Cardio metabolic Care and ed health sys tems, and a research including private, State and General Medicine for South East Africa | Jürgen Schulze and development agenda for public-private partnerships. South Africa European Diagnostic Manufacturers health that is focused on the needs • Quality assurance for local Roland Skhumbuzo Göhde Ngozwana Association (EDMA) | President | Belgium of African countries, with su- manufacturers and imported cient and consistent investment. medicines. 98 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 99

WORKSHOP RESEARCH AND INNOVATION

WS23 VISION RESEARCH Vision is the main source of human sens - oping novel diagnostic modalities to ation, and blindness is a burden for both predict both eye diseases and systemic ROOM 3 | STRESEMANN INNOVATION & CHALLENGES 9:00–10:30 individual health and society. There are diseases. This session will highlight those innovations in vision research for reduc- innovators in vision research, and pro- ing preventable blindness, establishing vide a glimpse of what is coming in the

screening framework to mitigate the ﬁeld of vision research in very near future. Antonia Jonathan burden of advanced diseases and devel- Joussen Shaw HOSTS SPEAKERS

Fukushima Medical University Akira Murakami Global Burden of Eye Diseases M8 Alliance: and Blindness Charité–Universitätsmedizin Berlin Juntendo University Tokyo | Professor and Head, Ophthalmology I Center for CHAIRS Prevention of Blindness | Japan Antonia Joussen Ryo David Jonathan Shaw Kawasaki Wong Charité–Universitätsmedizin Berlin | Epidemiology of Diabetes and Diabetic Management, Clinic of Ophthalmology | Retinopathy–Lessons from AusDiab, Germany 13 and Australian Screening Program Ryo Kawasaki Monash University | Head, Clinical

Fukushima Medical University | Diabetes and Epidemiology Group | M, TUE

Professor, Public Health | Japan Australia RA G

David Wong Akira RO Screening Experience in Hong Kong Murakami P University of Hong Kong | Chair, Professor| Hong Kong 100 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 101

WORKSHOP EVIDENCE TO POLICY

WS24 TRADE, DIPLOMACY The relationship between health, foreign strong resistance in accepting the same ( ROOM 4 | RATHENAU policy and trade is at the cutting edge principles with regard to NCDs. e.g. AND GLOBAL HEALTH ( ) ) 9:00–10:30 of global health diplomacy WHO , and cancer in Thailand, India . Also bilateral is the subject matter of much discussion trade and other treaties with IP provi- and literature, most notably with respect sions eroded the policy space for public

to the current and next generation of health protection within the multi -lateral Peter Leonel A. trade and investment treaties. This work- IP regime. Within this context, the work- Beyer Valdivia HOSTS SPEAKERS shop will review the ‘state of play’ (what shop will be an opportunity to: German Federal Foreign Oce (AA) Peter Beyer is known and theorized) about such trea - WHOs Experience from Free Trade ties as TTIP, TPP and TISA, among others. • discuss current challenges on inno- M8 Alliance: Agreements: Is Win Win Possible? It will address such burning questions vation/public health and on access World Federation of Academic World Health Organization (WHO) | as: how do these treaties a¬ect public to essential medicines, Institutions for Global Health (WFAIGH) Senior Advisor, Essential Medicines health particularly in low and middle in - • review the recent evolution and current & Health Products | Switzerland come countries (LMICs)? How can public IP issues in bilateral treaties (linking to CHAIRS health protection and equity concerns be the discussion at the 2014 WHS); Kevin Susanne Thomas Kra£t O’Brian Weber-Mosdorf Kevin O’Brian brought to bear in treaty negotiations? • O¬er a perspective on trade and GH Trade Agreement Negotiations: Handelsblatt GmbH Global Edition | Where are there good examples of ‘best diplomacy from the LMICs and NGOS; Implications for Global Health Editor in Chief | Germany practices’ in trade and global health and 13 Maastricht University | Professor, diplomacy? • present a the interplay between health Leonel A. Valdivia International Health | Netherlands policy and trade promotion viewed University of Chile | Director for M, TUE Srinath Reddy While, there is a rather great commit- from an ocial foreign ministry per-

International Relations, School of Public RA

Global Health Diplomacy Challenges ment with regard to global health con- spective. The workshop will give ample G Health, Faculty of Medicine | Chile cerns embedded in TRIPS ﬂexibilities opportunity for questions and com- Posed by the New Generation Srinath RO Susanne Weber-Mosdorf of Trade and Investment Treaties– related to HIV/Aids, there is evidence of ments from participants. Reddy P World Health Organization (WHO), a View from the Global South Oce European Union | former Executive Public Health Foundation of India | Director | Germany President and CEO | India 102 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 103

KEYNOTE EVIDENCE TO POLICY

KEY04 GLOBAL HEALTH POLICY Michael Myers Hiroki Nakatani PLENARY HALL | WELTSAAL IN THE G7/G20 The Planet as Doctor: The Japanese Presidency of the G7; 11:00–12:30 Building Public Health 2.0 Reminiscence and Perspectives The Rockefeller Foundation | Managing Keio University | Professor, Global Director | United States of America Health Initiatives | Japan

Ministry of Health, Labour and Welfare | Joe Mitchell Minister’s Assistant for Global Health | Japan Cerrell Morris HOSTS SPEAKERS

M8 Alliance Joe Cerrell The G7/G20’s Role in Helping All People Global health has gained in political Universal Health Coverage and to health The Rockefeller Foundation Live Healthy and Prosperous Lives rele vance and as a consequence there is security. This is even more relevant in The Global Fund Bill & Melinda Gates Foundation/ an increasing interest of political bodies view of the adoption of the Sustainable

European Oce | Managing Director, such as the G7 and the G20 to consider Development Goals. The panel will explore CHAIR Global Policy and Advocacy | global health challenges. The G7/G20 – with representatives of the G7/G20, as United Kingdom research group has shown that proposals well as major business and foundation Norbert Michael John Kirton Hauser Myers from these groups on health have been leaders how the G7/G20 can contribute University of Toronto | Director, G7 G20 Norbert Hauser taken forward – yet many have challenged to the achievement of the SDGs in relation Research Group | Canada Translating Political Commitment the leading economies in the world to to health and how they can provide the 13 and Financial Resources into Concrete provide more political and ﬁnancial com - political support to take the global health Results–The Role of the G7/20 on mitment to global health matters, espe- agenda forward. Global Health Policy M, TUE cially in relation to health development,

The Global Fund to Fight AIDS, RA Tuberculosis and Malaria | Chair of G

the Board | Switzerland John Hiroki RO Kirton Nakatani P Mitchell Morris Emerging Models of Health: Predictive Maintenance Deloitte Consulting LLP | Vice Chairman, Global Leader, Healthcare | United States of America 104 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 105

PANEL DISCUSSION RESEARCH AND INNOVATION

SYM04 NCDs: A CALL FOR COMMON ACTION Non-Communicable Diseases (NCDs) are largely preventable NCDs. Without any PLENARY HALL | WELTSAAL AND SUSTAINABLE CHANGE the world’s leading cause of death and action now, the NCD burden will increase 14:00–15:30 disability, bringing hardship to rich and globally by 17% in the next ten years, poor nations alike. Worldwide, the four and in the African region alone by 27%. main types of NCDs, namely cardiovascular ( ) diseases like heart attacks and stroke , Because of the size of the immense Douglas W. Linong cancers, chronic respiratory diseases challenges at hand, the diverse causes, Bettcher Ji HOST Linong Ji (such as chronic obstructed pulmonary and the universal impact, NCDs are How to Best Harness the Expertise, Sanoﬁ disease and asthma) and diabetes, everyone’s problem. No single actor or Knowledge and Resources of Academia account for 60% (35 million) of global sector can turn the tide on NCDs alone. for Improved Solutions to NCDs in CHAIR deaths. The largest burden – 80% Tackling the global NCD crisis requires the Field? (28 million) – occurs in low- and middle- a concerted and coordinated multi-sec- Catherine Fiankan-Bokonga International Diabetes Federation | income countries (LMICs), making NCDs toral response, committed to by world United Nations (UN) | Journalist and Vice President | Belgium a major cause of poverty and an urgent decision makers, academia, civil society International Correspondant | Mabvuto Kango development issue. and the private sector, and driven by Katie Suresh Switzerland Dain Kumar How to Set the Frame for Feasible, governments. Given the heterogeneity E£ective and Sustainable Solutions for This rapidly changing health and disease of situations across countries, tailoring SPEAKERS NCDs When Resources are Limited? proﬁle has serious implications for poverty global NCD actions and demands for 13 Douglas W. Bettcher African Union Commission | reduction and economic development, with policy change and resource mobilization NCDs: What are the key needs and gaps? Head for Health Nutrition & Population, severe impacts on individuals, communi- to local contexts will be critical to deliver M, TUE What should be the coordinating role Social A¬airs | Ethiopia ties, and countries. LMICs still grappling adapted, proven, cost-e¬ective solutions RA

of WHO? with heavy burdens of infectious disease that work. G Hon. Suresh Kumar World Health Organization (WHO) | risk being overwhelmed by this wave of Catherine Srinath RO

How Could the Health Industry’s P Director, Prevention of Noncommunicable Fiankan-Bokonga Reddy Expertise and Skills be Better Diseases (PND) | Switzerland Leveraged to Address NCDs Globally? Katie Dain Sanoﬁ Aventis Groupe S.A. | Executive What is the Role of Civil Society Vice President, External A¬airs & Former in Catalyzing E£orts Both at Global US Assistant Secretary of Commerce | and Local Levels in the NCD Fight? Switzerland The NCD Alliance | Executive Director | Srinath Reddy United Kingdom Which Partnerships Should be Fostered to Deliver a Sustainable Response to NCDs, in Particular for the Most Vulnerables? Public Health Foundation of India | President and CEO | India 106 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 107

WORKSHOP EVIDENCE TO POLICY

WS25 CLIMATE CHANGE Arnaud Fontanet Sir Andrew Haines ROOM 1 | BRANDT AND HEALTH Intelligent Use of the Institut Pasteur The Concept of Planetary Health 14:00–15:30 Network for Research and Surveillance (Lancet Commission): of Climate-Sensitive Infectious Diseases Old Wine in new Bottles? in Africa and Asia London School of Hygiene & Tropical

Institut Pasteur | Head, Epidemiology Medicine | Director | United Kingdom Robert Arnaud of Emerging Diseases Unit | France Barouki Fontanet HOSTS SPEAKERS

Leopoldina–German National Robert Barouki Academy of Science The “exposome”–a new Concept Although global warming may bring climate change will a¬ect a wide range Unifying Social and Environmental some localized beneﬁts – such as fewer of social and environmental factors that M8 Alliance: non-Genetic Determinants of Health winter deaths in temperate climes or inﬂuence health, and it also looks set to London School of Hygiene Across the Life Course. increased food production in certain have a serious impact on issues like clean & Tropical Medicine University Paris Descartes | Director areas – the overall health e¬ects of a air, safe drinking water, food supply and of Inserm Unit 1124, Toxicology Pharma- changing climate promise to be over- housing/shelter security. Anneliese Sir Andrew CHAIRS Depoux Haines cology and Cellular Signaling | France whelmingly negative. That’s because Antoine Flahault Boubacar Barry University of Geneva | Director, 13 Innovative Research Tools (Satallite Institute of Global Health | Switzerland Imagery, Meteo Station Information,

Rainer Sauerborn Crop Models, Population Cohorts) M, TUE

University Hospital Heidelberg | Head, to Quantify the Contribution of Climate RA Institute of Public Health | Germany Change to Malnutrition G West African Science Service Center Antoine Rainer RO Flahault Sauerborn P on Climate Change and Adapted Land Use (WASCAL) | Coordinator | Burkina Faso

Anneliese Depoux Increasing Interest of Media in the Health Aspect of Climate Change, 1992–2015: Print Media, Social Networks and Scientiﬁc Journals. Centre Virchow-Villermé (CVV) | Executive Director | France 108 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 109

WORKSHOP EDUCATION AND LEADERSHIP

WS26 EDUCATION AND TRAINING OF CLINICAL In response to the ever increasing num- together and capitalizing on existing ROOM 2 | ADENAUER AND TRANSLATIONAL SCIENTISTS ber of people su¬ering from common expertise and resources throughout 14:00–15:30 diseases such as cancer, cardiovascular, Germany, the DZGs are making signiﬁ- metabolic, infectious, pulmonary, or neu - cant inroads on the prevention, diag- rodegenerative diseases, between 2009 nosis and treatment of diseases which

and 2011 the German Federal Ministry are widespread in the population. A key Christian Ernst Th. of Education and Research (BMBF) initi- component of the DZG mission is the Boitard Rietschel HOSTS Elmar Nimmesgern ated the founding of six German Centers education and training of translational European Commission | Deputy Head, German Centers for Health Research for Health Research (DZG). A key aim of and clinical researchers. Ensuring that Innovative and Personalised Medicine | (DZG) the BMBF in establishing the DZGs was investigators have the comprehensive Belgium to create favorable research conditions skills they need to e¬ectively and e- Berlin Institute of Health Ernst Th. Rietschel in which to combat major public health ciently accelerate discoveries toward (BIH) Berlin Institute of Health (BIH) | problems by optimizing the translational better health is essential. Head of the Board | Germany research process. The six DZGs (The CHAIRS German Centers for Neurodegenerative In the panel discussion “Education and Petra Georg Georg Schütte Kaufmann Schütte Richard Friebe Diseases, Diabetes Research, Cardio- training of clinical and translational German Federal Ministry of Education Scientiﬁc Journalist | Germany vascular Research, Infection Research, scientists – Di¬erent models in di¬erent and Research (BMBF) | State Secretary | Lung Research, and the German Consor- countries” the speakers of the DZGs 13 Martin Krönke Germany tium for Translational Cancer Research) will be joined by guests from the interna- German Center for Infection Research e.V. Peter Suter are structured as long-term, equal partner- tional translational research community (DZIF) | Director | Germany M, TUE University Medical Center | President | ships between non-university research to share perspectives on translational RA

Switzerland institutions and universities with uni- training and education in their respective G SPEAKERS versity hospitals throughout Germany. countries/organizations. Elmar Peter RO Christian Boitard and DZG Representatives By bringing basic and clinical scientists Nimmesgern Suter P The National Institute for Health and Medical Research (INSERM) | Director | France

Petra Kaufmann National Center for Advancing Translational Sciences (NCATS) | Director, Rare Diseases Research and Division of Clinical Innovation | United States of America 110 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 111

WORKSHOP EVIDENCE TO POLICY

WS27 STRESS AND THE CITY: The rapidly growing cities of our world governance of integration processes fails ROOM 3 | STRESEMANN FLIGHT, MIGRATION AND MENTAL HEALTH are the primary destinations for both social conﬂicts and mistrust between 14:00–15:30 intra- and interregional migration includ- residents and migrants frequently impact EVIDENCE AND RESEARCH ing ﬂight. Particularly the last two years the social cohesion of urban areas and have witnessed substantial migration challenge mental health of all residents.

movements and the advent of refugees Therefore cities are in need of public Mazda Ute to Europe. Against this background cities mental health strategies which take mi - Adli Weiland HOSTS Ute Weiland are the essential integration motors of gration processes under clear consider- Opening and Closing Remarks Fliedner Klinik Berlin our societies. City authorities and health- ation. This workshop brings together Alfred Herrhausen Society– care services in particular have to deal views and lessons from mental health- M8 Alliance: The International Forum of Deutsche Bank| with populations who are frequently care and psychiatry, social sciences and Charité–Universitätsmedizin Berlin Deputy Director | Germany traumatized, present with culture and governance and aims at developing language barriers, su¬er from poverty consequences from an interdisciplinary CHAIRS SPEAKERS and experience social exclusion. If the debate. Mazda Adli Andreas Heinz Andreas Jacqueline Heinz Weekers Charité–Universitätsmedizin Berlin | Mental Health in Minorities in Inner Cities Director, Mood Disorders Research Group | Charité–Universitätsmedizin Berlin |

Germany Director, Clinic for Psychiatry and 13 Fliedner Klinik Berlin | Chair | Germany Psychotherapy | Germany

Sir Robin Murray Kenneth Miller M, TUE

King’s College London | Professor, War Child Holland | Senior Psychosocial RA Psychosis Studies | United Kingdom Advisor | Netherlands G

Sir Robin RO Jacqueline Weekers Murray P International Organization for Migration (IOM) | Senior Migration Health Policy Adviso, Migration Health Division | Switzerland 112 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 113

WORKSHOP GLOBAL HEALTH FOR DEVELOPMENT

WS28 ONE WORLD–ONE HEALTH Pathogens such as the Ebola and Nipah community than in the human medicine viruses are circulating in animal popu- community. ROOM 4 | RATHENAU WILDLIFE CONSERVATION, COORDINATED POLICIES AND ONE HEALTH 14:00–15:30 lations and can threaten both animal and human health. Thus both animal and Case studies, focusing especially on the human health sectors have a stake in, human/wildlife interface, will also show

and a responsibility for, their surveillance how health surveillance in wildlife and Detlev Fabian and control. humans living at the wildlife interface Drenckhahn Leendertz HOSTS SPEAKERS can act as an early warning system for M8 Alliance: Thomas R. Gillespie There is, therefore, a need for greater deadly infectious diseases such as Ebola. InterAcademy Medical Panel (IAMP) Emory College of Arts and Sciences | integration and coordination between Through improved health and hygiene Professor, Environmental Sciences | medical researchers and practitioners, rules in humans in close contact with Robert Koch Institute (RKI) United States of America and researchers and practitioners in- wildlife as well as surveillance systems, World Wide Fund for Nature volved in both domestic and wild animal disease transmission of zoonotic and Ilka Herbinger (WWF Germany) health. This integration has been defined other infectious diseases can be signifi- One Health and Conservation Strategies as the ‘One Health’ approach and is an cantly reduced and hence profit both Thomas R. Albert World Wide Fund for Nature Gillespie Osterhaus CHAIRS approach that has taken hold in many human and wildlife health. (WWF Germany) | Program Ocer Africa | developing countries where infectious Detlev Drenckhahn Germany diseases remain prevalent, but less so in Holding a dedicated session on One 13 World Wide Fund for Nature Fabian Leendertz developed countries. Health at the WHS is an opportunity to (WWF Germany) | President I One Health and the raise awareness of the One Health con- Chairman | Germany M, TUE Human-Wildlife Interface The proposed session will review the cept, especially among the human health RA

Lai-Meng Looi Robert Koch Institute (RKI) | Research One Health concept, outlining its current practitioners, researchers, and, perhaps G Academy of Sciences Malaysia | Leader, Epidemiology of Highly Patho- reach and impact, which is perceived to more importantly, decision-makers. Ilka Marcel RO IAMP Co-chair, Department of Pathology | genic Microorganisms | Germany be greater in the wildlife/veterinary Herbinger Tanner P Malaysia Albert Osterhaus Lothar Wieler The One Health Platform Foundation Robert Koch Institute (RKI) | President | University of Veterinary Medicine Germany Hannover | Professor, Wildlife Virology and Virus Discovery | Germany

Marcel Tanner History of and Introduction to One Health Lai-Meng Lothar Looi Wieler Swiss Tropical & Public Health Institute | Director | Switzerland 114 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 115

KEYNOTE EVIDENCE TO POLICY

KEY05 CLIMATE CHANGE Health is currently not prominent in ants”. Black carbon is of particular PLENARY HALL | WELTSAAL AND HEALTH climate policy. It is regarded as one of interest for climate policy, as reducing 16:00–17:00 33 climate sensitive sectors. However, its emissions leads to a fast reduction arguments deriving from health and of levels in the atmosphere. physiology, if properly communicated

to climate decision makers, could play a b) Recent population projections until Rita Schwarzelühr- Rainer strong role as a driving force to motivate 2100 significantly exceed previous Sutter Sauerborn HOSTS SPEAKERS them (and citizens) to accept new poli- UN estimates. Gerland et al. publishing Federal Ministry for the Environment, Rita Schwarzelühr-Sutter cies and new behaviors for the transfor- their modeling results in Science 2014, Nature Conservation, Building and Climate Change and Health: mation towards a low carbon society. project a 2100 population size of be- Nuclear Safety (BMUB) A Government Perspective This is based on three sets of arguments, tween 9.3 to 12.6 billion. This urgently Federal Ministry for the Environment, which have recently been corroborated calls for even greater e¬orts in volun- Leopoldina–German National Nature Conservation, Building and by new evidence (since IPCC AR5) and tary family planning, hence reaping Academy of Sciences e.V. Nuclear Safety (BMUB) | Parlamentary highlights further the need to communi- even larger the linked health benefits M8 Alliance State Secretary | Germany cate this evidence and the policy options accruing to mothers and their fewer Hartmut Hans Joachim Graßl Schellnhuber properly to the highest level of climate children. Sir Andrew Haines CHAIR policy makers. London School of Hygiene & Tropical • There are clear limits to society’s capa- 13 Hartmut Graßl Medicine | Director | United Kingdom • There are huge health benefits from city to adapt to the projected health Max Planck Institute for Meteorology Rainer Sauerborn climate friendly policies and behaviors. impact of climate change. This applies (MPI-M) | former Director | Germany M, TUE University Hospital Heidelberg | Although the concept is not new, new to some extent in a 2°C, but definitely RA

Head, Institute of Public Health | Germany evidence points to the large scope of in a 4°C warmer world, even given G known health beneﬁts accruing from maximal resource allocation to the task. Sir Andrew RO

Hans Joachim Schellnhuber P physical activity from walking and bik- Haines Potsdam Institute for Climate Impact ing, insulated housing, low meat diets. • Heat stress leads to a reduction in Research (PIK) | Director | Germany Two recently identiﬁed co-beneﬁts work productivity in a warmer world, Ali Sié generate considerable additional particularly in a 4° warmer climate. Research Center for Health of Nouna | health gains: This concerns mainly the large popula- Director | Burkina Faso tions in (sub-) tropical and arid areas a) Large health gains from reducing and applies both to outdoor work, such local pollutants, particularly in low and as farming and construction and to middle income countries. Fine particles indoor industrial production in non-air and black carbon have recently been conditioned buildings. recognized as “climate active pollut- 116 TUESDAY, OCTOBER 13, 2015 SUMMIT PROGRAM 117

KEYNOTE EVIDENCE TO POLICY

KEY06 GLOBAL HEALTH SECURITY– The Global Health Security agenda is PLENARY HALL | WELTSAAL M8 ALLIANCE STATEMENT an e¬ort to create synergies between 17:00–18:00 nation-states, international organizations & CLOSING CEREMONY and public & private stakeholders. Its goal is to accelerate progress toward

a world that is safe from threats posed Shunichi Luiz by infectious disease, and to promote Fukuhara Loures HOSTS SPEAKERS global health security as an international M8 Alliance Luiz Loures security priority. United Nations (UN) | Assistant Munich Security Conference Secretary-General | Switzerland Foundation gGmbH (MSC) UNAIDS | Deputy Executive Director | Switzerland CHAIRS Sir Robin Murray Shunichi Fukuhara Detlev Sir Robin King’s College London | Professor, Ganten Murray World Health Summit President Psychosis Studies | United Kingdom Kyoto University | Dean, Vice President,

School of Public Health, Vice President Richard Sezibera 13 Department of Healthcare Epidemiology | East African Community (EAC) | Japan Secretary General | Rwanda M, TUE

Detlev Ganten RA World Health Summit President G

Charité Foundation | Chairman of the Wolfgang Richard RO Ischinger Sezibera P Board | Germany

Wolfgang Ischinger Munich Security Conference Foundation gGmbH (MSC) | Chairman | Germany GENERAL INFORMATION 120 SUMMIT VENUE SUMMIT VENUE 121

HOW TO GET TO THE SUMMIT VENUE Europasaal tartup Pitches Federal Foreign Oce (Auswärtiges Amt) Center Oce Entrance: Unterwasserstraße 10 Speaker S tartup Media Europa-Foyer S Presentation Arriving by public transportation: Willy-Brandt-Saal Jungfernbrücke • From the underground station “Spittelmarkt“ (Line U2): Werderscher MAarktuswärtiges Amt (Neubau) Unterwasserstraße Registration Adenauer-Saal Walk along the left side of the water canal. Shortly after the Federal Foreign Oce (new building)

antique draw bridge, the Summit entrance will be on your left. Unterwasserstraße

Stresemann-Saal • From the underground station “Hausvogteiplatz“ (Line U2): Turn into “Oberwallstraße“, turn right onto Werderscher Markt, go past the Auswärtiges Amt and turn right again directly Rathenau-Saal afterwards. Continue along the side of the building to the Summit entrance. Entrance World Health Summit Unterwasserstraße 10 Arriving by air: • From Tegel Airport: Take the bus line X9 to “Ernst-Reuter-Platz“, Kurstraße

Lounge connect to the underground line U2 in the direction of Pankow Auswärtiges Amt (Altbau) The World Health Summit will be taking Presidential and exit at “Spittelmarkt“. Federal Foreign Oce (old building) place at the Federal Foreign Oce. Weltsaal • From Schönefeld Airport: Take the S-Bahn (train) to Oberwasserstraße

Please be advised that due to security M 8

Lounge “Friedrichstraße“, connect to bus line 147 in the direction of reasons, all delegates will be subject to Ostbahnhof and exit at “Spittelmarkt“. Alternatively take the a security check including a passport S-Bahn line S9 to “Schönhauser Allee“, connect to the line U2 identiﬁcation conﬁrmation. Area (underground train) in the direction of Ruhleben and exit at Please be aware: You will not be able to I nterview “Spittelmarkt“. enter the Summit venue, if you are not • Transfer time by taxi is approximately 25 minutes from Tegel able to present your passport or ID-card. Airport and 50–60 minutes from Schönefeld Airport. Bag Counter Unfortunately this procedure may pro-

duce a slight delay for entrance into the Arriving by train: Kleine Kurstraße building. We therefore kindly ask you to From Berlin Hauptbahnhof (main station): Take bus line 147 in refrain from bringing your luggage to the the direction of U Märkisches Museum and exit at “Spittelmarkt“. Summit venue, as this will slow down the Please check the area-map on page 123 for further orientation. Gertraudenstraße security check process. 122 ACCOMMODATION ACCOMMODATION 123

Hotel Name Address Distance to Category Single Double U Summit Venue Room Room NATURKUNDE- ROSENTHALER MUSEUM PLATZ U 1 Westin Grand Berlin Friedrichstraße 158–164 0.8 km 5* € 189.00 € 209.00 ROSA- LUXEMBURG- U 7 Radisson Blu Karl-Liebknecht-Straße 3 0.9 km 5* € 149.00 € 199.00 PLATZ CENTRAL 2 Soﬁtel Berlin Charlottenstraße 50 0.6 km 5* € 215.00 STATION

3 Arcotel John F. Werderscher Markt 11 0.2 km 4* € 139.00 € 159.00 Charité ORANIENBURGER ORANIENBURGER TOR U WEINMEISTER- U STRASSE STRASSE U 4 Cosmo Hotel Berlin Mitte Spittelmarkt 13 0.4 km 4* € 114.00 € 124.00

5 Courtyard by Marriott Berlin Axel-Springer-Straße 55 0.6 km 4* € 135.00 € 145.00

6 Motel One Spittelmarkt Leipziger Straße 50 0.4 km 2* € 76.50 € 99.00 HACKESCHER MARKT

ALEXANDERPLATZ U U U 7 FRIEDRICH- VENUE: STRASSE Radisson Blu Federal Foreign Oce Berliner Dom Berliner Werderscher Markt 1 Allianz Forum Dom

10117 Berlin KLOSTERSTRASSE Unter den Linden U Unter den Linden ENTRANCE: U Unterwasserstraße 10 BRANDENBURGER Federal Foreign Oce TOR 1 Friedrichstraße Auswärtiges Amt CONTACT: Westin FRANZÖSISCHE

Soﬁtel STRASSE U Friedrichstraße Friedrichstraße Arcotel Federal Foreign Oce Email: [email protected] Grand Berlin 3 Berlin John F. Auswärtiges Amt Gendarmen- U 2 markt U HAUSVOGTEI- FRANZÖSISCHE PLATZ Gendarmen- U STRASSE U markt U U STADTMITTE MÄRKISCHES MOHRENSTRASSE U MUSEUM HAUSVOGTEI- Leipziger Straße SPITTELMARKT PLATZ U Cosmo Hotel STADTMITTE Berlin Mitte 4 POTSDAMER PLATZ U U Leipziger Straße 6 SPITTELMARKT Motel One Spittelmarkt 5 Coutyard by Marriott Berlin U KOCHSTRASSE 124 CITY OF BERLIN CITY OF BERLIN 125

BERLIN: One of its most famous medical institutions is BERLIN¡–¡A CULTURAL the renowned Charité, Europe’s largest university A METROPOLIS FOR HEALTH hospital and one of Germany’s leading hospitals. METROPOLIS The doctors and scientists at the Charité are AND CAPITAL OF CULTURE well recognised in international medicine, and co-operate with foreign research institutes like the Along with first-class health services and scientific Johns Hopkins Bloomberg School of Public Health conferences, Berlin also provides varied cultural Health check in the morning, opera in the evening in Baltimore, USA. experiences. From ancient art by the Old Masters – hardly any other city combines culture, lifestyle to avantgarde design, from classical opera to and healthy living as well as Berlin. The capital’s 2014 saw Berlin host 193 events run by internatio nal musicals to pop concerts, Berlin’s cultural calendar tradition as a metropolis for health and science associations, ranking the city among the top 5 in leaves nothing to be desired. Visitors to the capital spans more than 300 years. Today, some 8,000 the ICCA (International Congress and Convention can choose from around 1,500 events a day. The autumn of this year will see the 25th anniver- doctors at the city’s approximately 81 hospitals Association) statistics, and further building on its sary of German reunification. With photographs, treat 780,000 patients every year. position as a suitable metropolis for major con- Culture and art enthusiasts can also admire new audio and video recordings as well as original ferences. The German capital is also increasingly styles and prominent works from all eras every exhibits from the reunification period, the exhibi- po sitioning itself as a location for events in science day in Berlin’s over 180 museums and approximate - tion “Unification–German society in transition” For more information on Berlin, and medicine: eleven per cent of the approximate ly ly 440 galleries. The city’s best known museums at the Deutsches Historisches Museum depicts the visit health.visitBerlin.com 131,000 meetings, conventions and events held include the five buildings at Museum Island process of re-uniting the two Germanys and its in 2014 were in the fields of medicine, science and (Museumsinsel), which is in the historic centre. impact on daily life not only in Berlin but through- research, according to the latest statistics. Inter- All buildings display valuable artistic treasures out the entire Federal Republic. national conferences such as the World Health from 3,000 years of human history, e. g. the famous Summit show that the German capital has been bust of Nefertiti in the New Museum, while the The Italian painter and draughtsman Sandro Botti - able to consolidate its strong position as a desti- Hamburger Bahnhof and Martin Gropius Building celli is regarded as one of the most important nation for medical events. present contemporary art. artists of the early Renaissance, with the “Birth of Venus” counting as one of his most famous works. More and more foreign guests are discovering Berlin is the world’s only city to have three opera In cooperation with London’s Victoria & Albert Berlin’s potential as a “health city”. In 2014, more houses: the Berlin State Opera (Berliner Staats- Museum, “The Botticelli Renaissance” exhibition than 11,000 international patients travelled to oper), the Deutsche Oper and the Komische Oper. in the Gemäldegalerie proves that, more than any the German capital to receive a medical treatment Classical music lovers can choose from a reper- other old master, Botticelli had a major impact on in one of Berlin’s top seven clinics. They combined toire of famous works, such as Mozart’s Don the art of the modern and contemporary periods. their trip with a relaxing holiday. Apart from Giovanni, or new and experimental operas. Apart excellent medical care, visitors to the capital can from these opera houses, the city’s eight large also enjoy its wide range of wellness hotels and orchestras, including the world famous Berlin For more events, go to spas, as well as its unique character. Philharmonic conducted by Sir Simon Rattle, also events.visitBerlin.com make for high-class musical enjoyment. 126 FEDERAL FOREIGN OFFICE FEDERAL FOREIGN OFFICE 127

THE HOUSE ON 1765 1945 1999 The “Royal Savings and Loan Bank“, (Königliche During the Second World War the “Reichsbank“ Thanks in part to the design by Berlin architects WERDERSCHER MARKT Giro- und Lehnbank) founded by Frederick the extension su¬ered severe damage. After the Thomas Müller and Ivan Reimann, a new building Great, moved into the building. Thanks to con - initialrepairs were carried out, the “Berlin City was added on Werderscher Markt to accommo- si derable economic growth and development Oce“(Stadtkontor) took over several rooms in date the Federal Foreign Oce (Auswärtiges in Prussia the following decades saw a number the house. Amt). The two buildings are connected by a Since its return to Berlin in 1999, the Federal of modifications and extensions to the building. shared courtyard. A photovoltaic system on the Foreign Oce has been located in the “Haus am 1949 roof of the older building with a connection to Werderscher Markt“ (House on Werderscher 1846 In autumn, the Ministry of Finance of the newly- the newer building’s heating network provides Markt). After the former Tempelhof airport termi- First as the “Prussian Bank“ (Preußische Bank) founded German Democratic Republic (GDR) an environmentally-friendly energy supply. nal, this is the second largest building in Berlin and then starting in 1876 as the “Reichsbank“ took over the building. with its 550,000 m3 of enclosed space. Like many (Reichsbank) the building continued to grow until other buildings in Germany’s capital, the building 1903 when it took up the entire block between 1959 and surrounding area is a Berlin icon which has Jäger-, Kur-, Oberwall- and Kleiner Jägerstraße. In summer, the Central Committee of the SED witnessed Germany’s eventful and turbulent (Socialist Unity Party) moved in. With this move, INTERIOR VIEWS − history. In 1913 the building on Werderscher Markt came to be THE FEDERAL FOREIGN OFFICE Even before the First World War, the premises at the center of political power in the GDR. 1690 of the “Reichsbank“ were too small. In 1913 the A court building was constructed to the south bankbegan to buy land in the surrounding area. 1989 west of Werderscher Markt. In the course of the political demise of the GDR, The old and new buildings of the Federal Foreign 1932 the central committee of the SED was dissolved Oce provide 62,500 mÐ oce space for more Plans were formulated for a new building close on December 8. than 2,000 employees. In addition, the two by, and two years later the foundation stone was buildings house several conference halls, the laid. 1990 political archives, medical and social services, In the first few weeks of the year, the house on a canteen, as well as the library. 1940 Werderscher Market was vacated. A little later After six years of construction, the building the building was renamed the “House of Par- The nerve center of the Federal Foreign Oce is was completed and the “Reichsbank“ moved in, liamentarians“ (Haus der Parlamentarier). This the old building erected in 1934, which served as atwhich time its main task had changed to pri- new name came about on March 18 when the the Reichsbank from 1934 to 1938. In 1959, the marily funding the war. The new bank building members had a free election to select their new building became the headquarters of the Socialist was locat ed on the opposite side of the road “People’s Chamber“ (Volkskammer), which would Unity Party of Germany, the ruling party in the from Werderscher Markt, but a bridge was built now occupy the space. GDR. The Central Committee and the Politburo between the two which provided access to the met there. In 1995 it was decided to locate the first floor of each building. Federal Foreign Oce in this building and to add a new building on Werderscher Markt. 128 FEDERAL FOREIGN OFFICE

The new building was designed by the architects THE WE LT SAAL Thomas Müller and Ivan Reimann and constructed from 1997 to 1999. The transparent facade of (WORLD HALL) glass and travertine stone invites visitors to enter the atrium and its visitor center, which is open to the public. All in all, the new building with its At the heart of the old building on the first floor three partially open inner courts recalls the link lies a large conference center, almost 900mÐ between the old building and the Spree Canal, in size. The former Reichbank Hall 1 was consider- Schlossplatz and Werderscher Markt. ably altered for use by the SED leadership as a conference hall. During this process the luminous The architect commissioned to refurbish and alter ceiling was covered over. When the Federal the old building, Hans Kollho¬, faced a threefold Foreign Oce was refurbished, however, it was task. Firstly, he had to make it evident that Ger- uncovered, as was the original wood paneling in many’s new foreign policy had nothing to do with the central part of the ceiling. the policies pursued in this building during the two German dictatorships. On the other hand, The entire room can be divided by a 9 meter high however, he could not simply wipe out all traces and 16 meter wide mobile partition. It was de- of the past. What is more, the building had to be signed by Gerhard Merz as part of the three layer redesigned to meet the Federal Foreign Oce’s concept. The surface consists of numerous small spatial and functional requirements. squares in various colors. This deviation here in the Weltsaal from the monochrome surface To this end, Hans Kollho¬ developed the three- principle applied in the rest of the Old Building layer concept. The first layer highlights the was intended to highlight the world’s cultural modern aspects of the old building, which should diversity. not be transformed solely as an embodiment of National Socialist architecture. The second layer The lower part of the walls and the doors to the preserves in an exemplary fashion the building’s lounges are clad in German cherrywood. The design during the GDR era. For the third layer, a interpretation booths, screened o¬ from the hall, color concept which developed in collaboration are situated on top. This screen is divided into with the artist Gerhard Merz whose large mono- three monochrome sections, each of which has a chrome surfaces lend the building a modern flair. slim aluminum frame. The lower sections consist of black glass, the larger middle sections of a white screen, while the upper sections are mirrors. 130 GENERAL INFORMATION GENERAL INFORMATION 131

ACCESS TO THE VENUE/SECURITY COFFEE BREAKS HOMEPAGE MEDIA

To enter the World Health Summit venue Refreshments will be served during the co¬ee For up-to-date information regarding the Media representatives have access to all (Federal Foreign Oce), participants are required breaks. World Health Summit, please visit ocial sessions of the World Health Summit. to present a valid identity card/passport or a www.worldhealthsummit.org. Prior accreditation is required via similar personal identification document (photo CURRENCY www.worldhealthsummit.org/press-media/ included). Please be advised that due to security INSURANCE AND LIABILITY accreditation reasons, all participants will be subject to a secur- The currency used in Berlin is the Euro (€ or EUR). ity check including a passport identification Automated teller machines (ATMs), are located The organizers cannot accept liability for per- MOBILE PHONES confirmation. This procedure may cause a slight everywhere in Berlin and they accept most main so nal injury, loss of or damage to belongings of delay for entrance into the building. We there - credit cards such as Visa, Mastercard and participants, either during or as a result of the As a courtesy to speakers and other attendees, fore kindly ask you to refrain from bringing your American Express. Summit. Please check the validity of your own we kindly request that all mobile phones and luggage to the venue, as this will slow down the insurance. Attendees are advised to arrange their similar devices will be turned to silent mode before security check process. CASH POINT own adequate travel and medical insurance for entering a session. medical treatment, accidents, cancellation of AVAILABILITY BBBank eG Berlin bookings etc. No responsibility will be accepted NAME BADGE Hausvogteiplatz 3–4 by the World Health Summit organizers. Please note that the capacity of the venue and 10117 Berlin A badge is required for admittance to all World of single session rooms is limited. If the maximum INTERNET/WIRELESS LAN Health Summit sessions and events. Each parti- number of delegates is reached, the organizers EMERGENCY NUMBERS cipant is asked to present the badge in order to reserve the right to refuse access. Complimentary Wi-Fi will be available within gain access to the Summit. Fire: 112 the venue: CERTIFICATE OF ATTENDANCE Ambulance: 112 Name: WorldHealthSummit PEOPLE WITH DISABILITIES Police: 110 Password: #WHS2015 A Certificate of Attendance for all registered The venue is accessible to participants with participants will be available upon request at the FILMING AND TAKING PICTURES LANGUAGE disabilities. Please contact the Secretariat for registration desk. assistance: Phone: +49 30 49855035 or The organizer will provide a broad spectrum The ocial World Health Summit language is [email protected] CLOAKROOM of pictures and other graphical material for the English. There will be no simultaneous translation. representation of all World Health Summit events. LOST AND FOUND A cloakroom will be open in the back of the venue These files will be made available at LUNCHES (next to the “Weltsaal“) during the registration www.worldhealthsummit.org. Lost items can be collected at the registration opening times. Lunches will be available during the lunch breaks. desk during the Summit. Any objects found during the event and not claimed will remain at the venue. 132 GENERAL INFORMATION GENERAL INFORMATION 133

LIVE-STREAM/WEBCASTS Fees: or a CD-ROM. Please note that you cannot run Short Trip 1,60 € the presentation from your personal laptop in All sessions in the “Weltsaal” will be available as (max. 3 stations, one way only) the session room. Video support is at the sole live-stream at www.worldhealthsummit.org. Single Trip AB 2,70 € (one way only) responsibility of the speaker. Recorded webcasts will be available online after Single Trip BC 3,00 € (one way only) the event. Single Trip ABC 3,30 € (one way only) The Speaker Center is open during the Day Ticket ABC 7,40 € (all directions) following times: PARKING (AB, BC, ABC are indicating the travel zone.) Detailed information regarding public trans- Sunday, October 11, 2015 09:00 – 18:00 Please note that there are no public parking por tation is available at www.bvg.de Monday, October 12, 2015 08:00 – 18:00 facilities at the venue. Tuesday, October 13, 2015 08:00 – 18:00 REGISTRATION PROGRAM CHANGES TAXIS The registration desk is open during the The organizers cannot assume liability for any following times: All ocial taxis are colored o¬-white with a yellow changes in the program due to external or un- taxi sign on the roof. The meter starts at a set foreseen circumstances. Please check the website Sunday, October 11, 2015 09:00 – 22:00 minimum price. for regular updates. The organizers reserve the Monday, October 12, 2015 08:00 – 19:00 right to cancel, postpone, relocate or change any Tuesday, October 13, 2015 08:00 – 19:00 Major Taxi Hotlines: of the sessions. Taxi Berlin +49 30 202020 SMOKING POLICY Taxi Würfelfunk +49 30 210101 POSTERS Taxi Funk +49 30 443322 It is forbidden to smoke in any part of the A poster exhibition will be located at the poster World Health Summit venue. If there is no taxi available, please ask the area in the “Europa Foyer”. registration desk sta¬ for assistance. SPEAKER CENTER PUBLIC TRANSPORTATION All speakers and presenters must report to the Berlin’s public transport provides safe and com- Speaker Center, located at the “Europasaal”, fortable rides to almost all destinations in the city. at least two hours prior to their presentation in Tickets can be purchased directly at most train order to check and upload their presentation. stations and in all busses. Please provide the data on a USB Memory Stick 134 MEDIA INFORMATION CONTACTS 135

MEDIA INFORMATION WHS Foundation GmbH Strategic Communications c/o Charité– Daniela Levy Universitätsmedizin Berlin [email protected] Media Registrations Media Access Charitéplatz 1 Tel.: +49 30 450 572 114 Media Registrations are available free of charge Media has access to all ocial sessions of the 10117 Berlin, Germany Fax: +49 30 450 517 911 to journalists (pending proof of aliation). Prior to World Health Summit. the Summit, please establish your accreditation WHS Presidents Secretariat online via www.worldhealthsummit.org. Media Oce Shunichi Fukuhara Pascale Schulte Location: Room “Europasaal“ Detlev Ganten [email protected] During the Summit, please contact the media accreditation counter at the registration desk. Sunday, October 11, 2015 09:00 – 20:00 Managing Directors Conference Manager/Oce Assistant Monday, October 12, 2015 08:30 – 17:30 Jörg Heldmann Sarah-Maria Riedel Tuesday, October 13, 2015 08:30 – 17:30 [email protected] [email protected] PRESS CONTACT Tel.: +49 30 450 572 118 Tel: +49 30 450 572 219 Tobias Gerber, Daniela Levy It is possible to arrange interviews with our Fax: +49 30 450 517 911 Fax: +49 30 450 517 911 [email protected] speakers in a designated interview-area. [email protected] Alexander Hewer PA to the Managing Director Tel.: +49 30 450 572 114 [email protected] Petra Neitzel [email protected] PRESS CONFERENCE Program Director Tel: +49 30 450 572 219 Date: Sunday, October 11, 15:30–16:30 Julian Kickbusch Fax: +49 30 450 517 911 Room: Europasaal [email protected] Tel.: +49 30 450 572 102 Organizing Secretariat Fax: +49 30 450 517 911 Agentur WOK GmbH Palisadenstraße 48 Press & Public 10243 Berlin Relations Director Tobias Gerber Project Manager [email protected] Katrin Meischner Partner and Co-Host Tel.: +49 30 450 572 114 Fax: +49 30 450 517 911 Registration Department Felix Heller 136 KEYNOTE SPEAKERS AND CHAIRS KEYNOTE SPEAKERS AND CHAIRS 137

MARGARET CHAN KATIE DAIN Margaret Chan is the Director-General Katie Dain is Executive Director of the KEYNOTE SPEAKERS of World Health Organisation. Born in the NCD Alliance. Sheis widely recognized as People’s Republic of China, Dr Chan joined a leading advocate and expert on NCDs, AND CHAIRS WHO as Director of the Department for and has authored or co-authored numerous Protection of the Human Environment in papers and commentaries on global health 2003. She was elected Director-General and development policy issues. She is a in 2006 and was appointed for a second member of advisory groups and committees SAÏD AÏDI CHRISTINA RÅNGEMARK ÅKERMAN five-year term in 2012. for a range of international NCD initiatives. Mr. Saïd Aïdi currently serves as Minister of Christina Rångemark Åkerman is President Health of Tunisia within the government of of the International Consortium for Health Habib Essid. He previously worked as Deputy Outcomes Measurement (ICHOM), a non- DAME SALLY DAVIES MARK DYBUL of Tunis 2 District (December 2014) and profit organization with the purpose to Prof Dame Sally Davies is the Chief Medical Mark Dybul is the Executive Director of the Minister of Vocational Training and Employ- transform health care systems worldwide Ocer for England and Chief Medical Global Fund to Fight AIDS, Tuberculosis and ment within the government of Mohamed by measuring and reporting patient out- Advisor to the UK Government. She founded Malaria. He has worked on HIV and public Ghannouchi and Beji Caid Essebsi (2011). comes in a standardized way. the National Institute for Health Research health for more than 25 years as a clinician, He also held presidency position of the (NIHR) in the UK, is a member of the World scientist, teacher and administrator. International Association “Education for Health Organization Executive Board and Employment Tunisia” until April 2013. has advised many others on research stra - tegy and evaluation. Dame Davies is Emeritus Professor at Imperial College. RIFAT ATUN MANICA BALASEGARAM Rifat Atun is Professor of Global Health Balasegaram is a medical doctor. He Joined Systems and the Director of Global Health MSF In 2001, working as a doctor in the field VICTOR J. DZAU CATHERINE FIANKAN-BOKONGA Systems Cluster at Harvard University, in several countries in Sub-Saharan Africa Victor J. Dzau is the President of The Ms. Fiankan-Bokonga has been a corres- Harvard School of Public Health. and Southern Asia. He then joined MSF Instit ute of Medicine at National Academy pondent in Geneva since 1999. She is also In 2006–2013, Dr. Atun was Professor Partner organization Drugs For Neglected of Sciences, USA. He is also Chancellor a presenter and producer of television news of International Health Management and Diseases Initiative (DNDi) in 2008, where of Health A¬airs, Director of Molecular and reports. She is the Vice President of the Head of the Health Management Group he worked for four and a half years, finishing Genomic Vascular Biology and President Foreign Press Association of Switzerland at Imperial College London. as DNDi’s Head Of Leishmaniasis Clinical and Chief Executive Ocer at Health System and Lichtenstein (APES) and a member of Development Team before joining the Access of Duke University Medical Center. the Board of the Swiss Press Club and the Campaign. Association of Accredited Correspondents to the United Nations (ACANU).

DOUGLAS WILLIAM BETTCHER JOE CERRELL SHUNICHI FUKUHARA DETLEV GANTEN Douglas William Bettcher is the Director Joe Cerrell, managing director, Global the Department for Prevention of Non- Policy and Advocacy, is based in the Gates Shunichi Fukuhara is a Professor and Dean of Detelv Ganten is the President of the communicable Diseases, World Health Foundation’s European Oce in London. the Kyoto University School of Public Health World Health Summit since 2009. Since Organization (WHO), Geneva, Switzerland. In this role, Joe oversees the foundation’s and Associate Dean of Graduate School of 2005 he holds the position as Chairman He was previously the Director of WHO’s relationships with donor governments in Medicine. He represents Kyoto University of the Foundation Board of the Charité Tobacco Free Initiative Department, which North America, Europe, Asia-Paciﬁc, and as a member of the M8 Alliance, academic Foundation, and Chairman of the joint has now become an integral programme the Middle East. His team seeks to expand advisors of the WHS and is the 2015 WHS Board of Trustees of the Max Planck within the new Prevention of Noncommuni- the foundation’s partnerships with these international co-president. Institute of Colloids and Interfaces and cable Diseases Department. governments. of the Max Planck Institute of Molecular Plant Physiology. 138 KEYNOTE SPEAKERS AND CHAIRS KEYNOTE SPEAKERS AND CHAIRS 139

HARTMUT GRASSL HERMANN GRÖHE JOSEPH JIMENEZ DEBRA A. JONES Hartmut Graßl is the former director of the Hermann Gröhe is the Minister of Health Joseph Jimenez has been Chief Executive Ms. Debra A Jones serves as Save the Max Planck Institute of Meteorology and of Federal German Republic. From 2005 Ocer (CEO) of Novartis since 2010. Children’s Director and UN Representative professor emeritus at the Hamburg Univer- to 2008, he acted as legal counsel to He is responsible for leading the company’s in New York, engaging with UN agencies, sity for General Meteorology. the CDU/CSU parliamentary group and, healthcare portfolio of businesses in delegations, and civil society partners from 2006 to 2008 as a spokesperson pharmaceuticals, eye care and generics. to create lasting positive change for the of the CDU/CSU parliamentary group in world’s poorest and most vulnerable the First Committee of Inquiry. children.

NORBERT HAUSER DAGFINN HØYBRÅTEN MACHARIA KAMAU ILONA KICKBUSCH Norbert is currently the Chair of the Board Dagﬁnn Høybråten is the Chair of the Mr. Kamau is currently the co-facilitator Ilona Kickbusch is the Director of the Global of the Global Fund to Fight AIDS, Tubercu- GAVI Alliance Board and the Secretary for the intergovernmental negotiations on Health Program at the Graduate Institute losis and Malaria. As a a former Member of General of the Nordic Council of Ministers. the post-2015 development agenda and of International and Development Studies, Parliament and international auditor from Mr Høybråten has held several senior posi - was the co-chair of the UN Open Working Geneva. She is a leading contri bu tor to Germany Mr. Hauser previously served as tions in Norwegian Government including Group on the Sustainable Development academic and political debates on govern- interim Inspector General at the Global Fund Vice President of The Norwegian Parliament Goals (SDGs). ance for health at the national and the in 2012–2013 and as a member of the High- representing the Christian Democratic Party global level. She conducts global health Level Panel that created a blueprint for and a member of the Standing committee diplomacy seminars in many countries and reform at the Global Fund. for Foreign A¬airs and Defence. regions and advises the WHO at global and regional level.

HARTWIG HULAND WOLFGANG ISCHINGER MARIE-PAULE KIENY JOHN KIRTON Hartwig Huland holds the position as Ambassador Wolfgang Ischinger is the Urologist and Chief Physician at the Martini chairman of the Munich Security Conference Marie-Paule Kieny was appointed Assistant John Kirton is Director of the G7 Research Klinik, Hamburg since 2004. He also is a on the initiative of the German government. Director-General at the World Health Group, established at the University of ( ) member of the German, European and Ischinger began his diplomatic career when Organization WHO in October 2010 Toronto in 1987, Co-director of the G20 American Society of Urology and serves he joined the Federal Republic of Germany’s and is now leading the Health Systems Research Group, Co-director of the Global as a reviewer for the American “Journal of Foreign Service. He initially worked in the and Innovation cluster. Health Diplomacy Program, and a Research Urology” and “European Urology”. Policy Planning Sta¬ and at the German Associate of the Munk School of Global Embassy in Washington, D.C. He became A¬airs. Political Director of the Foreign Oce.

BIRGIT KÖNIG SURESH KUMAR ZSUZSANNA JAKAB LINONG JI Birgit König is the ﬁrst female member of Suresh Kumar currently serves as Member Zsuzsanna Jakab is the World Health Linong Ji is a Professor of Medicine and the Executive Committee of Allianz Germany, of the Executive Committee and the Global ( ) Organization WHO Regional Director Vice-President of the International Diabetes as Head of the Management Board. She has Leadership Team as well as Executive Vice ( ) for Europe. In this role, she has engaged at Federation IDF 2013–2015. He is the a PhD in Biochemistry and is a member of President for External A¬airs. He has an ﬁrst hand with many partners and Member Director of Department of Endo crinology the European Health Care Practice. Economics degree from Delhi University States, making progress on a joint health and Metabolism at Peking Uni versity and a Masters in Management from Bombay agenda for the WHO European Region. People’s Hospital and Co-Director of the University and more than 30 years of Diabetes Centre of Peking University. experience in the healthcare industry. 140 KEYNOTE SPEAKERS AND CHAIRS KEYNOTE SPEAKERS AND CHAIRS 141

STEFAN LARSSON WIM LEEREVELD MITCHELL MORRIS LUKA MUCIC Stefan Larsson joined BCG in 1996 and Wim Leereveld is CEO and Founder of the Mitchell Morris is Vice Chair and the Global Luka Mucic is a member of the Executive is a Senior Partner. He is the global leader Access to Medicine Index, an NGO which Leader for the Healthcare Sector at Deloitte. Board and Global Managing Board of of BCG’s Health Care Payor and Provider ranks the world’s largest pharmaceutical He is responsible for leading the US and SAP SE and is the Chief Financial Ocer sector and a member of the global Health companies every two years on their policies global healthcare practice for one of the as well as Chief Operating Ocer (COO). care leadership team. Mr. Larsson has and practices for improving access to medi - world’s largest professional services ﬁrms worked across all aspects of the Health cine for people living in low-income and o¬ering audit, risk, tax, ﬁnancial ad visory Care industry. middle-income countries. and a range of consultative services.

FREDA C. LEWIS-HALL KLAUS LINDPAINTNER MICHAEL MYERS HIROKI NAKATANI As Chief Medical Ocer, Freda Lewis-Hall Klaus Lindpaintner is Chief Scientific Ocer Michael Myers performs a number of leader- Hiroki Nakatani is presently Advisor for leads Pfizer Medical, the division of Pfizer at Thermo Fisher Scientific Inc. He served as ship roles at The Rockefeller Foundation. International A¬airs to the Minister of responsible for the safe, e¬ective and a Roche Distinguished Scientist and director He leads the Foundation’s global health work Health, Labour and Welfare, Government appropriate use of the company’s medicines of the Roche Center for Medical Genomics, including its Transforming Health Systems of Japan, and, Professor for Global Initiatives and vaccines everywhere in the world. as well as global head of molecular medi- initiative and the campaign for universal at Keio University. He served as Assistant cine policy and external a¬airs for F. Ho¬man- health coverage. He also coordinates strate - Director-General of WHO from March 2007 La Roche AG. gies for the Foundation’s work in the United to May 2015. States with a focus on building inclusive economies in cities. LUIZ LOURES JEAN-CLAUDE MANUGUERRA Loures is a medical doctor with nearly Jean-Claude Manuguerra is a Virologist GÜNTHER H. OETTINGER AXEL R. PRIES 30 years’ experience in the AIDS response. at the Pasteur Institute in Paris. He is the Günther H. Oettinger is currently the Euro- Axel R. Pries holds the position Dean of He joined UNAIDS in 1996 and was appointed Chairman of the National Committee against pean Commissioner for Digital Economy the Charité since January 2015. He also Deputy Executive Director of Programme the flu and seats the Scientific Council of and Society. Following several years of work is the Head of the Institute of Physiology and Assistant Secretary-General of the United the global program against the flu by the as a lawyer, he entered the political arena, at the Charité–Universitätsmedizin Berlin. Nations in January 2013. He leads UNAIDS’ World Health Organization (WHO). where he has been active both in Baden- e¬orts in leveraging critical support to coun - Württemberg and the European Com- tries to meet the 2015 global AIDS targets mission. and establish a sustainable response to AIDS.

AMY MAXMEN SUERIE MOON K. SRINATH REDDY MELVIN SAMSOM Amy Maxmen is a science journalist, editor, Suerie Moon is the Study Director of the K. Srinath Reddy is currently President of Melvin Samsom has been the Chief Executive and photographer who covers the entangle- Independent Panel on the Global Response the Public Health Foundation of India (PHFI) Ocer of Karolinska University Hospital ments of evolution, medicine, policy and to Ebola, a joint initiative of the Harvard and formerly headed the Department of since October 1, 2014. Mr. Samsom has been of the people behind research. Her stories Global Health Institute, Harvard University Cardiology at All India Institute of Medical department chairman and division chairman appear in a variety of outlets, including and the London School of Hygiene and Sciences (AIIMS). at the University Medical Center Utrecht, National Geographic, Nature, Newsweek, Tropical Medicine. then becoming CMO, and in 2011 Chief Nova/PBS, Al Jazeera and the New York Executive Ocer of Radboud University Times. Medical Center. 142 KEYNOTE SPEAKERS AND CHAIRS KEYNOTE SPEAKERS AND CHAIRS 143

RAINER SAUERBORN HANS JOACHIM SCHELLNHUBER FRIEDRICH VON BOHLEN UND HALBACH FLORIAN WESTPHAL Rainer Sauerborn is the drector of the Hans Joachim Schellnhuber founded Friedrich von Bohlen und Halbach is a Florian Westphal currently works as Institute of Public Health at Heidelberg the Potsdam Institute for Climate Impact managing partner at dievini Hopp BioTech General Director at Médecins Sans Fron- University since 1997. He also holds the Research (PIK) in 1992 and has been its Holding GmbH & Co.KG., the company tières Germany. He worked for 15 years as position of a guest pofessor at Umea Director ever since. He holds a Chair in managing the life science activities and a member of the International Committee University in Sweden for “Global Health Theoretical Physics at Potsdam University investments of SAP co-founder Dietmar of the Red Cross (ICRC) in various countries and Climate Change”. and is an External Professor at the Santa Hopp. He has more than 15 years of entre- such as Democratic Republic of Congo, Fé Institute (USA). preneurial experience in the ﬁeld of Life Sierra Leone and Kenya and subsequently Sciences. served as the ICRC’s Head of Media.

LEWIS SCHRAGER RITA SCHWARZELÜHR-SUTTER LOTHAR WIELER OTMAR WIESTLER Schrager oversees and maintains key Rita Schwarzelühr-Sutter is Parliamentary external relationships focused on research State Secretary at the Federal Ministry for Lothar H. Wieler is the president of Robert Otmar Wiestler joined the Deutsches ( and development and represents Aeras at the Environment, Nature Conservation, Koch Institute, the central institution Krebsforschungszentrum German Cancer ) major scientiﬁc meetings and symposiums. Building and Nuclear Safety. responsible for disease control and pre- Research Center, DKFZ in Heidelberg He has held a variety of leadership roles vention in Germany. He is also a Professor as Chairman and Scientiﬁc Member of across several divisions at the FDA. of Veterinary Medicine at the Institute of the Management Board in 2004. Since Microbiology and Epizootics of the Free September 2015 he serves as the President University in Berlin and a diplomat of the of the Helmholtz Association in Berlin. European College of Veterinary Public Health. RICHARD SEZIBERA BT SLINGSBY Richard Sezibera is the current Secretary BT Slingsby is CEO and Executive Director General of the East African Community, of the Global Health Innovative Technology JOHN EU LI WONG ADA YONATH an Inter-Governmental Organization bring- Fund. Previously, he was Director for Global John Eu Li Wong is Vice Provost (Academic Ada E. Yonath won the Nobel Prize for ing together the Partner States of Burundi, Access Strategies for Eisai & Co., where Medicine) of the National University of Chemistry together with Venkatraman Kenya, Rwanda, the United Republic of he developed new business models for Singapore (NUS) as well as the Deputy Chief Ramakrishnan and Thomas Steitz for their Tanzania and Uganda. Research & Development and market access Executive of the National University Health work on ribosomal structure and function. in the developing world. He is a former System (NUHS), and Director of the National She is a professor at the Department of professional triathlete and member of the University Cancer Institute, Singapore Structural Biology and Director of The U.S. World Cup Team. (NCIS). Helen and Milton A. Kimmelman Center for Biomolecular Structure, Weizmann Institute, Israel. SAMBA O. SOW THOMAS SÜDHOF Samba Sow is Director General of the Thomas Südhof is the Avram Goldstein Center for Vaccine Development – Mali Professor in the School of Medicine (CVD Mali) and a Professor of Medicine at Stanford University. He performed his at the University of Maryland School of doctoral thesis work at the Max Planck Medicine. Previously, Mr. Sow has served Institute in his home-town of Göttingen as the coordinator for WHO Multi-Center and was awarded the Nobel Prize for Field Trial on Leprosy Chemotherapy. Medicine and Physiology in 2013 for his work on synaptic transmission. 144 SPEAKER INDEX WITH PICTURES SPEAKER INDEX WITH PICTURES 145

SPEAKER INDEX

ABBANY, ADLI, AERTS, AGEYKUM, AÏDI, ÅKERMAN, BESSER, BETTCHER, BEYER, BOITARD, BOUFFORD, BOURDEAUX, ZULFIKAR G. MAZDA ANN SYLVESTER OSEI SAÏD RÅNGEMARK DANIEL DOUGLAS W. PETER CHRISTIAN JO IVEY MARGARET Deutsche Welle | Charité–Universitäts- Novartis Foundation| Boehringer Minister of Health | CHRISTINA German Stem Cell World Health World Health The National Insti - The New York Brigham and Germany medizin Berlin | Switzerland Ingelheim GmbH Tunisia International Con- Network (GSCN) | Organization Organization tute for Health and Academy of Women’s Hospital Fliedner Klinik & Co.KG | Ghana sortium for Health Germany (WHO) | (WHO) | Medical Research Medicine | United Boston | United Berlin | Germany Outcomes Measure- Switzerland Switzerland (INSERM) | France States of America States of America ment (ICHOM) | USA

ALLEGRANZI, ALLSOPP, ANG, ARCH, ASLANYAN, ATUN, BUEKENS, BYARUHANGA, CADER, CANNY, CERRELL, CHAN, BENEDETTA TIM SOPHIA ROBERT GARRY RIFAT PIERRE JANET ZAMEEL BEN JOE MARGARET World Health Pﬁzer Inc. | National University Takeda Pharmaceu- World Health Harvard T.H. Chan Tulane University | African Union University of Oxford| Monash University | Bill & Melinda Gates World Health Organization United Kingdom Health Services | tical Company Ltd. | Organization School of Public United States Commission | United Kingdom Australia Foundation/ Organization (WHO) | Singapore United States of (WHO) | Health | United of America Ethopia European Oce | (WHO) | Switzerland America Switzerland States of America United Kingdom Switzerland

AULER JR., BALASEGARAM, BAROUKI, BARTSCH, BAUR, BEIER, CHIONG, CRESPIN, DAIN, DAVIES, DE CIDRAC, DEPOUX, JOSÉ OTÁVIO MANICA ROBERT ALEXANDRA CYNTHIA KLAUS YEE KEOW XAVIER KATIE SALLY CHARLES-ETIENNE ANNELIESE COSTA Médecins Sans University Paris European Students’ Centers for Disease Charité–Universitäts- National University West African Health International Government UK AXA Global Life | Centre Virchow- University of São Frontières (MSF) | Descartes | France Conference | Control and medizin Berlin | Health System Organization Diabetes Federation| Department France Villermé (CVV) | Paulo Medical Switzerland Germany Prevention | United Germany (NUHS) | (WAHO) | Belgium of Health | France School I Brazil States of America Singapore Burkina Faso United Kingdom 146 SPEAKER INDEX WITH PICTURES SPEAKER INDEX WITH PICTURES 147

DRENCKHAHN, DUDLEY, DYBUL, DZAU, EDWARDS, EKEKE MONONO, GILPIN, GLASZIOU, GÖHDE, GOOD, GRASSL, GRÖHE, DETLEV LILIAN MARK VICTOR J. NANCY MARTIN SUSAN PURCELL PAUL ROLAND SUJAVEE HARTMUT HERMANN WWF Germany | University of The Global Fund to National Academy Institute of Popu- World Health World Council of Bond University | Sysmex Partec World Health Max Planck Institute Federal Ministry of Germany Stellenbosch | Fight AIDS, Tuber- of Medicine | United lation and Public Organization Churches (WCC) | Australia GmbH | Organization | India for Meteorology Health | Germany South Africa culosis and Malaria | States of America Health (CIHR) | (WHO) Regional Switzerland German Healthcare (MPI-M) | Germany United States Canada Oce for Africa | Partnership (GHP) | of America Congo Germany

ERSDAL, FACEY, FIANKAN- FIKERT, FLAHAULT, FLORY, GROLMAN, GUERREIRO HAASE, HAGGENMILLER, HAHN, HAINES, HEGE KAREN BOKONGA, KRYSTIAN ANTOINE EGBERT DAVID C. BAPTISTA LEITE, MAREIKE CHRISTIAN HORST KARL SIR ANDREW Stavanger Acute University CATHERINE MyMind Ltd. | University Paul-Ehrlich- Pﬁzer Inc. | Australia RICARDO Brot für die Welt– LinkGlobalHealth. Fraunhofer Institute London School of medicine Founda- of Glasgow | United Nations (UN)| Ireland of Geneva | Institut| Germany AUGUSTUS Evangelischer org | Germany for Medical Image Hygiene & Tropical tion for Education United Kingdom Switzerland Switzerland Parliament of Portu- Entwicklungsdienst| Computing MEVIS | Medicine | and Research guese Republic | Germany Germany United Kingdom (SAFER) | Norway Portugal

FONTANET, FUKUHARA, GANTEN, GEFFERT, GILLESPIE, GILMOUR, HAUSER, HEIM, HEINZ, HERBINGER, HERFURTH, HOEVELER, ARNAUD SHUNICHI DETLEV KARIN THOMAS R. JILL NORBERT CHRISTINE ANDREAS ILKA TANYA ARND Institut Pasteur | Kyoto University | Charité Foundation | German Medical Emory College of Imperial College The Global Fund to Charité–Universitäts- Charité–Universitäts- WWF Germany | Young Leaders for European France Japan Germany Students’ Associa- Arts and Sciences | London | Fight AIDS, Tuber - medizin Berlin | medizin Berlin | Germany Health (YLH) e.V. | Commission | tion (bvmd) e.V. | United States United Kingdom culosis and Malaria | Germany Germany Germany Belgium Germany of America Switzerland 148 SPEAKER INDEX WITH PICTURES SPEAKER INDEX WITH PICTURES 149

HOLDEN, HOLMQVIST, HOOI, HØYBRÅTEN, HULAND, HURRELMANN, KARIUKI, KATSUNO, KAUFMANN, KAWASAKI, KHOO, KICKBUSCH, JESSICA ROLF SHING CHUAN DAGFINN HARTWIG KLAUS THOMAS KEI PETRA RYO DAPHNE ILONA Médecins Sans Linköping National University Gavi, The Vaccine Martini Klinik at UKE Hertie School Alliance for Accel- Global Health National Center Fukushima Medical Ministry of Health | The Graduate Frontières (MSF)| University | of Singapore | Alliance | GmbH| Germany of Governance | erating Excellence Innovative Techno- for Advancing Trans- University | Japan Singapore Institute of Interna- Australia Sweden Singapore Switzerland Germany in Science in Africa logy Fund | Japan lational Sciences tional and Develop- (AESA) | Kenya (NCATS) | United ment Studies | States of America Switzerland

ILIC, ISCHINGER, IYER, JACKSON, JAKAB, JI, KIENY, KIESELBACH, KIRTON, KOLPATZIK, KÖNIG, KORNELY, DRAGAN WOLFGANG JAYASREE CAITY ZSUZSANNA LINONG MARIE-PAULE BERIT JOHN KAI BIRGIT FRANK Monash University | Munich Security Access to Medicine Women in Global World Health International World Health World Health University AOK Allianz Private Boehringer Australia Conference | Foundation | Health | Sweden Organization | Diabetes Federation| Organization | Organization | of Toronto | Bundes verband | Krankenversiche- Ingelheim GmbH Germany Netherlands Denmark Belgium Switzerland Switzerland Canada Germany rungs-AG | Germany & Co.KG | Germany

JIMENEZ, JOSEPH JOHNSTONE, JONES, JØRGENSEN, JOUSSEN, KAMAU, KRÄMER, KRANENBURG, KRISAM, KÜHLEN, KUHN, KUMAR, Novartis International ANDREW DEBRA A. MARIE BIRK ANTONIA MACHARIA ALEXANDER JOCELINE MATHIAS BARBARA HEIKE SURESH AG | Switzerland European Patients Save the Children | National Research Charité–Universitäts- United Nations (UN)| Bielefeld University | Global Health Next Charité–Universitäts- Oxfam Deutschland German Federal Sanoﬁ Aventis European Federation Forum (EPF) | United States of Center for the medizin Berlin | United States of Germany Generation Network medizin Berlin | e.V. | Germany Ministry for Eco- Groupe S.A. | of Pharmaceutical ( ) Industries and Asso - United Kingdom America Working Environ- Germany America GHNGN | Germany nomic Cooperation Switzerland ciations (EFPIA) | ment | Denmark Netherlands and Development Belgium (BMZ) | Germany 150 SPEAKER INDEX WITH PICTURES SPEAKER INDEX WITH PICTURES 151

KUMAR, KÜMMEL, LAMBERT, LARSSON, LEEK, LEENDERTZ, MAAS, MAKANGA, MAKGATO-MALESU, MANGION, MANSARAY, MANUGUERRA, VISHWAJEET BJÖRN SANDRA STEFAN JEFFREY FABIAN JOCHEN MICHAEL DORCAS JONATHAN SHECKU KAWUSU JEAN-CLAUDE Shivharh Community Federal Ministry of Merck (Pty) Ltd. | The Boston Johns Hopkins Robert Koch Sanoﬁ-Aventis European and Ministry of Health | Thermo Fisher Inc. | Sierra Leone Adult Institut Pasteur | Empowerment Lab | Health (BMG) | South Africa Consulting Group | Bloomberg School Institute| Germany Deutschland GmbH| Developing Coun- Botswana United Kingdom Education Asso- France India Germany Sweden of Public Health | Germany tries Clinical Trials ciation (SLADEA) | United States of Partnership (EDCTP) | Sierra Leone America South Africa

LEEREVELD, LEWIS, LEWIS-HALL, LIM, LINDBERG, LINDPAINTNER, MARTIN, MAXMEN, MCGRATH, MICHIE, MISSMAHL, MLADOVSKY, WIM CHRIS FREDA C. AYMERIC CASJA KLAUS ULRICH AMY PETER SUSAN INGE PHILIPA Access to Medicine Department for Pﬁzer Inc. | National University UNG Diabetes | Thermo Fisher German Stem Cell Pulitzer Center on The World University College Ipso gemeinnützige London School Foundation | International United States Hospital | Singapore Sweden Scientiﬁc Inc. | Network (GSCN) | Crisis Reporting | Aca demy of London | Gesellschaft mbH | of Economics Netherlands Development of America United States Germany United States Sciences | United Kingdom Germany and Political (DFID) | of America of America Italy Sciences | United Kingdom United Kingdom

LODBROK, LOEWENBERG, LOOI, LOURES, LUNZE, LYRAS, MOON, MÖRÖY, MORRIS, MUCIC, MÜLLER-JUNG, MURAKAMI, OLAF SAMUEL LAI-MENG LUIZ KARSTEN DENA SUERIE TARIK MITCHELL LUKA JOACHIM AKIRA Elsevier GmbH | Pulitzer Center on Academy United Nations (UN)| Boston University Monash University | Harvard T.H. Chan Clinical Research Deloitte Consulting SAP SE | Germany Frankfurter Juntendo University Germany Crisis Reporting | of Sciences | UNAIDS | School of Medicine I Australia School of Public Institute Montreal LLP | United States Allgemeine Zeitung Tokyo | Center for United States Malaysia Switzerland United States Health | (IRCM) | Canada of America (FAZ) | Germany Prevention of of America of America United States Blindness | Japan of America 152 SPEAKER INDEX WITH PICTURES SPEAKER INDEX WITH PICTURES 153

MURKE, MURRAY, MWEHONGE, MYERS, NAKATANI, NAPIER, PACCAUD, PASTORE, PATEL, PELEG, PETROVA- PFUNDNER, JULIUS SIR ROBIN KENNETH MICHAEL HIROKI DAVID JEAN-PIERRE MANUELA VIKRAM ANTON BENEDICT, HAGEN Young Leaders for King’s College Coalition for Health The Rockefeller Keio University | University College Drugs for Neglected Boehringer London School Monash University | ROUMYANA Roche Pharma AG | Health (YLH) e.V. | London | United Promotion and Foundation | Japan London | Diseases initiative Ingelheim GmbH of Hygiene & Australia International Verband Forschen- Germany Kingdom Social Development United States Ministry of Health, United Kingdom (DNDi) | & Co.KG | Germany Tropical Medicine | Organization for der Arzneimittel- (HEPS) | Uganda of America Labour and Welfare| Switzerland United Kingdom Migration (IOM) | hersteller e.V. (vfa) | Japan Belgium Germany

NDOMONDO- NEUMANN, NGOZWANA, NIMMESGERN, NOLAN, NOLL, PINTSCHER, PIPELEERS, POLGLASE, PRIES, RABBOW, RAPPAGLIOSI, SIGONDA, MARKUS SKHUMBUZO ELMAR CANICE JENNIE LYDIA DANIEL GRAEME AXEL R. MICHAEL ANDREA MARGARETH Bioscientia–Institut Serenus Biothera- European European Pennsylvania Wikimedia Brussels Free Monash University | Charité–Universitäts- Boehringer Sanoﬁ Pasteur The New Partnership für Medizinische peutics Ltd. | Commission | Commission | State University | Deutschland e.V. | University (VUB) | Australia medizin Berlin | Ingelheim GmbH MSD | France For Africa’s Develop- Diagnostik GmbH | South Africa Belgium Belgium United States Germany Belgium Germany & Co.KG | Germany ment (NEPAD) | Germany of America South Africa

O’BRIAN, OELRICH, OETTINGER, OLDGREN, OSBORNE, OSTERHAUS, REDD, REDDY, REDDY, REEDER, RIETSCHEL, ROOS, KEVIN STEFAN GÜNTHER H. JONAS RICHARD ALBERT CHRIS DAVID SRINATH JOHN ERNST TH. ANDREAS Handelsblatt GmbH| Sanoﬁ Aventis European Uppsala University | Deakin University | University of Universities Allied Medicines for Public Health World Health Berlin Institute of VAMED Manage- Germany Deutschland GmbH| Commission | Sweden Australia Veterinary Medicine for Essential Malaria Venture Foundation of India| Organization | Health (BIH) | ment und Service Germany Belgium Hannover | Medicines (UAEM) | (MMV) | Switzerland India Switzerland Germany Schweiz AG I Germany United Kingdom Switzerland 154 SPEAKER INDEX WITH PICTURES SPEAKER INDEX WITH PICTURES 155

RUCZINSKI, RYLL, SADALLAH, SAMARASEKERA, SAMSOM, SAUERBORN, SOW, STANLEY-BAKER, STOCK, STURCHIO, SÜDHOF, SUTER, INGO BETTINA FATIHA DUJEEPA MELVIN RAINER SAMBA O. MICHAEL GÜNTER JEFFREY THOMAS PETER Johns Hopkins Melanoma Patient Innovative Medi- National University Karolinska University Hospital Center for Vaccine Max Planck Institute Berlin-Brandenburg Rabin Martin | Stanford University University Medical Bloomberg School Network Europe | cines Initiative | Health System | University Hospital | Heidelberg | Development | Mali for the History of Academy of United States of School of Medicine | Center | Switzerland of Public Health | Sweden Belgium Singapore Sweden Germany Science | Germany Sciences and America United States United States Humanities (BBAW)| of America of America Germany

SAVIOLI, SCHÄFERS, SCHELLNHUBER, SCHRAGER, SCHÜTTE, SCHWARZELÜHR- TANAKA, TANNER, TEPEL, ULBERT, ULBRICH, ULRICHS, LORENZO REINHARD HANS JOACHIM LEWIS GEORG SUTTER, RITA ELLY M. MARCEL RALF CORNELIA JUTTA TIMO Global Schistoso- WHS Foundation Potsdam Institute Aeras | United German Federal Federal Ministry for Center for Regener- Swiss Tropical Karl Kübel Stiftung Duisburg-Essen AbbVie Akkon Univerity miasis Alliance GmbH–World for Climate Impact States of America Ministry of Educa- the Environment, ative Therapies TU & Public Health für Kind und Familie| University | Germany Deutschland GmbH for Human Science | (GSA) | Switzerland Health Summit | Research (PIK) | tion and Research Nature Conservation, Dresden (CRTD)| Institute | Germany & Co.KG | Germany Koch-Metchnikov ( ) Building and Nuclear ( ) Germany Germany BMBF | Germany Safety (BMUB) | Germany Switzerland Forum e.V. KMF | Germany Germany

SEBBAG, SEHOULI, SEZIBERA, SHAW, SIBAL, SLINGSBY, UNSCHULD, VALDIVIA, VERMURI, VILCINSKAS, VON BOHLEN WALLACE, ROBERT JALID RICHARD JONATHAN ANUPAM BT PAUL ULRICH LEONEL A. MOHAN C. ANDREAS UND HALBACH, EUAN Sanoﬁ | France Charité–Universitäts- East African Monash University | Apollo Hospitals Global Health Charité–Universitäts- University of Chile | Thermo Fisher Fraunhofer Society | FRIEDRICH Monash University | medizin Berlin | Community (EAC) | Australia Group | India Innovative medizin Berlin | Chile Scientiﬁc Inc. | Germany dievini Hopp Australia Germany Rwanda Indraprastha Apollo Technology Fund | Germany United States BioTech holding Hospitals | India Japan of America GmbH & Co.KG | Germany 156 SPEAKER INDEX WITH PICTURES SPEAKER LIST 157

SPEAKER LIST

A Crespin, Xavier 96 Gilpin, Susan Purcell 50 Ji, Linong 104 Abbany, Zulﬁkar G. 46 Glasziou, Paul 54 Jimenez, Joseph 76 Adli, Mazda 110 D Göhde, Roland 56, 78, 96 Johnstone, Robert Andrew Aerts, Ann 58 Dain, Katie 104 Good, Sujavee 80 44 Ageykum, Sylvester Osei 52 Davies, Sally 64 Graßl, Hartmut 114 Jones, Debra A. 74 Aïdi, Saïd 86 de Cidrac, Charles-Etienne Gröhe, Hermann 60 Jørgensen, Marie Birk 80 WATSON-STRYKER, WEBER-MOSDORF, WEEKERS, WEILAND, WESTPHAL, WIELER, Åkerman Rångemark, 78 Grolman, David C. 94 Joussen, Antonia 98 ELLA SUSANNE JACQUELINE UTE FLORIAN LOTHAR Christina 76 Depoux, Anneliese 106 Guerreiro Baptista Leite, Médecins Sans Former Executive International Alfred Herrhausen Médecins Sans Robert Koch Ricardo Augustus 84 Frontières (MSF) | Director of the Organization for Society–The Inter- Frontières (MSF) | Institute | Germany Allegranzi, Benedetta 44 Dhatt, Roopa 61 K United States WHO Oce Migration (IOM) | national Forum of Germany Allsopp, Tim 82 Drenckhahn, Detlev 112 Kamau, Macharia 74 of America European Union | Switzerland Deutsche Bank | Ang, Sophia 54 Dudley, Lilian 78 H Kango, Mabvuto 104 Germany Germany Arch, Robert 58 Dybul, Mark 74, 76 Haase, Mareike 50 Kariuki, Thomas 40 Aslanyan, Garry 40 Dzau, Victor 60 Haggenmiller, Christian Katsuno, Kei 58 Atun, Rifat 74 42, 46 Kaufmann, Petra 108 Auler Jr., José Otávio 44, 45 E Hahn, Horst Karl 56 Kawasaki, Ryo 98 Edwards, Nancy 40 Haines, Sir Andrew 107, 114 Kekulé, Alexander 56 B Ekeke Monono, Martin 50 Hauser, Norbert 102 Khoo, Daphne 44 Balasegaram, Manica 64, 96 El Khormi, Myriam 60 Heim, Christine 72 Kickbusch, Ilona 78, 92 Barouki, Robert 106 Ersdal, Hege 68 Heinz, Andreas 66, 110 Kieny, Marie-Paule 64 Barry, Boubacar 106 Herbinger, Ilka 112 Kieselbach, Berit 72 WIESTLER, WONG, WONG, YANKAH, YONATH, YOONG, OTMAR D. DAVID JOHN EU LI CHARLES ADA E. JOANNE Bartsch, Alexandra 38 F Herfurth, Tanya 38 Kirton, John 102 Helmholtz Asso- University of Hong National University African Cultural Weizmann Institute National University Baur, Cynthia 80 Facey, Karen 84 Hoeveler, Arnd 82 Kolpatzik, Kai 80 ciation | Germany Kong | Hong Kong of Singapore | Institute | Germany of Science | Israel of Singapore | Beier, Klaus 72 Fiankan-Bokonga, Catherine Holden, Jessica 68 König, Birgit 60 Singapore Singapore Berntgen, Michael 84 104 Holmqvist, Rolf 72 Kornely, Frank 52 Besser, Daniel 82 Fikert, Krystian 52 Hooi, Shing Chuan 54 Kra¬t, Thomas 100 Bettcher, Douglas W. 104 Flahault, Antoine 88, 106 Høybråten, Dagﬁnn 74 Krämer, Alexander 46 Beyer, Peter 100 Flory, Egbert 82 Huland, Hartwig 76 Kranenburg, Joceline 38 Boitard, Christian 108 Fontanet, Arnaud 107 Humberg, Kerstin Maria 52 Krisam, Mathias 38 Bou¬ord, Jo Ivey 70 Friebe, Richard 108 Hurrelmann, Klaus 80 Krönke, Martin 108 Bourdeaux, Margaret 42 Fukuhara, Shunichi Kühlen, Barbara 50 Buekens, Pierre 40 60, 88, 116 I Kuhn, Heike 78 Byaruhanga, Janet 96 Ilic, Dragan 54 Kumar, Suresh 104 G Ischinger, Wolfgang 116 Kumar, Vishwajeet 68 YZER, C Ganten, Detlev Iyer, Jayasree 68 Kümmel, Björn 50 CORNELIA Cader, Zameel 82 56, 60, 66, 88, 116 Federal Govern- Canny, Ben 38, 68 Ge¬ert, Karin 38 J L ment Berlin | Germany Cerrell, Joe 102 George, Elisabeth 84 Jackson, Caity 38 Lambert, Sandra 96 Chan, Margaret 60 Gillespie, Thomas R. 112 Jakab, Zsuzsanna 74 Larsson, Stefan 76 Chiong, Yee Keow 54 Gilmour, Jill 40 Janke, Christian 42 Leek, Je¬rey 48 158 SPEAKER LIST SUPPORTING INSTITUTIONS 159

Leendertz, Fabian 112 Murke, Julius 38 R T Leereveld, Wim 92 Murray, Sir Robin 110, 116 Rabbow, Michael 52, 78, 96 Taib, Nezar Ismet 42 SUPPORTING INSTITUTIONS Le Jeunne, Claire 84 Mwehonge, Kenneth 50 Rappagliosi, Andrea 84 Tanaka, Elly M. 82 Lewis, Chris 40 Myers, Michael 102 Redd, Chris 38 Tanner, Marcel 112 SESSION CO-HOSTS Lewis-Hall, Freda C. 74 Reddy, David 58 Tepel, Ralf 52 Lim, Aymeric 44 N Reddy, Srinath 100, 104 Lindberg, Casja 82 Nakatani, Hiroki 102 Reeder, John 41 U Lindpaintner, Klaus 86 Napier, David 66 Rietschel, Ernst Th. 56, 108 Ulbert, Cornelia 50 A G Lodbrok, Olaf 48 Ndomondo-Sigonda, Roos, Andreas 45 Ulbrich, Jutta 48 AbbVie Deutschland GmbH & Co.KG Geneva Health Forum Loewenberg, Samuel 46 Margareth 96 Ruczinski, Ingo 48 Ulrichs, Timo 94 Allianz Deutschland AG German Centers for Health Research (DZG) Looi, Lai-Meng 112 Neumann, Markus 56 Ryll, Bettina 84 Unschuld, Paul Ulrich 67 German Federal Foreign Oce (AA) Loures, Luiz 96, 116 Ngozwana, Skhumbuzo 96 B German Federal Ministry for Economic Cooperation ( ) ( ) Lunze, Karsten 68 Nimmesgern, Elmar 108 S V Berlin Institute of Health BIH and Development BMZ ( ) Lyras, Dena 94 Nolan, Canice 94 Sadallah, Fatiha 82 Valdivia, Leonel A. 100 Bielefeld University German Federal Ministry of Health BMG ( ) Noll, Jennie 72 Samarasekera, Dujeepa 54 Vermuri, Mohan C. 82 Boehringer Ingelheim GmbH & Co.KG German Healthcare Partnership GHP M Samsom, Melvin 76 Vilcinskas, Andreas 57 Brot für die Welt–Evangelischer Entwicklungsdienst German Medical Students’ Association (bvmd) Maas, Jochen 56 O Sauerborn, Rainer 106, 114 von Bohlen und Halbach, German Stem Cell Network (GSCN) Makanga, Michael 41 O’Brian, Kevin 100 Savioli, Lorenzo 58 Friedrich 86 C Global Health Innovative Technology Fund (GHIT) Makgato-Malesu, Dorcas Oelrich, Stefan 56 Schäfers, Reinhard 66 Charité–Universitätsmedizin Berlin Global Health Next Generation Network (GHNGN) 78 Oettinger, Günther H. 86 Schellnhuber, Hans Joachim W Mangion, Jonathan 48 Oldgren, Jonas 76 114 Wallace, Euan 68 D H ( ) Mansaray, Shecku Kawusu Osborne, Richard 80 Schrager, Lewis 64 Watson-Stryker, Ella 67 Drugs for Neglected Diseases initiative DNDi Harvard Medical School 50 Osterhaus, Albert 112 Schulze, Jürgen 96 Weber-Mosdorf, Susanne 100 Helmholtz Association of German Research Centres e.V. Manuguerra, Jean-Claude Schütte, Georg 108 Weekers, Jacqueline 110 E Hertie School of Governance 92 P Schwarzelühr-Sutter, Rita 114 Weiland, Ute 110 EBiSC Martin, Ulrich 82 Paccaud, Jean-Pierre 58 Sebbag, Robert 96 Westphal, Florian 42, 92 Elsevier GmbH I ( ) Maxmen, Amy 92 Pastore, Manuela 52 Sehouli, Jalid 66 Wieler, Lothar 64, 112 European Commission Innovative Medicines Initiative IMI McGrath, Peter 70 Patel, Vikram 73 Sezibera, Richard 79, 116 Wiestler, Otmar D. 86 European Federation of Pharmaceutical Industries Institut Pasteur ( ) ( ) Meddeb, Aymen 61 Peleg, Anton 94 Shaw, Jonathan 98 Wong, David 98 and Association EFPIA InterAcademy Medical Panel IAMP ( ) Michie, Susan 55 Petrova-Benedict, Roumyana Shirwadkar, Swati 73 Wong, John Eu Li 44, 64 European Students’ Conference ESC Miller, Kenneth 110 46 Sibal, Anupam 45 J F LinkGlobalHealth.org Initiative Missmahl, Inge 66 Pfundner, Hagen 56 Sié, Ali 114 Y Federal Ministry for the Environment, Nature Conservation, Johns Hopkins Bloomberg School of Public Health Mladovsky, Philipa 46 Pintscher, Lydia 48 Slingsby, BT 64 Yankah, Charles 46 Building and Nuclear Safety (BMUB) Moon, Suerie 92 Pipeleers, Daniel 82 Sow, Samba O. 92 Yonath, Ada E. 64 Fliedner Klinik Berlin K Möröy, Tarik 48 Polglase, Graeme 68 Stanley-Baker, Michael 66 Yoong, Joanne 55 Fraunhofer-Institut für Bildgestützte Medizin MEVIS Karl Kübel Stiftung für Kind und Familie Morris, Mitchell 102 Pries, Axel R. 60 Stock, Günter 66 Yzer, Cornelia 57, 88 Mucic, Luka 86 Sturchio, Je¬rey 79 Fukushima Medical University Koch-Metschnikow-Forum e.V. Müller-Jung, Joachim 82 Q Südhof, Thomas 86 Z Murakami, Akira 98 Qosaj, Fatime Arenliu 42 Suter, Peter 108 Zaim, Lana 61 160 SUPPORTING INSTITUTIONS SUMMIT PARTNERS 161

POLICY MAKERS

L T Partner & Co-Host: Leopoldina–German National Academy of Science The Boston Consulting Group (BCG) London School of Hygiene & Tropical Medicine The Global Fund The Graduate Institute Geneva M The Graduate Institute of International M8 Alliance and Development Studies

Monash University The Rockefeller Foundation 1965 - 2015 50 שנה ליחסי הדיפלומטיי (Munich Security Conference Foundation gGmbH (MSC ישראל- גרמניה 50 Jahre U Diplomatische Beziehungen Deutschland-Israel N UNAIDS National University Health System Singapore (NUHS) United Nations (UN) National University of Singapore (NUS) Universities Allied for Essential Medicines (UAEM) University of Geneva (UGE) O ACADEMIA Oxfam Deutschland e.V. V VAMED P Pennsylvania State University W Pulitzer Center on Crisis Reporting World Federation of Academic Institutions for Global Health (WFAIGH) R World Health Organzation (WHO) Rabin Martin World Health Organization Regional Oce for Europe Robert Koch Institute (RKI) World Wide Fund for Nature (WWF Germany)

S Y Sanoﬁ Young Leaders for Health (YLH) e . V. StemBancc Stiftung Preussischer Kulturbesitz (SPK) 162 SUMMIT PARTNERS SUMMIT PARTNERS 163

PRIVATE SECTOR CIVIL SOCIETY

Strategic Partner Major Partner General Partners

MEDIA PARTNERS Supporting Partners

In Zusammenarbeit mit:

Polish Healthcare Journal

Ogólnopolski System Ochrony Zdrowia

ASSOCIATES Service Aides

Concept Partner: Printing Partner: Mobility Partner:

Foundations 164 NOTES NOTES 165 S AVE THE DATES!

WHS REGIONAL MEETING Photo Credits Federal Foreign Oce, Page 2 © photothek/Auswärtiges Amt Brandenburger Tor, Page 19 © Noppasin/Shutterstock.com Bärbel-Maria Kurth, Page 21, © Robert Koch Institute/Dugnus GENEVA, SWITZERLAND Timo Ulrichs, Pages 21, 95, 155 © akkon monbijou Fernsehturm, Page 28 © turtix/Shutterstock.com Allianz Forum, Page 34 © Allianz Forum A P RIL 19–21, 2016 Weltzeituhr, Page 36 © pio3/Shutterstock.com Hermann Gröhe, Pages 61, 138, 147 © Bundesregierung–Ste¬en Kugler Berlin by Night, Page 62 © Mapics/Shutterstock.com Otmar Wiestler, Pages 87, 143, 156 © DKFZ Gendarmenmarkt, Page 90 © badahos/Shutterstock.com Wim Leereveld, Pages 93, 140, 150 © Patricia Wolf WORLD HEALTH SUMMIT Hans-Joachim Schellnhuber, Pages 115, 142, 154 © Frédéric Batier East-Side-Gallery, Page 118 © Jana Schoenknecht/Shutterstock.com Charité, Page 124 © Charité–Universitätsmedizin Berlin Molecule Man, Page 125 © visitBerlin, Foto: Karin Willms BERLIN, GERMANY Federal Foreign Oce, Page 126, 129 © photothek/Auswärtiges Amt

Layout Eta Friedrich, Berlin OT COBER 09–11, 2016

Printer Laserline, Berlin

www.worldhealthsummit.org Summit Organizer / Academic Office

WHS Foundation GmbH World Health Summit c/o Charité – Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany

Tel.: +49 30 450 572102 Fax: +49 30 450 572911

[email protected]